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Abstract 
The fabrication and employment of nano-size vehicles for the effective delivery of 
drugs for therapeutic applications is an emerging and promising field in nanotechnology. 
Although a diverse range of drug delivery vehicles exist today, most lack the finer control 
over their size and monodispersity which is essential if they are to be introduced into the 
body. This thesis exploits template particles for the fabrication of polymeric nanocapsules 
with structurally unique characteristics. To achieve this, silica nanoparticles acting as 
templates were first investigated, where the effects of the experimental parameters on the size 
and monodispersity of the templates was explored and optimized using both single and 
multivariable experiments, so that the particles could be tailored to their required application. 
Following template fabrication, a comparison study of two template-facilitated approaches to 
nanocapsule synthesis were investigated, and the combination of the solid core/mesoporous 
shell (SC/MS) approach along with the polymer material chitosan was found to be the most 
effective drug delivery systems (DDS). Through modification of the same SC/MS approach, 
seven structurally unique chitosan nanocapsules were fabricated, and the size of the vehicle 
was identified to be the most influential characteristic when comparing the cytotoxic 
efficiency. The body of this work identifies a promising nanocapsular drug delivery system 
for the future, which has demonstrated good control over the size and monodispersity of the 
nanocapsules, a high loading capacity for the water-labile drug curcumin, biocompatibility, 
and high cytotoxic efficiency when the drug is incorporated.  
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CHAPTER 1 
INTRODUCTION 
 
 
 
This chapter provides an overview to the thesis by introducing the field of nanotechnology, 
current advances in the field of biotechnology, and the way that these two fields are merging 
together to produce advanced and innovative materials for applications in drug delivery. The 
chapter also focuses on the approaches currently employed to synthesise a variety of 
nanoparticles and nanocapsules to act as drug delivery vehicles. Finally, a chapter-wise 
summary of this thesis has also been provided. 
 
 
  
3 
 
1.1 An Introduction to Nanotechnology 
If you have ever become tangled in a spider web and been amazed at how something 
so small and seemingly so fragile has such strength and flexibility, then you wouldn’t be 
alone. You may not know it at the time but this is due to the phenomena of nanotechnology. 
When particles (or materials that are made of particles) consist of only a small number of 
atoms or molecules, the material no longer acts as it would in comparison to its bulk form. 
Instead, quantum forces begin to dominate and the material can take on surprising new 
properties. 
 
Figure 1: A scale to represent the nano-sized devices compared to other materials. Courtesy of 
Technologies and Tendencies in Cyberspace.
1
 
Nanotechnology is not any particular scientific discipline, nor is it really a field as 
much a way of thinking about the world around us. The simplest definition of nanotechnology 
is ‘technology at the nanoscale’,2 and encompasses the manipulation of matter on the atomic 
or molecular level, as well as the technologies and technical processes it employs. The prefix 
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‘nano’ originated from the Greek word ‘nannos’, meaning ‘dwarf’, which represents one-
billionth (10
-9
) of a base unit. For example, one nanometer is equivalent to 1 x 10
-9
 meters 
(0.000 000 001 meters). Nanotechnology essentially studies the phenomena that occur in a 
system when it contains nano-sized features, or features that are typically less than 100 nm in 
at least one dimension.  
Amazingly, the application of ‘nano’ effects has been traced to glass dating from the 
4th century. The famous Roman Lycurgus cup made of a diachronic glass appears green in 
daylight (when light is reflected off the outer surface), and appears red when lit from within 
(light transmitted through the vessel). The brilliant optical effects are due to inclusions of 
minute gold and silver dust particles which undergo surface plasmon resonance.
3-5
 
 
Figure 2: The Lycurgus cup demonstrating different optical effects depending on whether the light 
is reflected off the glass surface (A) or transmitted through the glass (B). Image adapted from 
http://www.guardian.co.uk/nanotechnology-world/nanotechnology-is-ancient-history  
Mother Nature has also devised nano-sized structures that, due to millions of years of 
evolution, are so elegant and precise in architecture that engineers today are still unable to 
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replicate. Nature has successfully developed an impressive and ingenious variety of nano-
sized structures including nanocavities in butterflies,
6,7
 nanofibers in spider webs,
8
 inorganic 
nanocrystals fabricated by bacteria,
9
 and nanorods for superhydrophobic surfaces in lotus 
leaves.
10
 
One of the main ambitions in science is to emulate these intricate and elegant 
nanostructures already prevalent in nature. Richard Feynman was the first to shed light on the 
concept in 1959 during his speech “There’s plenty of room at the bottom”, where he spoke of 
the possibility of using precise tools to manipulate individual atoms and molecules. Now there 
seems to be a ‘nanotechnology mania’ sweeping through the scientific and commercial world, 
with the National Institute of Health stating in a report in 2000 that ‘Every once in a while, a 
new science and technology emerges that enables the development of a new generation of 
scientific and technological approaches. Nanotechnology holds such promise’.11 
One peculiar advantage of nano-sized materials is that their chemical, optical, 
magnetic and electronic properties can be drastically altered by slight modifications in their 
physical structure.
12-14
 This is because the physical or chemical laws on which macroscopic 
materials rely do not always translate to the nano world, and as such nanoscaled systems with 
a scale length in the order of the electron de Broglie wavelength have to be considered to 
behave within quantum mechanical limits. As one approaches the range of the nano world, the 
mass of objects becomes increasingly negligent, therefore gravitational forces become less 
influential while electrostatic attractions and van der Waals forces become increasingly 
important.
2,15
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The factors that can strongly affect these properties include the material size,
16-21
 
shape,
22-24
 surface composition,
25-28
 interparticle interactions,
29-33
 and dielectric conditions in 
which they are held.
34-36
 Such significant variations in the properties of nanomaterials are due 
to their dimensions being comparable to that of the de Broglie wavelength.
37,38
 In addition, 
their small dimensions allow for fast frequency motion, as well as amplified pressure values 
due to the small surface areas involved.
2,39
 
The most commonly used method for developing structures on the submicrometer 
scale are the ‘top-down’ approaches which involve the miniaturization of larger, basic units to 
smaller units. For example, lithographic techniques project a condensed and shrunken 
replication of a much larger template from which nanoscaled elements are etched. This 
approach can be considered to be the way that scientists initially learned to fabricate materials 
and, after time, engineered the structures at submicron levels. However, on approaching sizes 
below 100 nm, the resolution and replication speed is severely limited by the available 
technology. As a result the ‘bottom-up’ approach becomes more important when reaching 
sub-micron size regions. 
The ‘bottom-up’ method involves the fabrication of individual units to form a larger 
subsystem. The synthesised nano-sized articles are formed from atomic or molecular 
compounds using highly controlled conditions and can be tailored to follow specific growth 
energetics and kinetics. This approach obtains better defined microscopic growth of 
nanostructures without the need for subsequent manipulation.
39
 Within bottom-up methods, 
two different approaches exist. The first is through understanding and attempting to imitate 
the complex systems already manifested by Nature, which is capable of feats far beyond what 
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is currently possible in the laboratory. The second approach is through non-biological 
molecular mechanisms where a controlled reaction occurs at either a surface or in a liquid, 
producing complex structures that are influenced at the atomic scale.
40
 Using the second 
approach, new and unique nanostructures can be developed for innovative applications. 
1.2 Nanotechnology for Cancer Therapy 
One of the most intensively studied areas in nanotechnology is in the engineering of 
nanoparticles for biomedical applications, with nanoparticles for cancer therapies and 
diagnostics being one of the fastest expanding fields.
41
 Nowadays these engineered particles 
are multifunctional with abilities to not only encapsulate and release anticancer drugs in a 
highly controllable way, but also specifically target cancerous tissue for drug release while 
enhancing contrast for diagnostic purposes.
42
  
Cancer is a major public health issue that at some point will directly or indirectly 
affect every person in their lifetime. One in two Australians are diagnosed with cancer by the 
age of 85, and out of those cancer patients more than 30% do not survive five years after 
diagnosis.
43
 Furthermore, cancer treatment in Australia costs the government approximately 
$3.8 billion annually. However, according to Cancer Council Australia the survival rate for 
many common cancers has increased by 30 % due to recent advancements in cancer research 
and newly available treatments.
43
 
Cancer is a general term used to characterise any disease that arises due to the 
uncontrolled proliferation of abnormal cells.
45
 As these cancerous cells can be generated from 
almost any type of tissue cell in the body, the collective term ‘cancer’ can refer to more than 
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200 different diseases.
46
 This also makes it extremely difficult in treating cancerous 
malignancies as they can vary significantly. Effective treatments that are currently employed 
include surgery, radiotherapy, chemotherapy, hormone therapy and immunotherapy.
47
  
 
Figure 1.3: A representation of the number of cancers most commonly diagnosed in Australia 
(2007), courtesy of the Australian Institute of Health and Welfare.
44
 
Unfortunately there are several drawbacks with all these conventional cancer 
therapies. The surgical option is often a very effective method in removal of a cancerous 
tumour. However, this method is not always viable due to the location of the tumour, or if it is 
viable it can be very invasive. In addition, surgery often fails in removing 100% of affected 
cells that can potentially spread and grow into secondary tumours.
48
 In contrast, the majority 
of non-surgical therapies (radio-, chemo-, and immuno-therapy) cannot appreciably 
differentiate between normal and tumour cells and consequently, although these therapies are 
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very effective at killing cancer cells, they may also be very toxic to normal cells in the 
process, causing severe systemic toxicity and adverse side effects.
48
  
There have been several approaches to improve the effectiveness and selectivity of 
anticancer drugs. One approach has been to develop new and innovative drugs that interfere 
with specific pathways only active in cancerous cells.
49,50
 Another method is the development 
of systems that deliver currently employed anticancer drugs more effectively and selectively 
by means of drug carrier vehicles,
47,51
 where the aim is to ensure acute toxicity to the target 
cells, while the normal cells remain unaffected. This latter approach is known as a drug 
delivery system or DDS.   
1.3 Controlled Drug Delivery Systems 
A drug delivery system (DDS) is a catch-all term used to describe the encapsulation or 
attachment of drugs to optimised carriers, which modify its pharmacokinetics, its localization 
in the body, and its uptake into different cells and tissues.
52
 The development of controllable 
drug delivery systems has recently received increased focus in an effort to overcome the 
drawbacks that continue to plague current cancer therapies. Over the past few decades, a 
variety of multifunctional and/or biocompatible drug delivery systems with increased drug 
encapsulation, release kinetics and targeting abilities have been fabricated.  
Nano-sized drug delivery systems have received the greatest attention due to the 
advantages of their sub-cellular size and high surface area to volume ratio.
53,54
 In addition, 
depending on the components of the vehicle, these nano-systems have shown increased drug 
specificity, efficacy, tolerability and therapeutic index.
55-61
 The concept of using nano-sized 
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carriers for the delivery of drugs was first employed by Speiser and Kopf in the 1970s,
62
 with 
the field rapidly expanding since to include a wide variety of organic, inorganic and hybrid 
drug delivery vehicles, including but not limited to micelles,
63,64
 liposomes,
65,66
 solid lipid 
nanoparticles,
67,68
 polymeric nanoparticles,
51,53,69
 polymerosomes,
70,71
 capsosomes,
72,73
 carbon 
nantotubes,
74,75
 and gold nanoparticles.
76-79
 
Specifically, a variety of silica-based particles have become more abundant in DDSs 
due to the materials inert nature, low toxicity, low susceptibility to microbial attack, and its 
demonstrated ability to be easily fabricated and conjugated to a range of biocompatible 
components.
80,81
 Such drug-loadable silica-based particles include hollow silica 
nanocapsules,
82
 polymer-coated silica nanoparticles,
83
  mesoporous silica nanoparticles,
80,81
 
and multifunctional magnetic and fluorescent silica nanoparticles.
84-86
  
1.4 Silica 
Silicon dioxide, also known as silica, is composed of oxygen and silicon and is one of 
the main components of the Earth’s crust. It is most commonly found in nature as sand or 
quartz, and is often manufactured in the forms of fused quartz, crystal, fused silica, silica gel, 
aerogel, and colloidal silica.
87
 Without it many of our modern day technologies would be very 
different, with silica used in modern day glass and ceramics, as catalysts in oil refineries, 
microelectronics and fibre optics,
87
 and is more recently finding a broad range of potential 
applications in the world of nanobiotechnology.
88
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Figure 1.4: Space-filled representation of the tetrahedral coordination of oxygen ions with silicon, 
figure appropriated from Breck
89
 
Although the building block of silica is consisted of a silicon atom surrounded by four 
oxygen atoms (Figure 1.4), the chemical formula of silica is SiO2 as the oxygen atoms are 
shared through either a crystalline or amorphous network. The differences in the way that the 
tetrahedral [SiO4]
-4
 units are linked together is described by polymorphism. Quartz has the 
densest structure as all four oxygen atoms are shared to create a three-dimensional network 
(Figure 1.5A) and is an example of a highly ordered crystalline silica form. Contrastingly, in 
amorphous silica the packing of [SiO4]
-4
 units is random, resulting in a non-periodic structure 
where the subunits come together by either sharing two oxygen atoms with adjacent groups to 
form a chain, or three oxygen atoms are shared to form a sheet-like structure (Figure 1.5B).  
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Figure 1.5: Two-dimensional schematic representation for crystalline (A) and amorphous (B) 
packing of SiO4 subunits. (C) Two-dimensional schematic representation of a fully hydroxylated 
colloidal silica particle. Courtesy of Pauling and Bergna.
87,90
 
1.5 Colloidal Silica 
As areas in science and technology grow, so does the demand for uniform and 
monodispersed particles. Colloidal silica is of special interest as the system is dominated by 
short-range forces such as van der Waals and surface forces.
91
 The term colloidal typically 
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refers to particles dispersed in a solvent that have the dimensions of 1-1000 nm in at least one 
direction. The most important characteristic of colloidal particles is that they are larger than 
the molecules of the surrounding solvent, allowing them to diffuse via thermal motion. During 
this diffusive movement the particles undergo fluctuations in their motions due to random 
collisions with the solvent molecules, this is usually referred to as “Brownian motion”.92,93 As 
a result the colloidal particles exhibit similar phase behaviour to that of molecules and atoms, 
however the main advantages of colloidal particles is that their diffusion is orders of 
magnitude slower than atoms, making them easier to observe and study. Colloidal materials 
can be referred to as ‘soft’ as they respond to small external forces,94 and they can be studied 
using light scattering and optical techniques since their size is comparable to the wavelength 
of visible light. Furthermore, the structural characteristics of colloidal particles such as sizes, 
shapes and chemical properties have been shown to be readily tunable during synthesis.
34,87,95
 
Colloidal silica synthesis is expanding with increasing demand for industrial uses such 
as pigments,
96
 stabilizers,
97
 catalysis,
98
 chemical mechanical polishing,
99
 and in numerous 
scientific fields.
66,93
 There has been extensive investigation into broadening the size of 
particles, improving uniformity and monodispersity, and simplifying the synthesis processes. 
Colloidal silica has been fabricated via a variety of methods and from a variety of raw 
materials such as silicon,
100
 silicon tetrachloride,
101
 water glass,
102
 silica powder,
103
 and 
alkoxysilanes.
104,105
 However, while the many possibilities for colloidal synthesis are 
acknowledged, this thesis focuses only on the synthesis of colloidal silica from alkoxysilanes. 
In 1956, Kolbe was the first to report on the synthesis of solid, non-porous, 
monodispersed silica particles through the hydrolysis and subsequent condensation of silicon 
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alkoxides in a short-chain alcohol solvent.
104
 Later in 1968, Werner Stöber expanded Kolbe’s 
work further in a pioneering study where he investigated the reaction conditions and their 
effects on particle size, and in doing so, was able to synthesize highly homogenous and 
monodispersed particles in the sub-micron range.
105
 To this day the study is regarded as 
providing the simplest and most robust method for producing colloidal silica.  
The experimental procedure for the Stöber method is relatively straight forward, 
however, the mechanisms responsible for the nucleation and growth of the particles are not. 
The synthesis involves the ammonia-catalysed reaction between tetraethylorthosilicate 
(TEOS) and water in a low-molecular weight alcohol solvent. There have been numerous 
research groups investigating the complex mechanisms of nucleation and the influence of the 
reaction conditions on the particle size.
106-114
  
In brief, the overall conversion of TEOS into SiO2 can be described as; 
                          Eq. 1.1 
where R represents the alkoxy group of a low molecular weight alcohol. 
Controlling the size and monodispersity of solid silica particles is of the upmost 
importance due to the high demand for such particles, where the size can dictate their future 
applications. Furthermore, the ability to predict particle size based on the experimental 
parameters is even more sought after as a specific size may be required for a desired 
application.  
Many trends of the effects of the experimental parameters on the sizes of the particles 
have been proposed. These parameters include the reaction solvent,
105,113-115
 TEOS 
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concentration,
113-116
 ammonia,
105,110,113-115
 water quantity,
110,113-115
 and reaction 
temperature.
113,115
  Many of these studies are in agreement that a general trend of smaller 
particle formation is observed when a lower molecular weight solvent is used, when there is a 
decrease in TEOS concentration and when the reaction temperature is increased. Whereas the 
effect of ammonia and water content are not as predictable and have not always been 
consistent in the literature.
114,115
 However, these investigations required single variable 
changes and therefore numerous experiments were necessary and laborious, furthermore, 
when multiple variables are changed it is extremely difficult to predict the final particle size 
due to the complex changes occurring in the experimental solution, such as interparticle 
forces, viscosity, zeta potential and pH.
117
 One method to overcome this is by employing 
computing models which can simulate multiple effects of the parameter during a reaction. 
These models can generate more comprehensive conclusions about the system, while also 
reducing the number of experimental investigations required to be performed.  
1.6 Artificial Neural Networks (ANN) 
Through millions of years of evolution, the human brain has been developed into an 
“organic computer” capable of performing complex tasks simultaneously and many times 
throughout a day. Without a brain we would not be able to recognise the people around us, 
drive a car, write an essay, or even perform the simplest of actions. Our brains are a 
component of a very complex and elegant nervous system, yet when broken down it consists 
of relatively simple units called neurons. Neurons are small single cell structures that enable 
the transmission of electrical signals around the body, enabling it to function. The brain gains 
it’s abilities through the massively interconnected network of these neurons, with 
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approximately 15-30 billion neurons in the human brain that is each connected to several 
thousand other neurons through synapse pathways. The massively interconnected system 
allows for complex tasks/pathways to be processed by analysing the information received 
through the senses, and combining this with information available about the needs of the 
organism, along with previous memories of success or failure.  
Inspired by the learning capabilities of the human brain and their structures, 
mathematical functions were developed to mimic and act as “artificial neurons”. An Artificial 
Neural Network (ANN) is an interconnected framework of these ‘artificial neurons’, or nodes, 
which can be seen as computational units that receive and process inputs, and in doing so 
produce outputs to create a computational pathways capable of solving complex and extensive 
problems that linear computing cannot.
118
  Similar to human brains, ANNs are typically 
adaptive systems that can “learn” and change the way the neurons are connected, which in 
turn can change the way inputs are processed. 
ANNs consist of multiple layers of artificial neurons, including the input neurons, a 
specified number of processing neurons, and the output neurons (Figure 1.6). Since the input 
and output layers are the most important to the user, the middle neurons are typically referred 
to as the hidden layer despite performing the most important tasks. Depending on the 
complexity of the task, the hidden layer can consist anywhere from 1 to any number of 
“neurons”.   
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Figure 1.6: A simplified model of the layer of neurons in an artificial neuron network.  
As the neurons are interconnected and receive signals from multiple sources, they can 
judge each input based on applied mathematic functions and decide which signals are more 
important and require more ‘weight’ during processing before the output is transmitted to the 
next node. This continues until the final outputs have been produced, however the first 
attempts by the nodes to process information is often not accurate. To increase accuracy the 
ANNs must learn through a technique called back propagation. This is done by comparing the 
desired (or expected) outputs with the outputs received, and adjusting the “weights” of the 
neurons back though the layers in an effort to reduce erroneous values. Back propagation is 
typically repeated many times until the outputs resemble the desired outcomes very closely. 
The closeness to the desire value is referred to as its precision and denoted as a fraction of 
one. However, as ANN only process algorithms and identify patterns in systems, they must 
first be adapted to an experimental situation in some way.  
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In scientific studies, experiments are often carried out in a full factorial manner, where 
one variable is changed at a time while all other variables are kept constant. In very complex 
or large studies where there can be any combination of the parameter values which can be 
virtually plotted out in a 3 dimensional matrix. For example, if there are three parameters that 
require investigation, their combinations can be visualised within a 3-dimentianal cube, or a 
matrix, where the axis x, y, and z represent the parameters. This can create an overwhelming 
number of sample points, and if one wants to try and test each sample point, they could be 
there for a very, very, very long time. Therefore statistical experimental designs are often 
implemented.  
Experimental designs involve fitting sample points in an even distribution over the 
matrix of variables in a system, and identifying the experiments required to extract the most 
information out of the smallest number of experiments. In contrast to full factorial experiment 
designs, Box-Behnken,
119
 and Doehlert,
120
 are multivariable experiment designs, and they 
involve two or more variables changing between each experiment. These multivariable 
techniques offer the advantage of further reducing the number of experiments required, and 
also generate more information on the interactive effects among the variables. 
As the experiment design only defines the experiments which are required, it is the 
ANN which correlates the variables to the results to generate information which can be 
interpreted. The ANNs then correlates the multiple experimental values to the results in a 
virtual 3 dimensional map using specified algorithms. The computer model then recognises 
patterns in the 3D projection (something that is a little too complex for the human mind), and 
creates a continuous map that precisely forecasts the position of results with regards to the 
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parameters. In some cases, ANNs have been applied to systems where the size of a fabricated 
particle is affected by certain experimental conditions.
121-123
 Using this combination of 
experimental design and ANNs, investigations into the dynamic effects of a system can be 
observed, and particles sizes based on those conditions can be predicted. Due to the 
complexity of ANNs, only a brief introduction has been included in this section, however for 
more information please refer to the ANN review by Basheer et al,
124
 or the short video 
available at youtube.
125
  
1.7 Core-Shell Silica 
The design and controlled fabrication of core-shell colloidal materials has also been 
explored, wherein core-shell colloids demonstrate unique optical, structural and surface 
properties that are dictated as a function of their size, composition and structural order.
94
 A 
core-shell particle is defined as having an internal material composed of a different substance, 
or having different properties to, an outer (encapsulating) material to form a dual component 
system. The synthesis of core-shell particles with defined morphologies and properties can be 
described as particle engineering.
126,127
 Composite colloids have been used in coatings, 
electronics, catalysis, separations and diagnostics.
80,87,88,95,128
  The addition of an outer shell 
onto a particle is typically performed to enable tailoring of the surface properties without 
losing the initial properties of the encapsulated particle. Often the shell is achieved by coating 
or encapsulating the core particle with a preferred material in an attempt to alter the charge, 
functionality, and reactivity, and/or enhance the stability and dispersion of the particles (See 
Figure 1.7).
127
 Consequently, core-shell particles often exhibit improved chemical and 
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physical properties in comparison to their single-component counterparts, and offering 
potential in a broader range of applications.
127
  
 
Figure 1.7: A simplified representation of Core/Shell particles and the potential properties of the 
components.  
In the literature there has been a plethora of core-shell particles reported in which 
silica acts as the shell or coating.
129-132
 This is usually to increase stability, biocompatibility, 
functionalisation capabilities and enhance optical properties. However, there have been 
relatively fewer core-shell particles where colloidal silica is utilised as the core, surrounded by 
a secondary material. Such silica core-shell particles that have so far been fabricated include 
shells of various polymers for enhanced biocompatibility and stealth characteristics,
104,105
 and 
enhanced optical, electric, magnetic, catalytic and absorbent properties.
101,133
  
An additional type of core-shell particle that is possible is a solid silica core 
surrounded by a mesoporous silica shell, or an SC/MS. This was developed in 1998 by Büchel 
et al, who adapted the Stöber method to synthesise a solid silica core (SC), but added a 
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subsequent step where a mesoporous silica shell (MS) is grown onto the solid core. The 
mesoporous shell step follows similar Stöber mechanisms where TEOS is hydrolysed onto the 
silica surface; however there is an addition of the porogen substance octyltrimethoxysilane in 
the secondary silica mixture which is later removed by calcination to create pores in the outer 
silica shell, resulting in the formation of solid silica cores with outer mesoporous silica 
shells.
134
  The SC/MS particles have received a great deal of interest in more recent years as 
promising candidates for multimodal nanoparticle systems,
84,129-131,135,136
 especially in 
biological applications due to their relatively simple fabrication, controllable structural 
properties, and their ability to be easily functionalised.
87,98,105,116,137,138
  
Despite the high potential of silica nanoparticles, whether they are only solid cores, 
fully mesoporous or solid core/mesoporous shell silica nanoparticles, concerns have been 
expressed about the possible hazards of utilising inorganic nanoparticles in biological 
systems, and the toxic affects they could potentially incur.
98,99,133,139
   The fear arises due to a 
lack of understanding of the interactions that can occur between the silica nanoparticles and 
cells and cellular membranes.
140,141
 As well as the discrepancies between the toxic effects 
studied in vitro and in vivo,
142,143
 the mechanisms of toxicity are not fully understood.
144
  
One solution proposed to overcome this problem has been to coat the various silica 
nanoparticles in polymeric shells.
100-102
 The polymer shells can provide colloidal stability and 
increase blood circulation time,
145
 but as the silica particle is still introduced to the body it 
will remain a potential hazard until it is excreted. A safer approach is to utilize the highly 
controllable and monodispersed silica nanoparticles as templates, whereby a polymeric outer 
shell is grown, deposited or infused, followed by subsequent removal of the silica core matrix 
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through an etching process. Using this approach all the superior structural characteristics such 
as homogeneous size, mesoporous shell, and controllability of the silica particle can be 
retained, while negating the introduction of potentially hazardous silica particles into the body 
or tissue. This approach results in highly homogeneous polymer-based nanocapsules, which 
depending on the polymer used, can also be biocompatible and biodegradable in nature. 
1.8 Polymeric Nanocapsules for Drug Delivery 
Nanocapsules are defined as spherical structures with an ultrathin shell enclosing a 
solvent-filled interior,
146
 and have been the subject of significant investigation in recent years 
to act as carriers for the controlled release and delivery of pharmaceutical drugs.
69,147-156
 They 
are often described as a ‘reservoir’ system as the drug is confined to an aqueous or oily 
cavity.
157,158
 When the nanocapsular system is well designed, this delivery vehicle is able to 
protect the drug from decomposition during transport throughout the body before it is released 
at the target site. Nanocapsules offer a greater advantage over solid nanospheres in reference 
to delivery applications as they have a potentially larger capacity to carry drug molecules not 
only on the capsule surface, but also in the hollow interior.  
More specifically, polymeric nanocapsules have been extensively studied as drug 
carriers given the polymeric material can be selected based on their potential application. 
Polymers are large macromolecules made up of repeating structural subunits which are 
typically linked together by covalent bonds to form long, linear chains.
159
 The choice of 
polymeric material is of great importance as this material comes into direct contact with the 
body, and depending on the desired mode of delivery, the polymeric carrier may either be 
identified or not identified by the immune system. The biocompatibility, biodegradability, low 
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immunotoxicity, and longevity in the circulatory systems are all properties which can dictate 
the polymer selected for a particular treatment.
149,151,160-163
  
Biodegradable polymers are highly advantageous in DDS because of their ability to be 
processed by the body, thereby not accumulating and negating the need to be surgically 
removed. Biopolymers are a special class of biocompatible and biodegradable polymers 
which are produced by living organisms. One such biopolymer which has been extensively 
used in DDSs is chitosan due to its low immunogenicity, high biocompatibility, and it being 
readily available and cheap.
164-168
 Although biopolymers are usually cheap, they can also vary 
greatly in purity and often require cross-linking which can alter their properties. Therefore, 
synthetic versions are often used. The most utilized synthetic, biodegradable polymers include 
poly(lactic acid), poly(glycolic acid),  and poly(lactic acid)-poly(glycolic acid) copolymers.
169
 
However, these polymers are considerably expensive, may not have a long shelf life, and tend 
to be sensitive to experimental conditions, making them not always feasible.  
Synthetic, non-biocompatible polyelectrolytes are another alternative as they tend to 
be much cheaper and more robust. Furthermore, if a biocompatible material is essential for in 
vivo or in vitro research, the preliminary investigations can be carried out using a much 
cheaper polymer, and later the biocompatible (and more expensive) polymer can be 
substituted. One such synthetic polymer is poly(allylamine) hydrochloride (PAH), which is 
cationic in nature due to the presence of an amine group. Another common synthetic polymer 
is poly(sodium 4-styrene sulfonate) (PSS), but unlike PAH, PSS is anionic in nature due to the 
presence of the sulfonate group.  Although both synthetic polymers are relatively cheap, 
readily available, and their properties have been heavily studied,
170-173
 they do not tend to be 
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as biocompatible as the biopolymers. Therefore any prospective polymers must be thoroughly 
investigated, their properties weight up, and chosen based on their suitability to the potential 
application.  
Polymer-based nanocapsules are usually prepared via one of six classical methods; 
nano-precipitation, emulsion-diffusion, double emulsification, emulsion-coacervation, 
polymer-coating and layer-by-layer (LbL) assembly methods.
69
 Many of these methods have 
shown to be very successful at producing hollow nanocapsules. However, the self-assembly 
methods of synthesis that do not utilize a particle template (nano-precipitation, emulsion-
diffusion, double emulsification, and emulsion-coacervation) often produce particles with 
broad size distribution, some of which are in the nano-to-micrometer range. In addition, the 
experimental conditions in some of these methods are relatively harsh, making them 
unsuitable for certain materials that are desired for encapsulation.  Moreover, the biggest 
drawbacks in the template-free processes is the lack of control over the capsule’s structural 
characteristics with the occurrence of large distributions in the capsule size, wall thickness 
and uniformity.
174
 These variations can have significant impacts on the consistency of their 
drug loading and release profiles, rendering them unsuitable for many clinical uses.  
To overcome these obstacles, sacrificial template particles, typically silica, of 
controllable size and structural features can be employed.
105,175-178 
The most common 
templating method that has been used in the past to fabricate polymeric nanocapsules is the 
LbL approach.
72,120,135,139-142
 The LbL approach typically involves the sequential layering of 
oppositely charge polymers onto a template surface, building up enough polymeric material to 
form a capsule after template is removed. Another template method is the lesser known 
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SC/MS approach.
156
 This approach involves the infiltration of polymers into tiny mesopores 
scattered throughout the outer shell of a silica template particle, followed by polymer cross-
linking.  
The employment of silica template particles to fabricate polymeric nanocapsules 
allows for improved monodispersity, homogeneity, and capsule integrity. Furthermore, due to 
the commercial availability and well-established methods to synthesize colloidal silica 
template particles of near-monodispersed size distribution in a wide size 
range,
105,107,110,134,138,179
 capsules fabricated using the LbL and SC/MS templating methods can 
achieve an equally broad size range.   
Despite the obvious advantages of using templating methods for nanocapsule 
fabrication, it is unclear which method demonstrates the greatest potential as a drug delivery 
platform.  Furthermore, the polymeric material employed in fabrication is of great 
significance and needs comprehensive investigation. A superior drug delivery system is 
developed through the combination of a range of complementary components.  
Through systematic investigation in this thesis, an attempt has been made to 
demonstrate that by employing artificial neural network (ANN) approaches, the fabrication of 
highly homogenous and controllable template particles was achieved. These particles were 
then exploited for the fabrication of different polymeric nanocapsules with enhanced and 
controllable characteristics, ideal for drug delivery applications. Such an approach contributes 
to the existing knowledge gap in the field of nanocapsule-based drug delivery systems.  
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1.9 Thesis Overview 
The work presented in this thesis describes the synthesis of smooth solid core (SSC) 
and solid core/mesoporous shell (SC/MS) silica template nanoparticles which can be used to 
fabricate a variety of nanocapsules of different polymeric material and with several different 
structural features. The effect of these physical features on the nanocapsules and their 
efficiency to act as drug delivery vehicles has been investigated.  
The chapters in this thesis can be broken down as follows: 
Chapter 2 introduces the different instrumental techniques that have been employed 
for the chacterisation of the materials that had been synthesised. The silica template particles 
and nanocapsules were investigated using scanning and transmission electron microscopy 
(SEM and TEM), energy-dispersive X-ray (EDX) spectroscopy, dynamic light scattering 
(DLS), BET surface analysis (BET), UV visible spectroscopy (UV-vis), confocal laser 
scanning microscopy (CLSM), and thermogravimetric analysis (TGA).  
Chapter 3 discusses the synthesis and characterisation of solid core silica 
nanoparticles fabricated based on the Stöber method, whereby tetraethylorthosilicate is 
hydrolysed in an ammonia-catalysed reaction, performed in a low molecular weight alcohol 
solvent. Through experimental processes, the effects of the solvent, ammonia and water 
content, and reaction temperature were investigated. Furthermore, these effects which had 
been found not to be exclusive from one another, were modelled using artificial neuron 
networks to help explain the complex interaction of these parameter, and to enable the 
accurate prediction of particle size in multivariable experiments.  
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Chapter 4 compares two dissimilar templating methods and three polymers to 
fabricate nanocapsules as drug delivery systems. The first templating method involves solid 
core/mesoporous shell template particles that are employed to fabricate single component 
chitosan and poly(allylamine hydrochloride) capsules by way of infusing the polymer into the 
pores within the template shell. The second method involved the sequential deposition of 
positively and negatively charged polymers onto a smooth silica templates to fabricate 
combined poly(allylamine hydrochloride) and poly(sodium 4-styrenesulfonate)  nanocapsules 
using a layer by layer approach. Through the comparison of the drug loading capabilities, the 
cellular uptake, and the cytotoxicity of the capsules, the chitosan capsules fabricated by the 
SC/MS method was identified to be the best candidate for further investigation as a drug 
delivery system.  
Chapter 5 carries on from chapter 4, and demonstrates that alterations in the structural 
features of the SC/MS template particles can be translated to develop structurally unique 
chitosan nanocapsules. Through modifications of the size of the solid silica core based on 
investigations carried out in chapter 3, and additional modifications to the mesoporous shell 
thickness and porosity of the SC/MS template particles, the size, capsules wall thickness and 
wall porosity of chitosan capsules fabricated using these templates can be controlled.  In total, 
seven structurally unique chitosan capsules were fabricated, their drug loading ability 
investigated, and in vitro cellular uptake and cytotoxicity studies were carried out. 
Chapter 6 provides a summary of the research undertaking and the results that were 
yielded in this PhD candidature. This chapter also provides a scope for future work that could 
be carried out in the area.   
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CHAPTER 2 
CHARACTERISATION TECHNIQUES 
 
 
 
This chapter examines the various characterisation techniques employed throughout this thesis  
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2.1 Introduction 
The main aim of this thesis is to develop multifunctional nanoparticle templates onto 
which various biodegradable and biocompatible polymer shells are grown. Followed by the 
subsequent removal of the silica matrix of the template, various polymer-based nanocapsules 
with a variety of structural properties have been produced. In order to determine the 
successful development of the components, testing has been carried out throughout the stages 
of synthesis, as well as additional investigations into the functionality of the drug delivery 
system developed. These techniques include Scanning Electron Microscopy (SEM), 
Transmission Electron Microscopy (TEM), Energy dispersive X-ray analysis (EDX), 
Dynamic Light Scattering (DLS), BET surface area analysis, UV-visible absorption 
spectroscopy (UV-vis), Confocal Laser Scanning Microscopy (CLSM), and 
Thermogravimetric analysis (TGA). This chapter is devoted to explain the basic fundamentals 
of the techniques used to characterise the materials of this PhD. 
2.2 Electron Microscopy (EM) 
Both the size and shape of nanoparticles used in drug delivery systems can have a 
profound effect on their biocompatibility and their ability to hold and release incorporated 
drug solutions. Although many features of the particles can be revealed by other techniques 
such as XRD, direct images of the particles and capsules are only possible by using scanning 
and transmission electron microscopes. The microscope images allow for qualitative and 
semi-quantitative analysis of particle morphologies (size and shape) and the aggregation 
states.
1
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Electron microscopes operate on a similar principle to light microscopes but due to 
limitations of the resolution of optical microscopes, development of alternative techniques 
was required. In contrast to optical microscopes, the light beam is replaced by an electron 
beam, and the optical lenses are replaced by magnetic lenses. The electron source is 
preferentially used due to a direct relationship between the wavelength of the beam and the 
resolution of the resulting image.
2
 A stream of electrons is generated from an electron gun 
when a potential is applied, which is then confined and focused using metal apertures and 
magnetic lenses. As the sample is irradiated by the sample beam, interactions occur, affecting 
the beam in a variety of ways, it is these interactions and effects that are detected and 
transcribed into an 2-dimensional image (see Figure 2.1).
3
   
Electrons can possess significant energy and are capable of removing the tightly bound 
inner shell electrons from the nucleus by transferring kinetic energy to them.
2
 Following the 
de Broglie concept, the wavelength of an electron decreases as the kinetic energy of the 
electron increases. The rapidly accelerated electrons have very short wavelengths and 
consequently, are capable of producing images with a resolution several magnitudes better 
than that of optical microscopes as determined by the formula: 
            
Where λ represents the wavelength and α corresponds to one-half the aperture.  As 
electrons have wavelengths 100,000 times shorter than that of visible light (where the 
wavelength of an electron is 1.54 Å), in principle it is possible to achieve resolution as low as 
a few Angstroms in electron microscopes.
4
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As the electron beam interacts with the sample, the electrons can undergo either elastic 
or inelastic scattering. In elastic scattering, only the trajectory changes while the kinetic 
energy and speed remain constant, conserving the energy of the electron. Conversely during 
inelastic scattering, some of the electrons from the beam source interact with the electrons in 
the sample, transferring energy to, and displacing the sample atom’s electrons from the shells 
of the nuclei, these interactions transform the atoms of the sample into an excited and unstable 
state. It is these inelastic interactions between the beam source and sample that enable 
electron microscopy to work.  
 
Figure 2.1: A representation of the signals generated when the electron beam interacts with a 
specimen. Courtesy of https://bsp.med.harvard.edu/node/221
5
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2.2.1 Scanning Electron Microscope (SEM) 
The SEM is able to provide extensive information about the surface of a material 
which can be very useful when determining the sample morphology. The microscope works 
by passing an electron beam over the sample surface and detecting the energy which is 
reflected or emitted by the sample. Emitted by either thermionic emission from a Cathode, or 
from a field emission gun (FEG), the electron beam strikes the sample surface where electrons 
interact with atoms in the top few layers of the specimen. Some of the electrons are reflected 
off the surface via elastic scattering, whereas some undergo interactions and inelastic 
scattering as per the above discussion.  
In SEM, the specimen is often sufficiently thick and prevents the electron beam from 
being transmitted through the sample. Therefore the energy from these electrons is re-emitted 
from the surface in other forms such as heat, visible light, x-ray emissions, backscattered 
electrons, diffracted backscattered electrons and low-energy secondary electrons.
3
 Although a 
number of these forms of energy can be used to understand the properties of the sample, the 
backscattered and secondary electrons are the most commonly detected signals used to 
construct pseudo 3-dimensional SEM images.  
Backscattered electrons consist of high energy electrons which have originated from 
the beam source but have been reflected or ‘back-scattered’ from the specimen surface. The 
production rate of these electrons is highly dependent on the atomic number and therefore can 
give indications of the density of a material, with denser materials appearing brighter (i.e. 
heavier elements produce more backscattered electrons).  
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In contrast, secondary electrons are emitted from the surface of the sample after the 
incident electron beam dislodges an electron. When an electron from the beam source excites 
an electron from the sample it transfers energy and allows the electron to move toward the 
surface as a secondary electron. However, as this secondary electron moves towards the 
surface it undergoes elastic and inelastic collisions along the way. If it still has sufficient 
energy it will be ejected from the surface and can be detected. Due to the high energy 
requirements of escape from the surface, only electrons in the first few layers are emitted (<10 
nm). Therefore any changes in the height of the sample will yield differences in the secondary 
electron intensity. This intensity profile provides the pseudo 3-dimensional detail of the 
surface,
3,6
 and when incorporated with the backscattered electron signal information, a highly 
resolved pseudo-3D image is created.  
SEM analysis of all samples was performed on a FEI NovaSEM, operating at an 
accelerating voltage of 15 kV, with a spot size of 3.5 nm and a working distance of 5 mm. All 
samples were drop cast directly onto an aluminium SEM stub.  
2.2.2 Transmission Electron Microscope (TEM) 
A transmission electron microscope differs from a scanning electron microscope in 
that the electron beam used to create an image is passed through an ultra-thin sample instead 
of being reflected or emitted from the sample surface. Therefore, in contrast to SEM, this 
technique results in a true 2D image and can be utilised to provide information about the 
structures/components within a sample. In a conventional TEM, a beam of accelerated 
electrons interacts with the specimen in one of two ways.
2
 The electrons transmitted through 
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the specimen undergo either elastic or inelastic scattering much like in SEM, where elastic 
scattering conserves all energy and in inelastic scattering a portion of energy is lost.  
The electrons that undergo elastic scattering constitute the majority electrons of the 
electrons that are collected, however, the inelastic scattered electrons that do not lose a 
significant amount of energy can also contribute to the image of an object. In a TEM contrast 
is achieved as a result of differences in the density of different areas of the specimen, as it is 
directly related to the beam interacting with different elements in the sample and causing 
different scattering potentials. This interaction can be described by the Rutherford formula: 
   
     
  
 
Where K is the deflection potential, e is the electron charge, Z is the positive nuclear 
charge and r is the distance between electron and nucleus. As the atomic number of an 
element increases, so too does the r distance. This in turn affects the deflection potential and 
changes the light intensity (contrast).  
All TEM analysis was performed on a Jeol 1010 TEM, operating at an accelerating 
voltage of 100 kV. All colloidal samples were prepared in solution and drop cast onto copper 
grids coated with 200 mesh strong carbon. For ultramicrotomed samples, cross sectional slices 
were placed on copper grids. The samples were imaged after all solvents had evaporated at 
room temperature.  
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2.3 Energy-Dispersion X-Ray (EDX) Analysis  
Energy-dispersive X-ray (EDX) spectroscopy is a relatively simple yet powerful 
technique that is used to identify the elemental composition of a material. Often used in 
conjunction with scanning electron microscopy, a sample surface is bombarded with an 
electron beam which forces electrons from the innermost orbitals of the sample atoms to be 
ejected. This causes a momentary electron hole within the sample atom and renders it unstable 
(as an atom in an excited state). This electron hole then induces an electron from a higher 
energy shell to relax, or “fall” down to fill the hole within the lower energy shell.  During the 
transition of the electron from a higher energy shell to a lower energy shell, the excess energy 
is released in the form of a photon, with an energy corresponding to the energy difference 
between the two orbitals, see Figure 2.2. As all elements have a unique electron configuration,  
 
Figure 2.2 Schematic representation of the ejection of a K-shell electron to create an electron hole 
into which an M- or L- shell electron later fills while emitting the corresponding x-ray in the 
process. Adapted from http://oxford-labs.com/x-ray-fluorescence/the-basic-process 
7
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they generate a unique X-ray spectrum, and therefore, can be identified. In addition, the X-ray 
spectra produced can be used to semi-quantitatively determine the ratios of elements within a 
composite. 
EDX analysis of the presented work was performed on a FEI Nova NanoSEM 
instrument coupled with an EDX Si(Li) X-ray detector. 
2.4 Dynamic Light Scattering (DLS) 
Dynamic light scattering, also known as photon correlation spectroscopy, is one of the 
most popular methods used to measure the size distribution profile of colloidal particles. The 
measurements are made by detecting the speed at which particles are diffusing through a fluid 
due to Brownian motion, and relating the motion to the particle size. Brownian motion occurs 
due to the collision of the particles with the solvent molecules which themselves are moving 
due to thermal energy.
8,9
 As photons interact with the randomly moving particles they are 
scattered in all directions, however, due to the motion of the particles the photon undergoes a 
Doppler shift, changing the wavelength of the incoming photon. This change is detected as a 
fluctuation of intensity over a time period of nano to milliseconds. The particle size is then 
determined by the amount of Brownian motion observed, where larger particles undergo 
slower Brownian motion than smaller particles. The velocity of the particle motion is defined 
by a property known as the translational diffusion coefficient. 
Using the translational diffusion coefficient, the size of the particles can be calculated 
from the Stokes-Einstein equation: 
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Where d(H) is the hydrodynamic diameter, k is Boltzmann’s constant, T the absolute 
temperature, η is the viscosity, and D is the translational diffusion coefficient.  
However, as there is often a concentration of ions, or any surface structures around the 
particles that can affect how the particles diffuse within a fluid, the diameter that is measured 
in DLS is known as the hydrodynamic diameter and can often be larger than that measured by 
electron microscopy.  
All measurements were carried out on an ALV 5022F Fast DLS particle sizing 
spectrometer, at 22 °C with a fixed angle of 90° on highly dilute aqueous solutions.  
2.5 BET Surface Area Analysis 
Surface area analysis was performed using the BET characterisation method first 
proposed by Stephen Brunauer, Paul Hugh Emmett and Edward Teller.
10
 Based on the 
Langmuir theory of monolayer molecular adsorption, the BET theory describes the changes in 
pressure during multi-layer adsorption of inert molecules onto a surface.  
 
       
   
 
   
 
   
   
 
  
 
And 
                
Where Vm is the monolayer adsorption amount, V is the adsorption amount at the 
equilibrium pressure P, and C is a constant
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The theory relies on three assumptions in order for the isotherms to be accurate. The 
analysis assumes that adsorption occurs by multilayer formation and that the number of 
adsorbed layers is infinite,
11
 there is no lateral interaction between layers, and that the 
Langmuir theory can be applied to each layer.  
All measurements were carried out on a Micromeritics ASAP 2000 surface analysis 
instrument utilising the Brunauer-Emmett-Teller (BET) technique. 
2.6 UV-Visible (UV-vis) Spectroscopy  
Spectrophotometry, or spectroscopy, is the study of interactions between 
electromagnetic radiation and matter.
12
 When electromagnetic radiation is passed through a 
solution of particles, the emerging radiation is always less intense than that entering. This is in 
part due to reflection or scattering of the beam, but is primarily due to absorption by the 
particles.  
When energy is absorbed in the UV or visible regions it results in a change in the 
electronic energy of the molecule, known as electronic transition. As the radiation energy is 
absorbed, electrons shift to a higher energy, exited state. The energy required for the transition 
from the ground state to the excited state is detected, with the depletion in the amount of 
radiation exiting/transmitted through the solution being inversely related to the amount 
absorbed at that particular wavelength. The energy absorbed in an electronic transition can be 
described as: 
      
  
 
      
51 
 
Where ΔE is the energy required to induce a molecule from a low energy/ground state 
to a higher energy/excited state. This is dependent on the frequency (v) and wavelength (λ), 
where (h = 6.626 x 10
-34
) is the Planck’s constant, (c) is the velocity of light and (   is the 
wavenumber. Therefore, the larger the energy required for electron excitation, the smaller the 
wavelength absorbed. 
The amount of energy required to drive the electrons into this excited energy state is of 
a unique wavelength for that particular molecule. As the source beam is absorbed, the 
depletion in the amount of radiation exiting the solution is detected and inversely corresponds 
to the amount absorbed at that particular wavelength. What is produced is an absorption 
spectrum which shows the change in degree of absorption as a function of the wavelength at 
which it was absorbed. The resulting spectrum is characteristic of the material and can 
therefore be used to identify it. 
The principle characteristics of an absorption spectrum are not only the positions of 
absorption features that correspond to the wavelengths at which electronic transitions are 
achieved, but also the intensity. The intensity at this point is largely dependent on both the 
difference between excited and ground states, and the probability of an interaction occurring. 
If the solution is highly concentrated the probability of absorption by the particles increases 
proportionally. This relation can be used to determine the concentration of the analyte, and is 
described in the Beer-Lambert Law: 
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Where (A) is the measured absorbance, (e) is the molecular absorptivity which is 
characteristic of the particular solute and solvent, (c) is the analyte concentration and (l) is the 
path length of the cell.  
UV-visible spectroscopy (UV-Vis) is often used in analytical chemistry to 
quantitatively identify analytes, such as conjugated organic compounds, bio-macromolecules, 
and transition metal ions. UV-vis can also be employed for the characterisation of colloidal 
particles.
13-15
 The optical absorption features of semi-conducting nanoparticles are highly 
dependent on their electron-hole pairs created by the excitation of the valence shell electrons 
to the conduction band. Any change in the nanoparticle size has a dramatic effect on the width 
of the electron bands and therefore on the energies required to shift electrons into excited 
states. As a result the nanoparticle size can be quantified based on its absorption spectrum. 
The dependence of the change in the band gap energy (∆E) in relation to the size of the 
semiconductor nanoparticle in terms of the radius (R) can be expressed as: 
      
    
 
 
 
  
 
 
  
 
 
  
 
     
 
 
 
 
 
Where me and mh represent the effective masses of electron and hole, respectively, and 
ε represents the (static) dielectric constant of the semiconducting material.16 
Absorption spectroscopy in the UV and visible regions is a highly effective tool in the 
analysis of chemical compounds. In the following thesis, UV-visible spectra were obtained on 
a Cary 50 Bio spectrometer, operating at a resolution of 1 nm over a wavelength range of 200-
800 nm, to determine the extent of loading of a curcumin-in-oil solution into various 
biocompatible nanocapsules.   
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2.7 Confocal Laser Scanning Microscopy (CLSM) 
Confocal laser scanning microscopy (CLSM) has become an invaluable tool when 
imaging the subcellular structures of living and fixed cells. It is an optical imaging technique 
that offers increased optical resolution and contrast in comparison to conventional optical 
microscopes, as well as the ability to obtain in-focus images from a defined depth. In contrast 
to the traditional fluorescent microscopy where an entire specimen is illuminated by a light 
source, confocal imaging uses point-by-point scanning illumination and detection. This is 
achieved by passing the laser beam through ‘pinhole’ apertures at both the illumination and 
detection ends. Typically a laser excitation source is directed through the first of two pinhole 
apertures (ideally diffraction limited), to eliminate any out-of-focus light rays. Next, the light 
is reflected off a dichromatic mirror and sent to the objective lens where the beam is refocused 
onto the specimen. As the excitation beam scans along the specimen in a defined focal plane, 
secondary fluorescence is emitted from points on the specimen. These fluorescent emission 
rays then pass back through the dichromatic mirror to be refocused to a second focal point 
before passing through the second (detector) pinhole aperture, see Figure 3.3. Any emission 
rays that have come from points too far above or below the objective focal plane are 
considered to be out-of-focus and are eliminated by the second pinhole aperture. Elimination 
of these out-of-focus rays enables better quality images of increased contrast and resolution. 
In addition, this pinhole technique enables collection of a series of optical sections at  
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Figure 3.3: Schematic diagram of the components and optical pathway in a laser scanning confocal 
microscope. Courtesy of Paddock et al.
18
 
different, and very narrow, depths of a specimen, after which the images can be built up to 
generate a highly resolved 3-dimentional image. Furthermore, the fluorescent filters can be 
used on the emission beam to generate fluorescent images of a specific wavelength.
17
  
CLSM has been used in this thesis to obtain information about the up-take of 
nanocapsules in-vitro. The nanocapsules were incubated with live cells, and then the cells 
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were washed and seeded on glass slides for observation using a Nikon, A1 Confocal 
Microscope. 
2.8 Thermogravimetric Analysis  
Thermogravimetric Analysis (or TGA) is a thermal analytical technique used to 
determine the change, and rate of change, in the physical or chemical properties of a material 
with regards to temperature, and is primarily used to determine the composition and thermal 
stability of a sample material. The technique involves precise measurement of the percentage 
weight loss (or in some cases gain) due to dehydration, oxidation, or decomposition of a 
sample as it is exposed to a controlled temperature profile, in a controlled atmosphere. The 
percentage weight is then plotted against the temperature to give a curve that can provide 
information about the composition of multicomponent materials, the thermal or oxidative 
stability of the sample, as well as any possible intermediates that might form at different 
temperatures. In this thesis, TGA was used to determine the weight (by mass percentage) of 
bio-polymer present in the fabricated systems. All analysis was performed on a Pyris-1 TGA 
Perkin Elmer instrument at a temperature gradient of 20 ºC/min and a flow rate of 20 mL/min 
in air.  
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CHAPTER 3 
SYNTHESIS AND CHARACTERISATION OF SILICA 
TEMPLATE PARTICLES: THE ROLE OF SOLVENT, 
TEMPERATURE, AMMONIA AND WATER ON THE 
PARTICLE SIZE AND DISTRIBUTION  
 
This chapter focuses on the synthesis and optimisation of monodispersed silica spheres to be 
utilized as template particles for the fabrication of drug delivery vehicles. Experimental 
parameters such as solvent, temperature, and concentrations of ammonia and water were 
individually investigated through single variable experiments to determine their effects on 
particle size and distribution. After the single variable experiments, an additional set of 
multivariable experiments were performed and the results applied to an artificial neural 
network (ANN) model in attempts to understand the complex interactions between 
parameters, that would otherwise be difficult and laborious to achieve through single variable 
experiments.  Through neural network modelling, the way in which the parameters interact 
and affect one another’s ability to influence particle size was investigated in an attempt to 
more accurately predict particle size based on experimental conditions.  
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3.1 Introduction  
When drug delivery (DD) vehicles are administered into the body, either via 
intravenous or oral routes, it is essential that they encompass a set of requirements to ensure 
that they can carry out their function as a therapeutic treatment, while ensuring they cause no 
unwanted effects due to their physio-chemical properties.  
In addition to the carrier materials, the size and distribution of the vehicles play a 
crucial role in their applicability as DD systems. The size of a particle will control the 
diffusion, permeation, and aggregation. If the administered particles are above a desired size 
range, they could become lodged in a passage and potentially cause critical side effects. For 
example, if the particles are < 6 nm they may be quickly removed by the body before they can 
achieve the desired function,
1
 whereas if the nanoparticles are too large they can become 
trapped in organs such as the spleen and liver, and if toxic, can cause life threatening 
complications.
2
 For these same reasons, development of optimum sized capsules devoid of the 
aforementioned is of equal importance. Despite achieving the majority of particles of a 
desired size, if there is only a very small number of particles that fall above or below the 
critical size, the vehicles will invade different parts of the body, and dreadful consequences 
ensue.  
In this thesis, the DD vehicles presented are fabricated with a templating approach, 
where the structural properties of the vehicles correspond to the structural properties of the 
template particles. Therefore any lack of control in the size and distribution of the template 
particles, which in this case are silica nanoparticles, is translated to the drug delivery vehicles. 
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Consequently, it is essential that a high degree of control over the structural properties of the 
templates must be achieved before the second stage of drug delivery vehicle fabrication is 
carried out. Silica was chosen as the template material as it has been previously demonstrated 
to carry the characteristics of a good template particle for the fabrication of capsules through a 
process called layer-by-layer.
3-6
  
To achieve template particles of a desired size and monodispersity, both single and 
multivariable experiments were undertake to identify the effects the experimental conditions. 
In the first section of the chapter (Chapter 3.2), traditional, single variable experiments were 
undertaken to identify the general trends of the parameters, while in the second section 
(Chapter 3.3), experimental design was used in conjunction with Artificial Neural networks 
(ANN) to investigate the dynamic interactions that occur between the parameters. Through 
the use of the two methods, the experimental conditions required to fabricate template 
particles of a desired size could be predicted. 
3.2 Single Variable Investigations 
The Stöber method was first developed in 1968,
7
 whereby highly monodispersed silica 
spheres of low polydispersity were synthesised through the hydrolysis and condensation of 
tetraethyl orthosilicate (TEOS). Since then there have been numerous research efforts 
investigating the effect of the various experimental parameters, trying to determine the 
mechanisms by which this method is governed, and in doing so, obtaining a finer control of 
the size and distribution of the silica particles.  
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To enhance the ability to fabricate monodispersed particles of a desired size, the 
reaction mechanisms of particle nucleation and growth need to be understood, yet despite the 
increasing investigation into Stöber synthesis, the mechanisms still remain vague due to the 
relatively fast reaction rate and the various intermediates produced.
8
 The current consensus is 
that the Stöber process follows the LaMer model where nucleation occurs very quickly, 
followed by a longer period of particle growth.
9,10
 When these processes are well separated, 
i.e. there is no secondary nucleation occurring during the growth stage; the particles grow to a 
uniform size. In comparison, if nucleation continues to occur while some particles are 
currently undergoing growth, a polydispersed colloidal solution will be formed.  
Nucleation occurs on introduction of the precursor into a reaction vessel which 
induces a sudden increase in precursor concentration (CPre), see Figure 3.1. If the initial 
increase in concentration overcomes a threshold value, nucleation will occur. This initial burst  
 
Figure 3.1: A depiction of the LaMer model representing the different stages of nucleation and 
growth, where ConcPRE represents the concentration of the precursor. Adapted from Capek et al.
11
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of nucleation partially reduces the supersaturation ratio, after which the CPre will eventually 
drop back below the nucleation threshold, driving the reaction into a growth stage. During the 
growth stage, as long as the rate of consumption of the reactants for particle growth is faster 
than the rate that precursors are added to the solution, any secondary nucleation is suppressed, 
resulting in very uniform particles.
11,12
   
The most currently updated mechanism of the reaction which describes the ammonia-
catalysed hydrolysis and condensation of tetraethyl orthosilicate (TEOS) with water while in 
the presence of a low-molecular weight alcohol solvent can be briefly summarised in the 
following chemical equation:  
                                                                              
The reaction can then be further broken down to the following equations where x, y 
and z are stoichiometric coefficients;
13
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From the proposed equations it can be seen that before the TEOS is introduced into the 
reaction solution, ammonium hydroxide dissociates in water to give ammonium (NH4
+
) and 
hydroxide (OH
-
) ions. The presented mechanism suggests that these hydroxide ions drive the 
hydrolysis of TEOS through the nucleophilic attack at the Si atom by replacing the alkoxide 
ions. From these equations we can see that the rate of TEOS hydrolysis is dependant only on 
the concentration of TEOS and the negatively charged hydroxide group (OH
-
). After 
hydrolysis of the TEOS has occurred, as-formed hydroxyl trimethoxysilane species can 
undergo either alcohol condensation (Eq 4) or water condensation (Eq 5). In alcohol 
condensation the newly acquired hydroxide group of the silicate undergoes deprotonation, 
allowing it to displace an alkoxide group while attacking the Si atom of another unhydrolysed 
TEOS molecule, generating alcohol in the process, whereas water condensation involves two 
hydroxyltrimethoxysilane, with the newly acquired hydroxide groups reacting together to 
produce water. These processors are further summarised in Figure 3.2. After the formation of 
dimers through either alcohol or water condensation, the molecules grow through addition of 
another monomer to form trisilicic acid,
14,15
 then oligomerization takes place in order to 
minimize the abundance of uncondensed Si(OH) bonds in favour of the condensed Si-O-Si 
bonds.
14,16,17
  
The parameters that have been investigated include the reaction solvent,
7,18-20
 reaction 
temperature,
8,18,19
 ammonia concentration,
7,8,18-20
 water quantity,
8,18-20
 TEOS 
concentration,
8,18-21
 the intermediate products,
13,22,23
 and the reaction kinetics.
8,13,23-25
 Despite 
the various investigations, many of these studies have not managed to achieve spherical 
particles in the perfectly tailored size range or with size distributions narrow enough for drug 
delivery applications. In the study by Wang and Wu et al the effects of solvent, TEOS, 
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ammonia, and water concentration were investigated,
19
 however, the particles that were 
fabricated demonstrated a broad size distribution, with relative standard deviations above 15 
% (with most of the deviation ranging between 20–30 % in size). In some particles this 
corresponded to a distribution of ± 100 nm, a very significant amount when drug delivery 
applications are considered. In a study by Wang and Shen et al, although numerous 
experiments were undertaken, much of the data produced include bimodal, aggregated or 
polydispersed particles.
20
 Furthermore, many of these studies have used vastly different 
synthesis conditions from one another, and in some cases have varying multiple parameters  
 
Figure 3.2: The mechanisms of the hydrolysis and condensation of TEOS.  
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simultaneously, therefore the parameters cannot be effectively correlated with the size and 
distribution of the particles, nor can the results from different studies be compared.
7,8,13,18-
21,26,27
 
3.2.0.1 Rationale 
As the applicability, effectiveness and safety of drug delivery vehicles has great 
dependence on their size and distribution, it is essential to control these properties to the best 
possible degree. The development of the DD vehicles presented in this thesis is through the 
use of silica spheres acting as template particles, where the size and distribution of the DD 
vehicles is reflected by the size and distribution of the silica particles, it is of great important 
to fabricate the particles to a particular size and below critical distributions. Despite the 
previous investigations, unfortunately it remains exceptionally difficult to accurately produce 
particles of a desirable size and of narrow distribution due to the complexity of the reaction, 
with unpredictable patterns in size occurring when any of the experimental conditions are 
varied due to their effects not being mutually exclusive.  Therefore, to fabricate particles 
required within the correct size range and distributions for the applications of this thesis, the 
parameter requires new and thorough investigation and optimisation, otherwise, until very 
thorough investigations into the experimental parameters and their interactions are 
investigated both individually and simultaneously, the application of these particles will 
continue to be dictated by, and limited to, the fate of the particles produced.  
In this chapter, the reaction solvent, temperature, ammonia and water concentration 
have been varied, and their effects on the size and distribution are investigated in an effort to 
identify the optimum parameters required to produce highly monodispersed silica 
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nanoparticles of a variety of sizes to be employed as templates for the development of drug 
delivery vehicles. 
3.2.1 Experimental Investigations 
3.2.1.1 Synthesis of Solid Core Silica Spheres 
In the first step, monodispersed, highly homogenous and stable solid silica core 
particles were prepared through the hydrolysis and condensation of tetraethylorthosilicate in a 
mixture of low molecular weight solvents such as ethanol, along with ammonia and water.
7
 
However, several modifications were made to the protocol to investigate their effects on the 
size of the silica, including variations to the solvent used, ammonia and water content, and 
reaction temperature. The reaction solutions were prepared using the solvents methanol, 
ethanol, butanol, n-propanol or pentanol. Different concentrations of both deionised water 
(MilliQ) and ammonia solution (28%) were used, ranging from 4.11 – 7.13 M and 0.62 – 1.85 
M, respectively, as specified in Figure 3.3. 
This was followed by mixing of the solution for 1 minute, and then allowing the 
solution to stabilize at a defined temperature (Figure 3.3) between 5 – 45 °C for 30 minutes in 
a thermomixer, after which, 75 µL of tetraethoxysilane (TEOS) was added to all the solutions 
and incubated for 1 hour at the appropriate temperatures without shaking. The resulting 
spheres were then washed repeatedly with centrifugation and redispersed in ethanol. Finally, 
to obtain the white powder of silica spheres, the centrifuged pellets were dried in an oven at 
100 °C . 
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Figure 3.3: The experimental conditions for investigation into the effects of solvent, temperature, 
ammonia and water concentration.  
3.2.1.2 Silica Particle Characterization 
Scanning and transmission electron microscopy (SEM and TEM) were used to image 
and measure the size of the silica sphere templates. SEM images were obtained by drop 
casting the silica sphere templates directly onto aluminium SEM stubs and analysed using the 
FEI Nova NanoSEM. TEM images of the silica templates were obtained by air-drying directly 
onto strong carbon grids and analysed using a Jeol 1010 TEM. In addition to the SEM 
measurements, the particle size and distribution was also analysed using Dynamic Light 
Scattering (5022F Fast DLS particle sizing spectrometer).  
3.2.2 Results and Discussion 
The effect of the synthesis conditions on the resulting diameter and polydispersity has 
been thoroughly investigated through single variable experimental techniques. During these 
investigations, one parameter, the solvent, temperature, ammonia or water concentration was 
varied while all other parameters were kept constant at 1.27 M ammonia and 5.66 M water, 
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and the reactions were carried out in ethanol at 25 °C. The morphology of the particles was 
observed with SEM, while their size was measured using both SEM and DLS for better 
precision. Generally the DLS method measures the hydrodynamic radius of the colloidal 
particles, therefore it is always slightly higher that the values obtained using the SEM. The 
polydispersity of the particles was also investigated and determined by the relative deviation 
of the particles measured by the SEM and displayed as a percentage.  
3.2.2.1 Effect of Solvent on the Solid Core  
To obtain the most effective silica sphere particles to act as templates for drug delivery 
vehicles, the best solvent needed to be identified before any further investigation into the 
effects of temperature, ammonia and water could be undertaken. In this section the solid silica 
particles synthesised in the different solvents; methanol, butanol, n-propanol and pentanol 
have been investigated while other experimental conditions remained constant (temperature 
25 ºC, ammonia 1.27 M, water 5.66 M). 
The SEM images displayed in Figure 3.4 revealed that the type of solvent used during 
the solid core synthesis has a dramatic effect on the outcome of the size and morphology of 
the particles, with the particles synthesised in methanol found to be very small, intermediate 
sized particles occurring in ethanol and n-propanol, and irregular, polydispersed, and non-
spherical particles occurring in butanol and pentanol. The average radii of the spheres are 
displayed in Figure 3.5. 
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Figure 3.4: SEM images of solid silica nanoparticles synthesised at 25 °C with 1.27 M ammonia and 
5.66 M water in different solvents.   
As can be seen in the SEM images (Figure 3.4), when butanol is utilized as the 
primary solvent, the silica particles have grown irregularly, with evidence that some of the 
particles have not separated properly during growth. Instead the particles demonstrate a 
‘budding’ effect, where they have grown atop each other to produce extremely large but 
irregular particles. It can be seen from the images that some of the fused particles are ca. 350 
nm in radii, while the overall particles are much larger, around 600 nm in radii. As a result the 
size distribution has suffered considerably, with these particles no longer considered as 
monodispersed. Although these particles are very large, their shape and size distribution is 
irregular, limiting their applications in drug delivery systems.  
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Figure 3.5: The average silica particle radius and standard deviation in the presence of different 
solvents, as measured by both SEM and DLS. 
In pentanol the particles range from ca. 600 nm – 1.05 µm in radius, however, it can 
also be seen that there are some smaller, fused particles of around 200 nm in radius. Similar to 
butanol, the particles made in pentanol are not all spherical and range significantly in size and 
shape. Both the particles formed in butanol and pentanol have very high polydispersity with 
relative deviations of around 20%, rendering them inappropriate for further investigation as 
drug delivery template particles.  
It is an often reported trend where an increase in the alkyl chain length of the solvent 
n-alcohol can result in larger particles,
7,23,24,28,29
 which is the case between particles 
synthesised in methanol compared to the longer chained ethanol, where the particles in 
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methanol are shown to have a radius 63% smaller than particles synthesised in ethanol. 
However this trend does not continue with the longer chained n-propanol, with particles 
produced in ethanol being ~18% larger than those produced in n-propanol. Although it would 
seem that this may be a result of experimental error during synthesis, it is in good agreement 
with Tan et al
18
 who also reported a 15% increase in particle size when ethanol was used over 
n-propanol. As n-propanol is a longer chained solvent than ethanol it would be expected to 
produce larger particles, yet the particles produced are smaller. This suggests that the simple 
statement that longer chained solvent produce larger particles may not be entirely accurate. 
The effect of the solvent on the particle size has also been suggested to be related to 
the dielectric constant of the solvents which causes a variation in the solvents ability to screen 
the opposite charges in the solution. As silica hydrolysis involves many steps which all 
contain charged intermediates, employing a solvent with a higher dielectric constant screens 
their charges and suppresses aggregation of the particle intermediates. This helps to explain 
the increase in particle size when referring to particles produced in methanol verses ethanol 
which has the dielectric constants 32.6 and 24.4, respectively (Figure 3.6), as well as the 
aggregation of nuclei in lower dielectric solvents such as pentanol and butanol. The high 
dielectric constant helps to explain why isopropanol has been reported to produce larger 
particles than what we have reported here using n-propanol. However, this trend does not 
coincide with the decrease in particles seen when n-propanol was employed which has a 
dielectric constant of 20.1 (Figure 3.6). It should however be noted that, the formation of 
ethanol as a side product from the condensation reaction may complicate the process further. 
This suggests that the outcome of the particle size using the Stöber process is more complex 
than simply the effect of alkyl chain length and the dielectric constant of the solvent. 
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Figure 3.6: The average particle size as a function of the dielectric constant of the solvent.  
The viscosity of the solvents is another property which differs between solvents, 
where the viscosity increases as the alkyl chain increases in size. When a less viscous solvent 
is used, the rate of the nucleation is fast, allowing for good separation between the nucleation 
and growth stages. Meanwhile, in a high viscous solution the precursor will take longer to 
diffuse through the reaction solution. This can create quick nucleation and growth at the 
interface, while the precursor away from the interface may not undergo nucleation for some 
time, creating a rather polydispersed colloidal solution.  
The size distribution of the particles is also found to be dependent on the solvent that 
was used. In Figure 3.7 it can be seen that there is an increase in the particle distribution as the 
molecular weight of the solvent increases, taking into account that the particles produced in 
both butanol and pentanol have shown polydispersity, it is not surprising that they 
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demonstrate extremely high distribution values (ca. 20%).  The distribution for methanol, 
ethanol and n-propanol are all relatively low and can be considered monodispersed enough for 
many applications, with the particles produced in ethanol demonstrating the lowest 
polydispersity. Furthermore n-propanol may not be as good a candidate for producing silica 
particles of an intermediate size range as their sizes fall within that of methanol and ethanol, 
while the monodispersity is compromised more than in both other solvents. While the spheres 
in methanol also demonstrated extremely narrow size distribution, with less than 8% relative 
variation measured from the SEM data, the particle size range is approaching that where 
toxicity has been found to increase,
30
 making these particles less suitable as templates for 
synthesis of drug delivery vehicles.  
     
Figure 3.7: The relative standard size distribution of the particles fabricated in the five different 
solvents. 
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As a result of these observations, ethanol was chosen as a solvent for particle synthesis 
due to its good particle production within the size and distribution desirable to be used as 
templates for the fabrication of monodispersed drug delivery vehicles.  
3.2.2.2 Effect of Temperature on the Solid Core 
The effect of temperature was investigated and is demonstrated to play a critical role 
in the outcome of the particle size, where it was determined that the particle size was 
inversely proportional to the reaction temperature. By altering the reaction temperature from 5 
to 45 °C while keeping all other parameters constant, the particle size could be reduced from 
533 nm to 104 nm, respectively. All particles with the exception of particles fabricated at 5 °C 
were extremely spherical and homogeneous, with intermediate particle radii occurring at 15 
and 25 °C, and much smaller particle radii occurring above 35 °C (Figure 3.8). Although the  
 
Figure 3.8: SEM images of silica particles synthesised at different temperatures. 
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relationship between the temperature and particle size was not perfectly linear, a general 
inverse trend could be seen between temperature and size of the particles.    
At the lowest temperature of 5 °C, the particle homogeneity was compromised with 
large, irregular, and non-spherical particles occurring. From the image at 5 °C (Figure 3.8) it 
can be seen that many smaller particles fused together into larger particles. In general, the rate 
of a reaction is controlled by the reaction temperature. At a low temperature the rate of 
formation of the nuclei and the rate of growth of seed particles would both be very slow, and 
may occur simultaneously.  
Aggregation is also thought to occur if the condensation rate is larger than the 
hydrolysis rate, which may be a result of the temperature affecting the reactions rates in 
different ways.
20
 Yet despite the aggregation obtained at the low temperature, the fused 
particle size was still much larger than those grown at higher temperatures, estimated to be 
around 350 nm. At lower temperatures it has been found that the distance between the 
vibrating particles becomes greater, permitting space for more monomer addition growth.
20
 
The radii of the sub-particle size at 5 °C, displayed as a (*) in Figure 3.9, also coincides better 
in the size verses temperature trend, which would obtain a better line of fit and would support 
the notion that the larger particles are more likely to have occurred due to the fusing of 
smaller subparticles. This demonstrated that although there is an increase in particle size by 
decreasing reaction temperature, there are limits to how far these parameters can be altered 
before the monodispersity of the colloids are compromised.  
Above the temperature of 5 °C, all other particles grown were found to be very 
monodispersed, with a general decrease in particle size as temperature increases (Figure 3.9). 
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In previous literature it has often been suggested that the temperature directly affects the rate 
of hydrolysis, which in turn affects the size of the seed particles, whereby a very fast 
nucleation rate produces smaller seed particles.
18,20
 This is related to the proportional 
relationship between temperature and diffusion, allowing for the TEOS to diffuse into the 
solution quicker.  
 
Figure 3.9: The SEM and DLS radii of the silica particles with regards to the reaction temperature. 
The relative standard deviation was investigated and shown in Figure 3.10, where the 
particles produced at 5 °C demonstrated an extremely high polydispersity which is due either 
to the fusing of unstable particles, uneven growth on the seed particles, or is a reflection of a 
large size distribution that could have occurred during the initial particle seeding. A large 
distribution in size renders these particles inefficient for many applications, especially in use 
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as drug delivery systems as size can have a dramatic and severe effect on the functionality of 
the particles. In contrast, all particles produced above this temperature demonstrated 
extremely good monodispersity with relative standard deviations below 5% and can therefore 
be categorised as highly monodispersed. With the exception of the particles produced at 5 °C, 
these results demonstrate that not only can silica nanoparticles be produced at a range of 
temperatures in ethanol, but also in a range of sizes without compromising their 
monodispersity, making them ideal for further investigation as templates for drug delivery. 
 
Figure 3.10: The effect of temperature on the relative standard deviation of the particles.  
3.2.2.3 Effect of Ammonia on the Solid Core 
It is thought that ammonia also has a significant effect on the size and polydispersity, 
with many previous reports generalising that the particle size increases with ammonia 
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concentrations,
8,19,26
 yet the relationship is not always as sight forward as this statement, with 
particle size maxima and minima often seen.
31
 In this section, the effects of ammonia were 
systematically investigated over a narrow but relevant concentration range from 0.62-1.85 M 
ammonia, in which monodispersed growth was seen throughout, yet with fine changes in both 
particle size and polydispersity. 
 
Figure 3.11: SEM images of silica spheres produced at different ammonia concentrations. All scale 
bars correspond to 500 nm.   
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As can be seen from Figure 3.11, all the silica spheres fabricated in the ammonia range 
appear homogenous with only small variations in size and polydispersity. In order to better 
determine the fine differences that have occurred due to the effects of ammonia, both the SEM 
and DLS results have been considered. From the graph presented in Figure 3.12 the general 
trend of particle radius increasing with an increase in ammonia concentration can be seen, 
however the trend is not entirely linear, with a small but notable drop in particle size at 1.42 
M before the increasing trend is re-established. 
 
Figure 3.12: The SEM and DLS radii with regards to ammonia concentration. 
From the currently proposed mechanisms of TEOS hydrolysis and condensation (Eq 
2-5), ammonia clearly plays a crucial role, whereby the ammonia instigates the production of 
the hydroxide ions (OH
-
) either through the deprotonation of water, or through the dissolution 
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of ammonia hydroxide. These OH
-
 groups then attack the Si atoms, initiating the hydrolysis of 
silica precursor (Eq3). Once the reaction is underway, the reaction is self-sufficient until all 
the TEOS is consumed.  
Although OH
-
 ions are required in catalytic concentrations, ammonia is not part of the 
rate determining step. Furthermore, since ammonia hydroxide is not a strong base, it will not 
completely dissociate into OH
-
 ions, and as the main composition of the reaction solution is 
ethanol, the pH of the solution would not drastically change as it would in pure water. This 
helps to explain the small impact of ammonia has on the size of the particles when the 
ammonia concentration has been increased.  
The distribution of the fabricated particles is seen in the relative deviation displayed as 
a percentage of the total particles size (Figure 3.13). Across this ammonia range the 
polydispersity is very low, and although there are two local minima in the relative 
distribution, all are within the range to be considered monodispersed (< 6%). Overall the size 
of the particles increases slightly with an increase in ammonia concentrations, with very little 
effect on the polydispersity over a narrow ammonia concentration range, however the trend is 
not entirely robust, with unexpectedly lower particles sizes occurring at 1.41 and 1.57 M. 
Therefore the effect of ammonia concentration on the particles size is not as straight forward 
as it seems, making it an extremely difficult task to accurately fabricate particles of a desired 
size.  
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Figure 3.13: The relative standard deviation over the ammonia concentration range. 
3.2.2.4 Effect of Water on the Solid Core 
The effect of water on the silica particle size and distribution was found to be more 
unpredictable when compared with all the other reaction parameters. In the investigation 
presented here, the range of experimental variation was kept narrow, from 4.11 to 7.13 M 
MilliQ water, where good particle growth was known to occur. The narrow concentration 
range allows for a more thorough investigation of the behaviour of water, with smaller 
intervals between sample concentrations than normally presented in many studies.
8,13,19,20
 The 
SEM images of the particles are shown in Figure 3.14. 
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Figure 3.14: SEM images of the silica spheres fabricated with the concentration of MilliQ water 
ranging from 4.11 M – 7.13 M. All scale bars correspond to 500 nm. 
The concentration of water was found to have a much smaller effect on the particles 
size, with no obvious trend in the radii which ranged from 220-230 nm. Although there was a 
small local maximum size at 4.90 M water, the overall variation in size was small at ca. ~7%.  
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Figure 3.15: The effect of water concentration on silica particle size. 
In contrast to a small effect on size, the concentration of water did show a significant 
effect on the polydispersity of the particles (Figure 3.16), with a steady increase in relative 
deviation once the water concentration increased from 6.0 M. This increase in deviation is in 
good agreement with the results obtained by Wang et al who also reported an increase in 
deviation from 4.7, 6.0 and 9 M concentrations.  
Since TEOS is immiscible with water, any increase in the water concentration will 
result in a slower reaction rate as the TEOS molecules will take longer to diffuse into the 
reaction solution. This will result in polydispersed particles as nucleation and growth are not 
well separated. Furthermore, similar to ammonia, water facilitates the production of OH
-
 ions 
which helps to stabilise the reaction solution of lower ionic strength.
20
 However, after a 
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critical ionic strength the OH
-
 concentration becomes too high, increasing the pH to a point 
where the silica particles may begin to dissociate, forming a variety of sizes. The increase in 
water will also intensify the effects of ammonia, increasing the pH further and resulting in 
more silica dissolution.  
 
Figure 3.16: The effect of water concentration on the polydispersity of the particles. 
A large deviation from monodispersity causes uncertainty and a variation in the 
properties and effectiveness in biological applications. Therefore a concentration of water 
around 5.0 to 6.0 M gives the optimum property of monodispersity.  
3.2.3 Summary 
In summary, the effects of solvent, temperature, water and ammonia concentration 
were investigated, and it was found that solvent and temperature were demonstrated to have 
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the largest effect on the particle size, followed by ammonia to a lesser extent. Meanwhile 
water did not demonstrate a large effect on particle size but did show a stronger influence on 
the polydispersity of the particles. From these results, it is possible to fabricate highly 
monodispersed particles of a variety of sizes that are of sufficient quality to be used as 
template for drug delivery systems.  
3.3 Multivariable, Artificial Neural Network Investigations 
When it comes to employing nanoparticles in drug delivery systems, therapeutic 
applications often call for particles to be within a very specific size range. As a result, the 
ability to identify the experimental parameters required to fabricate silica nanoparticles of a 
desired size could be invaluable in the scientific world. In the previous section it was shown 
how variation in one experimental parameter can control the particle size. Since each and 
every parameter affects the final particle size interdependently, it is extremely difficult to 
predict or control the particle size in experiments when multiple parameters are varied 
simultaneously. Furthermore, although it is possible to gain insight into the interactions of the 
variables through classic, single variable experimental investigations, this process would 
require an extremely large number of experiments, making it both time consuming and 
laborious.  
Artificial Neuron Networks (ANNs) may offer a solution for particles size prediction 
without the need for extensive experimental work by exploiting computational modelling 
programs. ANNs work by solving complex algorithms based on only a small number of 
experimental results defined by the experimental design, and in doing so, can identify patterns 
in the particle size. Through the implementation of these computational models, the complex 
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interactions of the experimental variables and their effects during the synthesis of the particles 
can be observed. However, the ANNs only relate the results and parameter values using 
certain algorithms, and do not define the combination of experiments needed to be carried out. 
Instead, ANNs are often coupled with an experimental design. 
Experimental designs are being employed more often in scientific systems due to their 
increased complexity, where the experiment design involves planning out the experiments to 
obtain the most amount of information about a system using the least number of experiments. 
The sample points in these designs are often evenly distributed over the range of variables in 
the system to cover all the possible interactions. There are numerous different experimental 
designs that can be applied to systems, including one-variable-changed-at-a-time full factorial 
designs, or multivariable Box-Behnken and Doehlert designs.
32,33
 These experimental design 
methods differ in the number of experiments required to complete a matrix, as well as their 
accuracy at interpreting information. As seen in Table 3.1, unlike the other experimental 
designs, the Doehlert design maintains efficiency while the number of variables and 
complexity of the system is increased. Therefore the Doehlert design has been implemented in 
the following section to study the effects of the experimental parameters on the size of the 
silica particles synthesised.  
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Table 3.1: A comparison of the efficiency of the central composite design (CCD), the Box-Behnken 
design (BBD) and the Doehlert design (DM). Adapted from Ferreira et al.
34
  
In the Doehlert design; 
           
where k is the number of variables, and N is the number of experiments required 
When the results from the experimental design are coupled with the algorithms of an 
ANN, the correlations between the parameter and experimental values are modelled, and the 
patterns and interactive relationships between them can be visualised in a 3-dimensional 
response map.   
To the best of the author’s knowledge, there is only a single report where ANNs have 
been employed to predict the size of silica nanoparticles based on the experimental parameters 
as reported by Leparoux et a.
35
 However, in their investigations they employed an inductively 
coupled plasma (ICP) process to fabricate the silica nanoparticles. Rather than the Stöber 
method where the size is a factor of solvent, temperature, ammonia and water concentration, 
in the ICP process size is a factor of quenching gas flow rates, and precursor feeding rates. 
Therefore the ANNs in this study were applied to vastly different parameters. Furthermore, 
CCD DM BBD CCD DM BBD
2 6 9 7 - 0.67 0.86 -
3 10 15 13 13 0.67 0.77 0.77
4 15 25 21 25 0.6 0.71 0.6
5 21 43 31 41 0.49 0.68 0.61
6 28 77 43 61 0.36 0.65 0.46
7 36 143 57 85 0.25 0.63 0.42
8 45 273 73 113 0.16 0.62 0.4
Efficiency (p/N )Number of experiments (N )Variables 
(K)
Number of 
coefficients (p )
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the size distributions of the particles produced in the previous study were far too great to be 
used as drug delivery vehicles.  
In the following section, a multivariable experimental method was employed where 
the effects of reaction temperature, ammonia and water concentration were varied 
simultaneously and their resulting effect on the size of the silica particles was investigated. In 
contrast to single-variable techniques where only one variable is changed per experiment 
while all others are kept constant, multivariable techniques allow for 2 or more variables to 
change simultaneously. Using multivariable methods the mutual effects of the variables can 
be studied, as well as taking into consideration the interconnected effects of experimental 
conditions. This also allows for a fast and more time effective study than the full factorial or 
traditional uni-variant methods.  
3.3.1 Experimental Theory 
In the previous section, the boundary where good silica particle growth was seen for 
each variable was determined. These results were used to define the following experiments, 
dictated by the Doehlert design, required to generate an accurate ANN model. After the 
experiments were carried out, the results were fitted using an artificial neural network (ANN) 
to obtain a complete 3D map of the size changes with changing synthesis variables.  
The experiments required to generate an accurate model are not decided randomly. 
Instead, the experiments required are based on a structurally symmetrical design which covers 
a large area of the 3D parameter matrix. Figure 3.17 displays the Doehlert design which 
required 21 experiments for this study. It is a double shell design with the inner matrix in the 
shape of a dodecahedron, and the outer matrix in the shape of an icosahedron. Although there 
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are many other experimental designs,
32-34,36,37
 this design was chosen due to its high efficiency 
at mapping space without overlapping, lower experiments numbers required for an accurate 
forecast model, and its potential for sequentiality.
34,38
  Each point corresponds to a unique 
combination of the three experimental conditions, defining the experiments required for 
testing in order to generate an accurate computer model.   
 
Figure 3.17: A modified version of the Doehlert design, where X1, X2, and X3 represent three 
experimental variables. Courtesy of Ahmad E. Kandjani in our group at NBRL 
(NanoBiotechnology Research Laboratory)   
The solid silica nanospheres were synthesized based on the same method used in the 
previous section of this chapter (section 3.2), with the hydrolysis of TEOS in a mixture of 
ethanol, ammonia and water. The Doehlert design called for 21 experiments to cover the 3D 
matrix required to accurately model the effects of temperature, ammonia and water 
concentration. Briefly, the temperature was varied from 10 – 36 ºC, ammonia content from 
1.0-1.8 M, and water content from 5.1-6.5 M, however instead of changing one variable per 
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experiment, multiple variables were changed simultaneously. Table 3.2 describes the 
experiments that were performed.  
 
Table 3.2: The experimental parameters for the 21 samples required to generate the artificial 
neural network. 
3.3.2 Particle Characterisation and Application of the Artificial Neural 
Network 
The particles were imaged using TEM, and the 2D images were used to determine the 
size of the particles with image processing software developed by Ahmad E. Kandjani in our 
group at NBRL (NanoBiotechnology Research Laboratory), displayed in Figure 3.18. 
Experiment No. Temp (°C) NH4OH (M) Water (M)
1 23 1.39 5.82
2 23 1.39 6.53
3 23 1.39 5.10
4 23 1.78 6.20
5 23 1.00 5.48
6 23 1.00 6.20
7 23 1.78 5.48
8 36 1.52 5.48
9 10 1.25 6.20
10 10 1.25 5.48
11 36 1.52 6.20
12 36 1.12 5.82
13 10 1.65 5.82
14 23 1.52 6.20
15 23 1.25 6.20
16 23 1.25 5.48
17 23 1.52 5.48
18 36 1.39 5.82
19 10 1.39 5.82
20 23 1.39 5.82
21 23 1.39 5.82
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In the first box the TEM image of the particles is shown, however, as some particles 
exist along the frame of the image, their size is truncated, therefore the image processing 
software was programed to omit these particles. The red box in the next window is required to 
define the boundaries within the image where the particles will be measured, where particles 
that are not within or touching the red box are discarded by the measuring program.  The 
particles which have been selected for measurement by the program are displayed in the box 
with blue to confirm that no particles have been truncated by the border of the image. Finally 
the particle diameters were measured, and to ensure the particles are measured as separate 
entities, a circle is generated in the centre of the measured particle. 
  
 Figure 3.18: An example of the image processing software used to determine the size of the silica 
particles. 
  The data produced using this technique is then correlated to the diameter of the 
particles, including the mean, median and mode diameters, and the particle size range and 
standard deviation. The scale bar is generated by correlating the number of pixels in the image 
with the scale bar generated by the TEM. 
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3.3.3 Results and Discussion 
After the measured diameters of the particles resulting from the 21 experiments were 
fed into the ANN network, an artificial model of the particle size with regards to temperature, 
ammonia and water was generated. The ANN model constructed three sets of 3-dimentional 
maps in which the response of two variables were plotted against one another, and between 
the three maps the interactions of each variable is plotted against all other variables. 
Information can be deciphered from these maps by observing the direction and gradient of the 
response slope. The direction provides information on the general trend of the parameter with 
regards to the particle size, while the gradient of the response describes the strength of the 
changing parameters influence on particle size.  
Changes in the direction or gradient of the response in one plane (sections observed 
either horizontally or vertically of the colour charts) can give information on one variable 
while the other two parameters remain constant, while changes across the 3D shape of the 
response can offer information on the interactions occurring between the parameters. The 
colour charts produced can help to give a clearer indication of these changes, where quicker 
colour changes in one plane indicate a steeper slope, or repeated colours identify local 
maxima and minima in particle size. 
The modelled data showed a 99% confidence in fitting, and the degree of influence of 
each variable was carried out using Garson method.
39
 The model demonstrates the highest 
influence on particle size was attributed to temperature, followed by the ammonia content, 
and finally water.  
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Figure 3.19: The silica particle size response compared with the variables temperature and 
ammonia concentration.  
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Figure 3.20: The silica particle size response compared with the variables temperature and water 
concentration.   
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Figure 3.21: The silica particle size response compared with the variables ammonia concentration 
and water concentration.  
 
 
5.10
5.35
5.60
5.85
6.10
6.35
6.30 1.01
1.53
1.40
1.14
1.27
1.66
1.79
Water (M) Ammonia (M)
290
230
260
200
170
R
ad
iu
s 
(n
m
)
5.10 5.35 5.60 5.85 6.10 6.35 6.30
Water (M)
1.01
1.53
1.40
1.14
1.27
1.66
1.79
A
m
m
o
n
ia
 (
M
)
205
235
210
215
220
225
230
B
A
96 
 
3.3.3.1 Effect of Temperature on the Solid Core 
Looking at the effects of temperature in Figure 3.19and Figure 3.20, there is always a 
gradual decrease in particle size as the temperature increases. Despite changes in the gradient 
of the response (looking at vertical sections moving from left to right of Figure 3.19B and 
Figure 3.20B), the general trend of the effect of temperature remains the same, with an inverse 
relationship between temperature and particles size.  
Observing the effects between temperature and ammonia in Figure 3.19, it is 
interesting to see that at the medium ammonia concentration (~1.3 M) changes in temperature 
between 20 to 30 ºC seem to be less influential on the particle size. In contrast, at high 
ammonia concentration the temperature becomes much more influential to the particle size, 
and the trend in particle size is more linear, allowing for better size prediction.   
When comparing the effects of temperature at different water concentrations, the 
particle size is a little more unpredictable. At low water concentrations, the influence of 
temperature on particle size is very strong, whereas at medium water concentrations 
temperature becomes less influential.  
This demonstrates that although there is always a decrease in particle size as 
temperature increases, the behaviour of the response of temperature varies significantly 
depending on the other parameters. Consequently, the particle size cannot simply be predicted 
based on an inverse linear relationship between temperature and particle size. However, at 
either a high concentration of ammonia, or a low concentration of water, the effects of 
temperature are both prominent and slightly more predictable. 
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3.3.3.2 Effect of Ammonia on the Solid Core 
The ANN model describes the influence of ammonia in Figure 3.19 and Figure 3.21 
where the results display the general trend of ammonia to be proportional to the size of the 
particles, yet with a lesser influence when compared with the effect of temperature.  When the 
effect of ammonia is compared to temperature in Figure 3.19, and this time the horizontal 
sections are analysed to represent a constant temperature, although the gradient of the 
response is not always constant it demonstrates a proportional relationship, where the particle 
size increases with concentration.  
When analysing the influence of ammonia on the response map with water (Figure 
3.21), the relationship is not as straight forward and different trends arise. Between the 
intermediate water concentrations ranging from 5.70 to 6.20 M, ammonia demonstrates a 
continuous increase in particle size as the concentrations is increased, however, at almost 
every other water concentration the response of ammonia results in dips and troughs in 
particle size, with no apparent trend occurring. This suggests that there must be some 
interaction occurring between the water and ammonia, which in turn affects the outcome of 
the particle size. This may indicate a point below which there are too few hydroxide ions 
being produced to facilitate the hydrolysis reaction at a fast rate, resulting in larger particles. 
In contrast, at the highest water concentration, an opposite trend occurs where a decrease in 
the ammonia concentration results in a dip in particle size. However, if the case of hydroxide 
availability was the only factor, then at a high constant of water, increases in ammonia should 
produce increased particle size, but as seen in Figure 3.21 the particle size dips before 
levelling out.  
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These results demonstrate that to obtain the strongest effects and greatest tunability 
from varying ammonia, the concentration of water must be considered, with a constant 
concentration of water at 5.80 M allowing for a more predictable outcome.  
3.3.3.3 Effect of Water on the Solid Core 
When looking at the response of water it is difficult to make a conclusion on its 
general trends, as it seems that both variations in temperature and ammonia concentration can 
result in a unique response shape and gradient. When comparing the effect of water against 
temperature (Figure 3.20) the particle size does not vary greatly which can be seen as a 
relatively flat gradient, with only one or two colour changes occurring at any constant 
temperature (seen as a horizontal section in Figure 3.20B). However there is no defined trend 
occurring, with size maxima and minima seen as dips and rises in the map.  At lower 
temperatures the maxima and minima only span over a small size range, meaning that changes 
in water concentration would not result in significantly large differences in particle size. In 
comparison, at high temperatures the maxima and minima difference is amplified, therefore 
an increase in water concentration would result in a range of sizes that would appear to follow 
no trend.  
When comparing the response of water against ammonia concentration, it becomes 
clear that there are not obvious trends, and that these two parameters interfere with each other 
parameter, which in turn influences the size of the particles. No matter what concentration the 
ammonia parameter is held at, the influence of water towards particle size is always 
fluctuating, making it very difficult to define any trends which could help in particle size 
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prediction. This demonstrates that the effect of water cannot be considered independently 
from the ammonia concentration.  
From these results, it can be seen that the effect of temperature is a parameter that has 
the most linear relationship with particle size, making this parameter the best option for 
controlling the particle size in a predictable manner. This is then followed by ammonia, which 
although is less predictable, will typically follow the general trend of increased particle size 
with an increase in ammonia concentration. Lastly, water is a parameter that appears to have 
no single and predictable trend with regards to particle size, making this parameter one that is 
best kept constant when endeavouring to fabricate particles of a desired size. The effect of the 
solvent was unable to be investigated due to the complexity and computational power 
involved in a 4-varibale model in comparison to a 3 variable model. 
3.3.3.4 Comparison of ANN with Single Variable Data  
In this next section, ANN results produced from a single plane of the size response 
(where two of the three variables are kept constant) enables the comparison of the ANN 
particle size prediction against the single variable results of the previous sections, where one 
variable is changing while two of the other variables remain at either 25 ºC, ammonia 
concentration at 1.27 M, and water concentration at 5.66 M. 
When comparing the size predictions generated from the ANN model with the data 
produced from the previous section, it can be seen that results are in good agreement with one 
another. Although the exact shape of the response with regards to the various parameters are 
not entirely consistent, the general trends are similar. Additionally, the size of the particles 
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that are predicted by the ANN are in the same range as the particles measured from the single 
variable experiments. 
 
Figure 3.22: A comparison of the temperature effect between the particle sizes observed using 
single variable experiments and the size predicted from the ANN.  
For the effect of temperature, the ANN generated the same general trend as the single 
variable experiment where there was a decrease in particle size as the temperature increased, 
however the results from the single variable experiments demonstrated a larger size range 
than the ANN predictions over the same temperature spectrum (Figure 3.22). The particles at 
35 ºC in the previous sections were measured to be 117 nm, while the ANN model predicted a 
much large particle size of 176 nm. In addition, the particles that were produced at 15 ºC were 
also overestimated, from 206 nm in the previous section to 231 nm for the ANN result. 
Conversely, the intermediate particles which were fabricated at 25 ºC showed only a minor 
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difference in sizes from 219 nm to 210 nm for SEM and ANN, respectively. This suggests 
that although the ANN model may be very accurate at predicting particle size with regards to 
temperature in a small temperature range, at the more extreme temperatures the ANN model 
becomes less accurate and there is more chance of error. Furthermore, the ANN data looks 
more like an average trend line, and may suggest that ANN lacks accuracy in accounting for 
the local maxima and minima which seem to have occurred during the single variable 
experiment.   
 
Figure 3.23: A comparison of the ammonia effect between the particle sizes observed using single 
variable experiments and the size predicted from the ANN. 
In the single variable experiments where the ammonia concentration was altered, there 
was a gradual increase in size with an increase in concentration, but with a small dip in the 
slope at 1.4 M. In comparison, the ANN values estimated radii very close to what was 
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obtained in the single variable experiments, with the ANN results lying both above and below 
the single variable radii at various different points. However the slopes of the relationship 
curve was slightly different, with a slight hump at the same position where the single variable 
experiments demonstrated a slight dip. Nevertheless, when trend lines are fitted for both the 
single variable and ANN results it can be seen that the results correspond very closely for both 
the size values and the influence of the parameter (gradient). 
 
Figure 3.24: A comparison of the water effect between the particle sizes observed using single 
variable experiments and the size predicted from the ANN. 
When comparing the ANN behaviour of water with the single-variant experiments, 
although there is not apparent relationship between concentration and particle size, there is a 
close correlation between the results, with an initial minimum which occurred in both the 
experimental and ANN at a water concentration of around 5.5 M. Furthermore, the gradual 
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increase in particle size from 5.5 – 6.5 M is in very strong agreement for both the previous 
data and ANN, with gradient of the slope almost identical.  
3.3.4 Summary  
Although numerous studies into Stöber based methods of silica synthesis have been 
undertaken,
7,8,18-21
 the complex and unpredictable effects of the experimental parameters 
cannot be fully investigated through single variable techniques. However, through the 
fabrication of silica nanoparticles using experimental conditions dictated by the Doehlert 
design, a 3-dimentional virtual map of particle size with regards to the three experimental 
parameters temperature, ammonia and water concentration has been generated using an ANN. 
This approach allows for the observation of such things as; the general relationship between 
the particle size and the parameter, the amount of influence the parameter has on the particle 
size, and identifying if the parameters are mutually exclusive from one another or if they 
interact to further affect the particle size in unpredictable ways. 
It was found that temperature had the largest influence on particles size and despite 
changes in the other parameters, its general effect remained the same, indicating little 
interference between the way in which temperature affects particle size and the way that the 
other parameters influence particle size. On the other hand, the effects on ammonia and water 
have demonstrated to disrupt one another’s influence on particle size, which indicates that 
these parameters display dynamic interactions. Since the dissociation of ammonia is 
dependent on the amount of water, it is difficult to decouple their individual effects of the 
final particle size. These intra-parameter interferences can make particle size prediction very 
difficult unless both parameters are considered, therefore the 3D maps produced in ANNs are 
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essential for accurately predicting particle size when ammonia and water concentration are 
varied simultaneously.     
We have also demonstrated that the model is capable of predicting particle size based 
on the parameters. Conversely, the model can be used to divulge the parameters required for a 
pre-specified particle size. Through the use of ANNs, the required number of experiments 
necessary for understanding the complex interactions and influences that the parameters 
temperature, ammonia and water have on the outcome of the silica sphere size and 
distribution can drastically reduce. 
3.4 Conclusion 
The individual effect of solvent, temperature, ammonia and water concentration on the 
size of the particles have been investigated using single variable experiments in order to 
identify general trends in areas where good particle growth was seen. This was then followed 
by multivariable investigations in which the experimental parameters of temperature, 
ammonia and water concentration were simultaneously altered, and the results were modelled 
using an ANN. This generated multiple 3-dimentional maps where the parameters were 
related to the size of the particles, allowing for the comparison of the parameter effects and 
interactions with one another. By employing both technique there is a better understanding of 
the dynamic effects of the experimental parameters, allowing for better prediction of particle 
size based on their parameters, or identifying the parameters required to manufacturing 
particles of a desired size.    
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CHAPTER 4 
COMPARISON OF TEMPLATING METHODS FOR 
THE SYNTHESIS OF POLYMERIC NANOCAPSULES 
 
 
Since the control of size and monodispersity in drug delivery vehicles is imperative, 
templating approaches in capsule fabrication are becoming increasingly popular. The Layer-
by-Layer approach has been used in countless studies, however, a lesser known templating 
approach utilising SC/MS template particles has also proven successful in establishing nano-
sized polymeric capsules. Until now these two templating approaches have yet to be 
compared in a single comprehensive study to determine which is more advantageous for 
developing nanocapsules for drug delivery (DD) applications. The following chapter not only 
compares the nanocapsules fabricated using these two templating approaches, but also 
investigates the polymeric materials chitosan, poly(allylamine hydrochloride), and 
poly(sodium 4-styrene sulphonate) and their effects on the drug loading capability, cellular 
uptake and cytotoxic efficiency. It was found that the combination of the SC/MS fabrication 
approach with chitosan acting as the polymeric material produced nanocapsules with the most 
desirable properties for drug delivery applications.  
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4.1 Introduction 
In past years there have been copious methods developed to fabricate various types of 
polymeric nanocapsules to be employed as drug delivery vehicles. These including emulsion 
techniques,
1,2
 the use of high pressure sieves,
3
 spray drying,
4-6
 and nanoprecipitation,
7-9
 with 
many more sub-classes within these methods.
10,11
 Although these approaches produce suitable 
capsules for many industrial applications, they tend to lack the finer size control and narrow 
homogeneity required for use as drug delivery vehicles.
10,12,13
 Furthermore, in techniques 
where the drug loading occurs during capsule synthesis, the experimental conditions can be 
harsh, and are not easily altered to the required conditions of the drug; therefore only robust 
drugs that are in accordance with these conditions can be incorporated.
10
 Alternatively, the 
use of a template particle onto which a polymer layer is deposited, followed by subsequent 
removal of the template matrix, ensures the superior control over the size and homogeneity of 
the nanocapsules.  
The most largely used template approach is the Layer-by-Layer (LbL) technique 
which was first adapted to the fabrication of capsules by Möhwald and Caruso et al in 1998, 
and involves the sequential layering of polymers onto a sacrificial template surface.
14-20
 
Another lesser used and more recently developed templating method for nanocapsule 
fabrication is the SC/MS template approach, developed by Wang et al in 2008,
21
 in which 
polymeric material is infiltrated and cross-linked in a porous template shell. Although both 
these methods require a secondary stage of template dissolution, the templates allow for 
extremely well defined capsules with improved monodispersity and capsule wall uniformity. 
Furthermore, as the capsules developed from LbL and SC/MS methods are porous, drug 
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encapsulation can be done after capsule synthesis and in a variety of conditions, broadening 
the range of potentially encapsulated drugs, to include typically unstable drug of both 
hydrophobic and hydrophilic nature.  
In LbL assembly, a smooth sacrificial particle, typically silica (similar to the particles 
optimised in chapter 3), can be used to sequentially deposit polymer layers onto the surface, 
followed by removal of the silica template to produce hollow polymer capsules.
14-20
  The way 
in which the polymer material can be stabilized onto the surface of the template particles can 
be achieved through a variety of different approaches. These include using click chemistry to 
covalently bond each layer together,
22-24
 hydrogen bonding to develop strong interactions 
between the hydrogen atoms of the polymer layers,
25,26
 or by using electrostatic interactions 
which occur between oppositely charged polymer layers. Although the click chemistry and 
hydrogen bonding approaches are very successful, these approaches can be very complex. In 
contrast, the fabrication of capsules by layering oppositely charged polymers onto a template 
particle, and allowing the electrostatic interactions between the polymers to hold the capsule 
together, is relatively straight forward and cheap. Depending on the strength of the 
electrostatic interactions of the polyelectrolytes, this approach can be applied to any 
oppositely charged entities such as organic particles, inorganic particles, oligomers, 
multivalent ions, dyes, proteins, synthetic and natural polymers.
27
 However, due to this LbL 
process depending on electrostatic or similar interactions,
28
 the overall thickness of the 
polymer layer is limited to the extent of these forces, and therefore the types of polymers used 
and the thickness of their layers is restricted by their properties.
21
 Furthermore, although 
possible through the exploitation of hydrogen bonding and click chemistry,
24,29
 the LbL 
approach typically requires two polymers for the layering to occur, and hence, single 
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component polymer capsules can be difficult to achieve. Another drawback of the LbL 
process is that, although it has demonstrated to be very successful at producing micro sized 
capsules, there are very few reports of sub-micron capsules as aggregation becomes 
problematic.
30-33
 Finally, one of the largest disadvantages of the LbL approach is that it is both 
labour-intensive and time-consuming, making it less suitable for large scale commercial 
applications.
19,21
 Recently Zelikin et al has published an outstanding review on the LbL 
approach, highlighting some of these issues while critically looking at the approach.
34
 
The employment of the SC/MS silica particles as templates for nanocapsules synthesis 
may offer significant advantages over the solid silica templates used in LbL techniques. 
Developed by Büchel et al,
35
 SC/MS particles are solid core (SC) silica nanoparticles with an 
outer mesoporous shell (MS) that are fabricated in a two-step process. The first step involves 
the fabrication of solid silica cores using the method optimised in chapter 3, while the second 
step involves the growth of an outer silica shell that is riddled with mesopores. It is in the 
mesopores of the template shell that polymeric material can infiltrate using simple charge 
interactions, creating a network of overlapping polymer chains with a simple polymeric 
material that is subsequently cross-linked to form a robust capsule. This allows for single 
component capsules to be fabricated which have only been previously achieved through click 
chemistry and hydrogen bonding when using templates. The potential advantages of single 
component capsules over duel component capsules include more predicable behaviour of 
capsule degradation, its interaction with the body, or drug loading capacity. Both the SC/MS 
and Layer-by-Layer approaches to nanocapsule fabricating have been summarised in Figure 
4.1 below.  
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Figure 4.1: A schematic detailing the solid core/mesoporous shell and Layer-by-Layer methods of 
nanocapsule synthesis. 
In comparison to the LbL method which has been employed in many studies over the 
past two decades, 
14-20,34
 the SC/MS method has only been reported in the literature once,
21
 
with the exclusion of the work carried out in the current thesis. In the previous study, Wang et 
al reported the successful fabrication of high monodispersity, single component 
poly(allylamine hydrochloride), (PAH); poly(L-glutamic acid), (PGA); and poly(L-lysine), 
(PLL), polymer nanocapsules using the SC/MS approach. Furthermore they achieved a sub-
micron size range (270 nm – 400 nm) of nanocapsules which is not often achieved in LbL 
approaches.
34
  However, this method has never been compared with the LbL technique in a 
single, comprehensive study.
21
  
Solid Core/
Mesoporous Shell
Layer-by-Layer
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The type of polymeric materials employed in nanocapsule fabrication is also very 
important, especially as the polymeric material comes into direct contact with the body and 
the immune system when acting as a drug delivery system. Furthermore, not only can the 
polymer dictate the capsule’s therapeutic drug loading ability, but it also affects its uptake into 
cells and its efficiency to induce cytotoxicity. The polymers poly(allylamine hydrochloride) 
(PAH), and poly(sodium 4-styrene sulphonate) (PSS) were chosen in the following 
investigations due to their extensive employment in previous LbL studies,
36-39
 allowing for a 
comparison of the capsules fabricated herein with previous studies. Moreover, the two 
polymers both have strong electrostatic charges, with PAH acting as a cationic polymer due to 
the presence of amine functional groups and PSS acting as an anion owing to the presence of 
a sulphonate group, making them ideal for the layer-by-layer approach. Chitosan was chosen 
due to its proven biocompatible and biodegradable nature. With the chemical structure [Poly-
(1,4) 2-amino-2-deoxy-β-D-glucan], chitosan is also a positively charged molecule, however 
it is not as cationic as PAH.
40
  
4.1.1 Rationale 
To our knowledge there have been no studies which have directly compared the 
Layer-by-Layer method of capsule fabrication against the lesser known SC/MS method. 
Furthermore, although the Layer-by-Layer approach has been extensively employed in the 
literature, the capsules fabricated are usually reported to be in the micron size range, with very 
few reports of capsules below 500 nm.
34
 In the following chapter, nanocapsules of ca. 300 nm 
have been synthesised by employing both the SC/MS and LbL methods, and the polymers 
chitosan, PAH and PSS. The effects of capsule aggregation, polymer loading, drug loading, 
cellular uptake and cytotoxicity of all systems were compared in an effort to identify the most 
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advantageous fabrication method and polymer material for drug delivery applications which 
would warrant further investigation. 
4.2 Experimental Section 
4.2.1 Fabrication of the SC/MS silica template particles 
The SC/MS silica template particles were fabricated through a two stage process. In 
the first stage, solid core (SC) silica nanoparticles of ca. 300 nm were fabricated based on the 
method optimised in chapter 3. This was achieved by the mixing of 1 mL of absolute ethanol, 
135 µL of deionized (MilliQ) water, and 113 µL of ammonia solution (28 %) in a 1.5 mL 
eppendorf tube, and heating the mixture to 25 ºC. Next 75 µL of tetraethoxysilane (TEOS) 
was added to the solution which was then mixed for 4 seconds. The solution was then kept 
very still and held at 25 ºC for one hour while the particles formed. 
In the second stage, an outer shell of ca. 40-50 nm with mesopores throughout is 
grown onto the solid core particles to produce the solid core/mesoporous shell (SC/MS) 
template. To achieve this, 65 µL of additional TEOS and 13 µL of n-
octadecyltrimethoxysilane (ODTMS) was mixed in a fresh 1.5 mL eppendorf tube, and the 
content was slowly added, drop-by-drop, to the solid core solution over a period of 20 min at 
25 °C under shaking conditions. After all the TEOS/OTMS solution was depleted, the 
particles were left to incubate for an additional hour under shaking conditions. Finally, the 
formed SC/MS particles were washed thrice with ethanol, and the powder was obtained by 
drying in an oven at 70 ºC, followed by a period of 6 h in a furnace at 550 ºC in air to remove 
the porogen ODTMS through calcination.    
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4.2.2 Fabrication of the solid silica template particles 
The solid core silica template particles were fabricated in the same manner as the solid 
cores of the SC/MS particles. However, in order to keep the LbL template particles of roughly 
the same size as the SC/MS particles which not only have a solid core but also an outer shell, 
the smooth particles for LbL were fabricated to be as close to 350 nm as possible. To achieve 
this, of 1 mL of absolute ethanol, 135 µL of deionized (MilliQ) water, and 113 µL of 
ammonia solution (28 %) was again mixed in a 1.5 mL eppendof tube, and heating the 
solution to 22 °C as opposed to the 25 °C employed in the SC/MS synthesis. Again 75 µL of 
TEOS was added and mixed for 4 seconds before incubation for 1 h, however for the LbL 
template particles there is no additional stage of shell growth. After incubation the particles 
were washed thrice with ethanol, and dried at 70 ºC to obtain the particles in powder form.  
The SC/MS and LbL silica templates were imaged by scanning and transmission 
electron microscopy (SEM and TEM). The particle size and distribution was determined using 
SEM where a minimum of 100 particles were measured for accuracy.  
4.2.3 Fabrication of Chitosan and PAH Nanocapsules Using the SC/MS 
Templating Approach 
The chitosan and (PAH) nanocapsules were both fabricated using (SC/MS) silica 
nanoparticles as templates, where the polymer is dissolved before being allowed to infuse into 
the pores of the outer template shell. Afterward, the infiltrated polymer, either chitosan or 
PAH, is cross-linked with glutaric dialdehyde to form a dense, interconnected network of 
material. Finally the template is removed to generate the SC/MS-chitosan or SC/MS-PAH 
capsule.   
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The polymer solutions were prepared separately, with the chitosan polymer stock 
solution containing 4 mg of low molecular weight chitosan that was dissolved in 1 mL of pH 
7.2 phosphate buffer saline (PBS 0.02 M) along with 0.8% acetic acid. The PAH stock was 
prepared by dissolving 2.5 mg of PAH in 1 mL of pH 8.5 Borate buffer (0.025 M). For the 
processing of the SC/MS template particles prior to use, 5 mg of particles was weighed into a 
1.5 mL eppendorf tube, and washed thoroughly with both ethanol and deionised water, before 
being redispersed in 450 µL of deionised water. The template particles were then mixed with 
either 1 mL of chitosan or PAH stock solution, and allowed to incubate together overnight on 
a rotary shaker.  
After the appropriate polymer was allowed to infuse into the mesoporous shell of the 
SC/MS particles, any excess chitosan or PAH was removed by separating the SC/MS particles 
with infiltrated polymer through centrifugation (6 rpm for 5 minute), followed by discarding 
the supernatant. The remaining infiltrated particles were redispersed (without sonication) in 
800 µL PBS before adding 20 µL of glutaric dialdehyde (25% w/v) to cross-link the 
polymeric material within the mesoporous shell. The solution was then incubated for a further 
2 hours on a rotary shaker. The cross-linked SC/MS-chitosan or SC/MS-PAH particles were 
washed three times with deionized water, followed by removal of the SC/MS silica templates 
with hydrofluoric acid (2M) in an ammonium hydroxide buffer (8M). (Warning: hydrofluoric 
acid is highly corrosive, and extreme care should be taken while handling hydrofluoric acid). 
The capsules were washed repetitively with deionised water to remove all hydrofluoric acid, 
and the polymer nanocapsules obtained were stored in water.  
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4.2.4 Fabrication of PAH/PSS Nanocapsules Using the Layer-by-Layer 
Approach 
PAH/PSS nanocapsules were fabricated using the layer-by-layer (LbL) technique, 
whereby solid silica template particles were incubated with alternating solutions of dissolved 
polymer. This enabled the build-up of layers of opposite charged PAH and PSS polymers onto 
the surface of the template. The PAH stock solutions was made with 2.5 mg mL
-1
 of PAH 
dissolved in borate buffer (0.025 M) and the pH was adjusted to 8.5 with 0.01M sodium 
hydroxide. For the PSS stock solution, 2.5 mg mL
-1 
of PSS polymer was dissolved in 
potassium hydrogen phosphate (0.01 M) and the pH adjusted to 6.5 with 0.1 M hydrochloric 
acid. After washing 10 mg of LbL template particles thrice each with ethanol and deionised 
water, the templates were allowed to incubate with the polymer solutions, starting with 2 mL 
of the positively charged PAH solution. After 30 minutes of incubation time the particles were 
centrifuged and the supernatant removed to discard any excess, un-adsorbed polymer. The 
particles were then washed once with pH 8.5 buffer solution which did not contain any 
dissolved polymer. After removing the pH 8.5 buffer solution, the same process was repeated 
with the PSS polymer layer, where 2 mL of PSS stock solution was added and allowed to 
incubate for 30 minutes. After incubation the particles were washed once with pH 6.5 buffer 
solution to remove any excess PSS. These steps were repeated multiple times until the 
particles were incubated with each polymer stock solution 5 times, ending in a final 
incubation with PSS.  
Finally, half the solution was removed and washed after the 10
th
 incubation step with 
PSS, while the other half underwent an additional incubation with PAH stock solution. This 
lead to half the particles possessing a final layer of PSS (LbL-PSS), i.e. (PAH/PSS)5, and half 
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the material possessed a final layer of PAH (LbL-PAH), i.e. (PAH/PSS)5PAH. Both particles 
were then washed thrice with deionised water. The nanocapsules were obtained by the same 
hydrofluoric acid treatment to remove the silica template as used in the previous section. This 
was followed by centrifugation (7 rpm for 5 minute) and repetitive washing of the remaining 
and intact capsules with deionized water.  
All the nanocapsules were imaged using TEM and the weight of polymeric material 
per capsule was obtained by by Thermogravimetric analysis (TGA) using Perkin Elmer Pyris 
1 TGA instrument.  
4.2.5 Curcumin Loading into the Chitosan Nanocapsules  
The capsules were loaded with the lipophilic drug mixture of curcumin dissolved in 
oleic acid using a method similar to the previously demonstrated for the loading of lipophilic 
chemotherapeutic drugs doxorubicin and 5-fluorouracil into poly(methacrylic acid) 
capsules.
41
 Briefly, the capsules were first dehydrated with ethanol to ensure no water was 
present in the capsule interior. The capsules were then incubated with a curcumin/oleic acid 
solution (10 µg curcumin per mL of oleic acid), and the oil mixture was allowed to infiltrate 
through the porous walls of the capsules for 12 hours. Following incubation, the capsules 
were washed with hexane to remove any non-infiltrated curcumin/oleic acid and any residual 
hexane was allowed to evaporate. A portion of the capsules were then used to determine the 
drug loading capacity by redispersing in ethanol to release the internalised curcumin mixture, 
followed by quantifying the amount of curcumin released by making standard curves using a 
Cary 50 Bio UV-Vis spectrophotometer at the absorbance maxima of curcumin at 430 nm.   
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4.2.6 Cellular Uptake and Cytotoxicity of Curcumin-loaded Nanocapsules 
MCF-7 cells were employed to study cytotoxicity and the cellular uptake of the four 
different types of polymeric capsules. The human breast cancer cell line (MCF-7) was 
obtained from American Type Culture collection and maintained in DMEM medium (Life 
technologies) supplemented with 10% Foetal bovine serum (Thermofisher Scientific). The 
culture was maintained at 5 % CO2 in a humidified incubator at 37°C.  
For cellular uptake studies, 50,000 cells were seeded on a glass coverslip overnight, 
followed by exposure to 2 x 10
9
 capsules in 2 ml media, and incubated for 24 hours. The 
coverslips were washed with phosphate buffer saline (PBS) and fixed with paraformaldehyde 
(3.7%) for 10 minutes. The coverslips were then washed again with PBS and mounted onto 
fresh slides along with Prolong Gold Antifade medium containing DAPI. Imaging of the 
coverslips was done using confocal microscope (CLSM; Nikon Confocal Microscope). As 
glutaraldehyde was used to cross-link both the SC/MS-chitosan and SC/MS-PAH capsules, 
these particles were highly fluorescent and therefore immuno-labelling was not required, 
however the LbL capsules did not fluoresce. For this reason all confocal images were taken 
with capsules that were infiltrated with curcumin which fluoresces at 490 nm. 
To study the cytotoxic efficiency of the four types of capsules, 20,000  cells were 
exposed to increasing concentrations of pristine (curcumin free) and loaded (curcumin-
infiltrated) capsules. The concentration of capsules ranged from 1 x 10
7
 – 125 x 107 capsules 
per well and were incubated for 24 hours in 96-well plates under appropriate growth 
conditions as explained in the previous section. The cell viability was measured using a 
soluble tetrazolium-based colorimetric assay (Promega MTS CellTiter 96® aqueous kit) and 
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the absorbance measured at 490 nm using a microplate reader (Perkin Elmer, USA).  To 
compare against the cytotoxicity of uncapsulated, free curcumin, increasing concentrations of 
curcumin dispersed in water was also tested. Each treatment was performed in triplicate and 
the data average was taken, with standard error of mean shown as error bars. 
4.3 Results and Discussion 
In the following section, four different nanocapsules have been synthesised and tested 
for their therapeutic efficiency as drug delivery systems. Two of the capsule types were 
fabricated using the solid core/mesoporous shell (SC/MS) method, where one set was single 
component, cross-linked chitosan capsules (denoted as SC/MS-chitosan), and the other set 
was single component, cross-linked PAH capsules (denoted as SC/MS-PAH). The next two 
capsule types were fabricated using the Layer-by-Layer (LbL) approach, where both capsules 
were composed of a combination of poly(allylamine hydrochloride) and poly(sodium 4-
styrene sulphonate), or PAH/PSS, however the capsules were terminated on either a PSS layer 
(LbL-PSS), or a PAH layer (LbL-PAH).  
4.3.1 Template characterisation 
After fabrication of the SC/MS and LbL template particles through the hydrolysis and 
condensation of TEOS which was optimised in chapter 3, their size and distribution was 
determined using SEM. (For the SC/MS templates, the size and distribution was measured 
both before and after growth of the mesoporous shell, while the LbL template particles only 
needed to be measured once, because the LbL templates didn’t contain a mesoporous shell).  
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The solid core of the SC/MS particles were found to be 290 ± 24 nm in diameter, with 
an outer mesoporous shell of 46 ± 7 nm in thickness. When combined, the overall size of the 
SC/MS particles came to 382 ± 38 nm. After the calcination and removal of porogen 
ODTMS, the mesopores were measured with BET surface analysis and found to be 3.68 nm 
in diameter. In contrast, the LbL templates were fabricated to 348 ± 28 nm, and due to the 
lack of pores on the surface of the particles as can be seen in Figure 4.2D, BET was not 
required.  
 
Figure 4.2: SEM (A and B) and TEM (C and D) images of the template particles, where (A) is the 
solid core particles of the SC/MS template, (C) is the solid core with mesoporous shell of the SC/MS 
templates, and (B and D)) are solid core silica particles of the LbL templates.  
C D
A B
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4.3.2 Characterisation of the Nanocapsules 
TEM imaging was performed on the fabricated nanocapsules after removal of the 
SC/MS silica template and is displayed in Figure 4.3. The main difference that can be seen 
from the images is the amount of aggregation occurring, with capsules made via the LbL 
method showing more aggregation that those made using the SC/MS technique. Although 
capsules fabricated via the layer by layer method have been shown to have good 
monodispersity in previous literature, these capsules are usually in the micron range, with 
very few successful capsules reported below 500 nm.
34
 At sub-micron ranges aggregation it 
thought to becomes more problematic as a result of stronger interparticle. Unlike the SC/MS 
approach where the bulk of the polymeric material resides within the mesoporous silica shell, 
the polymeric material is entirely on the surface in the LbL approach, providing more 
opportunity for interparticle interactions. This may indicate that although LbL capsules can be 
very successfully fabricated in the micron range, when approaching the sub-micron range, 
monodispersed and uniform capsules are very difficult to achieve.    
At further observation, the chitosan and PAH capsules fabricated by the SC/MS 
approach appear relatively thicker, with a more robust and uniform shell, in comparison with 
the capsules made using the LbL technique. However, to confirm and quantify the weight of 
polymeric material present, either infiltrated into or absorbed onto the template particles, 
thermogravimetric analysis (TGA) was performed.  Shown in Table 4.1, TGA demonstrated 
that the PAH and chitosan capsules made using the SC/MS method showed the largest and 
second largest amount of polymer loading, respectively. In contrast, both capsules made using 
the LbL approach demonstrated a lower amount of polymer absorbing onto the template 
123 
 
surface. The difference in the amount of polymer loading between these methods is not 
unexpected due to the extensive differences in the mode of polymer material attachment.  
 
Figure 4.3: TEM images of the fabricated nanocapsules (A) SC/MS-chitosan, (B) SC/MS-PAH, (C) 
LbL-PSS, and (D) LbL-PAH. All scales bars correspond to 500 nm. 
 
Table 4.1: Thermogravimetic analysis data of the capsule weight  
The polymer material in the SC/MS method drives itself into the oppositely charged 
pores riddled throughout the outer shell of the template. In this method the polymer loading 
A
C D
B
Capsule
% Weight at           
110 ºC
% Weight at           
600 ºC
 % Weight Loss
Weight of Polymer              
(mg/g template)
SC/MS-Chitosan 87.94 79.92 8.03 87.26
SC/MS-PAH 90.50 81.19 9.31 102.60
LbL-PSS 89.30 83.15 6.15 65.53
LbL-PAH 92.55 86.60 5.95 63.28
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step is only preformed once, yet through electrostatic attraction between the negatively 
charged silica and the positively charged polymer (either chitosan or PAH) a substantial 
amount of polymer embeds itself within the pores of the template shell, as well as a small 
amount onto the particle surface. Within these walls some of the pores containing individual 
polymer chains come into contact with one another, and during the cross-linking stage these 
chains are bonded together to give additional strength to the structure and reducing any 
desorption of polymeric material.  
Unlike the SC/MS method, the layer-by-layer method takes advantage of oppositely 
charged polymers. The polymers absorb onto a smooth template particle, immediately 
reducing their loading ability to the surface of the particle rather than the high surface area of 
a mesoporous shell. Once there is a build-up of one charge on the surface due to the polymer, 
no more of that polymer will absorb. Through multiple steps of alternating between 
differently charged polymers, a build-up of many layers is achieved. Unfortunately for this 
method to achieve the same capsule wall thickness achieved by the SC/MS approach, many 
incubation and washing steps need to be performed, which are very time consuming and 
laborious. For instance, if each polymer layer deposition step during LbL process typically 
leads to ~2 nm thick layer,
14,17,42 
it will require 15-30 LbL steps to obtain capsules of the same 
thickness as obtained by the SC/MS method in a single step. The LbL capsules presented here 
underwent 10 and 11 polymer layers, yet remained much thinner than the capsules fabricated 
in one step via SC/MS templates. 
The difference between the modes of polymer adhesion between these techniques can 
help to explain the significant variation in the polymer loadings. Although in some drug 
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delivery applications where polymeric nanocapsules are employed, a thin walled vessel may 
be required, it is usually the robust yet porous vehicles which are essential. It is more often 
required that the vehicles possess thick capsule walls to prevent rupture or degradation, and 
consequently, preventing premature loss of encapsulated drug during transportation. 
Therefore, capsules synthesised through the SC/MS template approach already demonstrate 
greater promise over the LbL approach in fabricating robust and thick walled capsules due to 
reduced aggregation and an increased amount of polymeric loaded in a single step. 
Furthermore, as the capsules made via SC/MS also undergo a stage of polymeric cross-
linking, the formed bonds induce additional strength to the capsule structure that is not present 
in those made via non-crosslinked LbL methods.  
4.3.3 Quantification of Curcumin Loading 
An important property of a drug delivery system is the amount of drug that can be 
loaded per carrier. As such, the drug loading capacity of the capsules was investigated, and 
the influence of the fabrication method and the polymeric material was compared. This was 
achieved by loading of a hydrophobic anti-cancerous drug curcumin into the capsules, and the 
weight per capsule quantified. To compare this and other characteristics between capsule 
types, the number of capsules present in the following investigations was kept constant. This 
method of quantification has been outlined in the Appendix and was calculated based on the 
assumption that each template particle resulted in a capsule. Due to this assumption it should 
be noted that there is potential for significant error, however as this method was the only 
available means of quantification, we believe this assumption is acceptable.   
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Curcumin was used as a model lipophilic drug due to its well-established anti-
cancerous properties, while oleic acid was employed as the oil phase as it has been FDA-
approved. Another reason why curcumin was chosen as a model drug was that curcumin is 
well-known to degrade in an aqueous environment,
43
 and therefore curcumin stabilized in a 
hydrophobic oleic acid phase within the cavity of the capsules provides a unique opportunity 
to study its drug efficiency during its stable and active form. 
Briefly, curcumin was first dissolved in oleic acid which acts as the oil phase, the 
nanocapsules were then allowed to incubate and be infused with a curcumin/oleic acid 
mixture overnight. After infiltration, all un-encapsulated mixture was removed through 
multiple hexane washes, before the remaining (encapsulated) curcumin/oleic acid mixture was 
dehydrated from the capsules with ethanol and detected using UV-vis spectroscopy. The 
curcumin detected was quantified against the standard curve displayed in (Figure 4.4). 
 
Figure 4.4: The linear absorbance curve plotted from standard curcumin concentrations.  
0 2 4 6 8 10 12 14 16 18 20 22
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
 
 
A
b
so
rb
an
ce
Standard Concentration (ng mL
-1
)
  y = 0.07837x
R
2
 = 0.99688
127 
 
From the viewpoint of drug loading capability, it can be seen in Figure 4.5 that there 
appears to be no obvious advantage in using either the SC/MS or the LbL method, with the 
SC/MS method demonstrating both the highest and lowest loading capacity per capsule 
(depending on the polymer), while the LbL approach displays an intermediate capacity. The 
SC/MS-chitosan capsules demonstrate the greatest drug encapsulation, followed closely by 
the LbL-PSS capsules, and then to a lesser extent LbL-PAH and SC/MS-PAH, respectively. It 
is likely that the loading is dependent on several factors which include the structural 
characteristic of the capsules such as the capsule size and wall thickness, in addition to the 
polymer material employed which may exhibit differences in drug binding. 
 
Figure 4.5: The curcumin loading capacity of the different capsules types.  
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4.3.4 Cellular Uptake of Curcumin-Loaded Nanocapsules 
The four different capsules fabricated through two dissimilar methods and comprising 
of three different polymers, were tested for both their cellular uptake and cytotoxic behaviour 
to evaluate their ability as drug delivery vehicles against MCF-7 breast cancer cells. To ensure 
cellular uptake was occurring, curcumin-loaded capsules were incubated with the MCF-7 cells 
overnight, followed by confocal imaging, with the results displayed in Figure 4.6. Curcumin-
loaded capsules were chosen for confocal images as curcumin is fluorescent, negating the 
need to add fluorescent tags to the capsules. 
 
Figure 4.6: Confocal images of MCF-7 breast cancer cells incubated for 24 hours with (A) SC/MS-
chitosan, (B) SC/MS-PAH, (C) LbL-PSS, and (D) LbL-PAH.  
A B 
C D 
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Although the most fluorescence is occurring in both confocal images with the LbL 
capsules (Figure 4.6, C and D), the capsules do not appear to have infiltrated the cells. 
Instead, the high intensity of the fluorescence is caused by the aggregation of the capsules 
above and around the cells. When looking at the LbL-PSS capsules, they have undergone the 
largest amount of aggregation, and although it is difficult to confirm that very little 
engulfment has occurred, the size of one of the aggregated masses is so large (~50 µm) that is 
would likely deter any take up by the smaller cells (~15 µm).  
In contrast, the SC/MS capsules are not nearly as aggregated, and more cell uptake can 
be observed. Looking at Figure 4.6A, it is clearly evident that the SC/MS-chitosan capsules 
are being taken up by the cells the most readily, with fluorescence clearly visible from the 
cytoplasm within the cells. It is likely that the cells are able to engulf the capsules through 
endocytosis.
44
 This would also have been aided by the reduced amount of aggregation by the 
particles, preventing them from agglomerating into masses above which the cells would be 
unable to internalise. Furthermore, chitosan is a positively charged material which would 
assist in the uptake across the negatively charged cellular membrane.  
The SC/MS-PAH capsules appear to be the next most engulfed capsules. Although 
these capsules do not demonstrate a large amount of fluorescence, this is in part due to the 
lower amount of curcumin per carrier. From the fluorescence which is occurring, it appears to 
be originating from within the cells. Like the SC/MS-chitosan capsules, SC/MS-PAH has also 
refrained from undergoing large amounts of aggregations, allowing for better engulfment by 
the cells.   
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4.3.5 Cytotoxicity of Curcumin-loaded Nanocapsules 
The cytotoxicity of the pristine (empty) and curcumin-loaded capsules was determined 
against MCF-7 breast cancer cells by incubating the cells with increasing concentrations of 
capsules and observing the cell viability as a percentage after 24 hours. Using the number of 
capsules present at each concentration, along with the calculated amount of drug present per 
capsule, the dosage of curcumin per cell was also calculated to allow for a clear comparison 
of the cytotoxic efficiency with regard to capsule type. The effect of the capsule fabrication 
method and polymer material was investigated, and the most effective capsule type was 
identified.  
Pristine capsules of each type, in which no curcumin was loaded, were tested to 
determine their cytotoxicity. It is very important that the capsules do not induce toxicity 
independently due to a number of reasons. One reason is that the control over cytotoxicity 
should reside in the drug itself or its dosage, as these properties can be tuned to each 
application. Another reason is that any cytotoxicity that occurs from pristine capsules will 
affect the cells in a different manner, where the mode of cytotoxicity will be dissimilar to that 
of the drug and possibly result in unexpected behaviour. Knowing the approximate number of 
capsules per concentration, and using the value of the number of cells seeded per well (2 x 
10
4
), the results have been displayed with reference to capsules per cell (Figure 4.7A).  
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Figure 4.7: The cytotoxicity profile before any loading with curcumin of (A) the four types of 
pristine capsules at the highest capsule concentration, and (B) the cytotoxic profile of SC/MS-PAH 
capsules as the capsule concentration increased.  
From the results seen in Figure 4.7A it is evident that all the capsules except the cross-
linked SC/MS-PAH capsules are not toxic before curcumin loading. For brevity, only the 
highest concentrations of the pristine capsules which showed low toxicity have been shown in 
Figure 4.7A, while the toxicity profile for the SC/MS-PAH capsules is displayed in further 
detail in Figure 4.7B . Even at very high concentrations there is no detectable cell death for 
the SC/MS-chitosan and both LbL capsules, which ensures that any cell death occurring after 
curcumin loading is a direct result of the drug. The only pristine capsules that have 
demonstrated a significant amount of cytotoxicity before any drug has been introduced is the 
SC/MS-PAH capsules, with less than 40 % cell viability at the highest concentration. 
Displayed as red bars in Figure 4.7B, it can be seen that the cell viability readily decreases 
with an increase in pristine SC/MS-PAH capsules.  
Despite the high toxicity of the SC/MS-PAH capsules before curcumin loading, it is 
clear from the high cell viability of the SC/MS-chitosan capsule that the toxicity is not a result 
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of the SC/MS method. Additionally, PAH is only toxic when in its cross-linked form. This is 
evident as both LbL capsule types also contain PAH, yet no toxicity was seen. Consequently, 
the significant toxicity of the SC/MS-PAH capsules before drug loading makes these capsules 
immediately less attractive as potential drug delivery vehicles.  
The cytotoxicity profile of the curcumin-loaded capsules, displayed in Figure 4.8, 
shows the required number of each type of capsule per cell to induce cell death. From these 
results it can be seen that the SC/MS-chitosan capsules are the most cytotoxic, requiring the 
lowest number of capsules per cell to induce cell death, followed by LbL-PAH. Interestingly 
the LbL-PSS capsules are more toxic than the SC/MS-PAH at lower concentrations, while at 
higher concentrations this is reversed. 
 
Figure 4.8: Profile of the number of capsules required per cell to induce cytotoxicity against MCF-7 
breast cancer cells. 
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From these results alone, there is no apparent advantage over the method of capsule 
fabrication that is used. At certain concentrations the SC/MS method demonstrates both the 
best and worst cytotoxicity. Instead it is a combination of the SC/MS approach along with 
chitosan acting as the carrier material which demonstrates the greatest cytotoxicity. This was 
not unexpected due to the combination of higher curcumin loading, low particle aggregation, 
positive polymer nature, and the greatest cellular uptake observed. Although all these 
properties contribute to the increase cytotoxicity seen by SC/MS-chitosan, it is unclear which 
factor is most influential.  
When observing the other capsules (SC/MS-PAH, LbL-PSS, LbL-PAH), there is no 
obvious trend between their cytotoxicity and cellular uptake, aggregation, or capsule charge. 
Nor is the cytotoxicity simply a reflection of curcumin loading per capsules. The drug loading 
of the LbL-PSS capsules is almost identical to that of SC/MS-chitosan, yet the cytotoxicity is 
much less. Furthermore, the curcumin loading of LbL-PSS is 28 % higher than that of the 
LbL-PAH capsules, yet the LbL-PAH capsules induce more toxicity.  
From the results in Figure 4.8 alone it is difficult to determine if the cytotoxicity is 
simply a result of cellular uptake. This is because the cytotoxicity will be dramatically 
affected by both the cellular uptake and the curcumin loading per capsule simultaneously, and 
as the loading is inconsistent between capsule types, it will be very difficult to interpret these 
two effects separately. This suggests the cytotoxicity is a result of a complex combination of 
properties. However, by using the calculations of the curcumin loading per capsules and the 
number of capsules at each concentration, the dose of curcumin that was present per cell could 
be plotted against the viability, allowing for a clearer comparison of the cytotoxic efficiency 
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of the different capsules and their chemical-physical effects regardless of the variation in 
curcumin loading.  
Only when the cell viability is plotted against the curcumin dose (Figure 4.9) it can be 
seen that the SC/MS template approach demonstrates a significant advantage over the LbL 
approach. The SC/MS-chitosan capsules are the most efficient at inducing cytotoxicity as they 
require the lowest dosage of 12 pg of curcumin per cell to induce 100 % cell death, followed 
next by SC/MS-PAH capsules which required 90 pg of curcumin. Although the LbL-PSS 
capsules never induced 100 % cell death, speculating from the graph it can be estimated that 
these capsules would have to deliver approximately 180 pg to each cell for >90 % cell death, 
while the LbL-PAH capsules require a dosage of 120 pg to each cell. Therefore, although the 
SC/MS-PAH capsules require more particles per cell to induce death, this is only a result of 
their decreased curcumin loading, and that they are actually more efficient at inducing 
cytotoxicity as the overall dosage of curcumin required is lower than that required by LbL 
capsules. As the drug loading is no longer a factor, the higher efficiency of the SC/MS 
capsules is likely due to the lower amount of aggregation that occurs when using the SC/MS 
templates which effects the amount of cellular uptake that occurs.  
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Figure 4.9: The cytotoxic efficiency of the different capsule types. 
Interestingly, the dosage required per cell by the LbL capsules are both over an order 
of magnitude more than the amount required for the SC/MS-chitosan capsules. From these 
results along with the confocal images, it becomes increasingly probable that at higher 
concentrations there is a very limited amount of cellular uptake of the capsules bar the 
SC/MS-chitosan capsules. This is also supported by the behaviour of toxicity as the capsule 
concentrations increase. Looking back at Figure 4.8, at low capsule concentrations (<5,000) 
both LbL capsules are relatively toxic, and dropping the cell viability down to 40 % very 
quickly. At this same concentration the SC/MS-PAH capsules have only dropped the cell 
viability to 70 %. In contrast, as the capsule concentrations increase (>25,000), although the 
SC/MS-PAH capsules continue to show a steady increase in toxicity, indicating proportional 
cellular uptake occurring, the LbL capsules begin to lose their effectiveness at inducing 
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toxicity as the concentration increases, suggesting that less uptake is occurring. This type of 
behaviour indicates that unlike the SC/MS-chitosan and SC/MS-PAH which has not 
demonstrated a large amount of aggregation, the LbL capsules aggregate once the capsule 
concentration increases above a point, so that the amount of cellular uptake is very limited. 
To compare the cytotoxic efficiency of encapsulated curcumin against un-
encapsulated, free curcumin, the curcumin powder was dissolved in media and added to the 
cells at similar concentrations to those where toxicity was seen. Both fresh curcumin and 
curcumin incubated in media overnight were tested to increase the accuracy of the results. The 
overnight curcumin was used to simulate the curcumin within the capsules that had been 
incubated for 12 hours during the drug infiltration stage. However, as curcumin is known to 
degrade very quickly in aqueous environments,
43
 fresh curcumin was also used to simulate the 
un-degraded curcumin that would have been present in the capsules.  
Seen in Figure 4.10, both the overnight and fresh free curcumin are much less efficient 
at inducing cytotoxicity than the encapsulated curcumin. It is believed that the lower 
efficiency of un-encapsulated curcumin may be due to an increase in drug degradation which 
would occur on exposure to the biological environment, instantly reducing its cytotoxic 
properties. In addition, as the curcumin is administered as free molecules, it would diffuse 
throughout the cell media. This would generate an even but low concentration of drug in the 
media, and as this molecule is taken up by the cell through diffusion, the local concentration 
may not be great enough for much internalization. In contrast, encapsulation of curcumin 
prevents drug degradation which results in a higher toxic effect, as well as potentially more 
curcumin internalisation due to capsule-facilitated endocytotic uptake. Similarly, it has been 
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previously demonstrated that loading drugs within nanocarriers significantly enhances its 
efficiency by allowing higher uptake of drug carrier system over free drug molecules.
21
 Since 
it is well known that curcumin and several other chemotherapeutic drugs are unstable in 
aqueous environments,
45-47
 nano-encapsulation of such drug molecules provides a significant 
opportunity to achieve higher efficiency of existing chemotherapeutic drugs.  
 
Figure 4.10: A comparison of the cytotoxicity of the free curcumin and the various curcumin-
loaded capsules.  
4.4 Conclusion 
This chapter demonstrates that the SC/MS method paired with the polymer chitosan 
establishes a capsule system of superior properties, optimal for the application in drug 
delivery. Although the LbL approach for capsule synthesis has been employed in countless 
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studies over the last two decades,
14-20
 there are few reports on its use at the nanoscale.
30,32-34
 
Furthermore, to the author’s knowledge there are currently no reports comparing the 
extensively used LbL method with the lesser used SC/MS method for capsule synthesis. 
Throughout this chapter the SC/MS and LbL methods have been compared, where it was 
found that employing the SC/MS approach for nanocapsule fabrication allows for an easier 
method of fabrication, with capsules that demonstrate improved capsule wall thickness and 
less aggregation when compared to the more laborious LbL approach. Furthermore, the 
increased aggregation occurring as a result of the LbL approach was found to be the 
influencing factor in the cytotoxic efficiency of the sub-micron capsules. When comparing the 
polymeric material used, chitosan demonstrated to be the most suitable due to its 
biocompatibility, high drug loading capacity, and its polysaccharide nature which encourages 
more cellular uptake. These properties combined establish a nanocapsule system which 
demonstrates the optimum cytotoxic efficiency and the greatest potential in drug delivery 
applications.  
 
 
139 
 
4.5 References 
1 Moinard-Checot, D., Chevalier, Y., Briançon, S., Fessi, H. & Guinebretière, S. 
Nanoparticles for drug delivery: Review of the formulation and process difficulties 
illustrated by the emulsion-diffusion process. Journal of nanoscience and 
nanotechnology 6, 9-10 (2006). 
2 Tiarks, F., Landfester, K. & Antonietti, M. Preparation of polymeric nanocapsules by 
miniemulsion polymerization. Langmuir 17, 908-918 (2001). 
3 Lee, M. Y., Min, S. G., Bourgeois, S. & Choi, M. J. Development of a novel 
nanocapsule formulation by emulsion-diffusion combined with high hydrostatic 
pressure. Journal of microencapsulation 26, 122-129 (2009). 
4 Randolph, T. W., Randolph, A. D., Mebes, M. & Yeung, S. Sub‐Micrometer‐Sized 
Biodegradable Particles of Poly (L‐Lactic Acid) via the Gas Antisolvent Spray 
Precipitation Process. Biotechnology progress 9, 429-435 (1993). 
5 Ré, M. Microencapsulation by spray drying. Drying technology 16, 1195-1236 (1998). 
6 Vehring, R. Pharmaceutical particle engineering via spray drying. Pharmaceutical 
research 25, 999-1022 (2008). 
7 Calvo, P., Vila-Jato, J. L. & Alonso, M. J. Evaluation of cationic polymer-coated 
nanocapsules as ocular drug carriers. International Journal of Pharmaceutics 153, 41-
50 (1997). 
8 Radtchenko, I. L. et al. Assembly of alternated multivalent ion/polyelectrolyte layers 
on colloidal particles. Stability of the multilayers and encapsulation of 
macromolecules into polyelectrolyte capsules. Journal of Colloid and Interface 
Science 230, 272-280 (2000). 
9 Stella, B. et al. Encapsulation of gemcitabine lipophilic derivatives into 
polycyanoacrylate nanospheres and nanocapsules. International Journal of 
Pharmaceutics 344, 71-77 (2007). 
10 Mora-Huertas, C. E., Fessi, H. & Elaissari, A. Polymer-based nanocapsules for drug 
delivery. International Journal of Pharmaceutics 385, 113-142 (2010). 
11 Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R. & Rudzinski, W. E. 
Biodegradable polymeric nanoparticles as drug delivery devices. Journal of 
Controlled Release 70, 1-20 (2001). 
12 Fernández‐Nieves, A. et al. Optically anisotropic colloids of controllable shape. 
Advanced Materials 17, 680-684 (2005). 
13 Hsu, P., Poulin, P. & Weitz, D. Rotational diffusion of monodisperse liquid crystal 
droplets. Journal of Colloid and Interface Science 200, 182-184 (1998). 
14 Donath, E., Sukhorukov, G. B., Caruso, F., Davis, S. A. & Möhwald, H. Novel 
Hollow Polymer Shells by Colloid-Templated Assembly of Polyelectrolytes. 
Angewandte Chemie International Edition 37, 2201-2205 (1998). 
140 
 
15 Caruso, F., Caruso, R. A. & Möhwald, H. Nanoengineering of Inorganic and Hybrid 
Hollow Spheres by Colloidal Templating. Science 282, 1111-1114 (1998). 
16 Caruso, F. Hollow Capsule Processing through Colloidal Templating and Self-
Assembly. Chemistry - A European Journal 6, 413-419 (2000). 
17 Peyratout, C. S. & Dähne, L. Tailor-Made Polyelectrolyte Microcapsules: From 
Multilayers to Smart Containers. Angewandte Chemie International Edition 43, 3762-
3783 (2004). 
18 Quinn, J. F., Johnston, A. P. R., Such, G. K., Zelikin, A. N. & Caruso, F. Next 
generation, sequentially assembled ultrathin films: beyond electrostatics. Chemical 
Society Reviews 36 (2007). 
19 Sablon, K. Single-component polymer nanocapsules for drug delivery application. 
Nanoscale Research Letters 3, 265-267 (2008). 
20 Wang, Y., Angelatos, A. S. & Caruso, F. Template Synthesis of Nanostructured 
Materials via Layer-by-Layer Assembly†. Chemistry of Materials 20, 848-858 (2007). 
21 Wang, Y., Bansal, V., Zelikin, A. N. & Caruso, F. Templated Synthesis of Single-
Component Polymer Capsules and Their Application in Drug Delivery. Nano Letters 
8, 1741-1745 (2008). 
22 Liang, K. et al. Charge-Shifting Click Capsules with Dual-Responsive Cargo Release 
Mechanisms. Advanced Materials 23, H273-H277 (2011). 
23 Ochs, C. J., Such, G. K., Sta  dler, B. & Caruso, F. Low-Fouling, Biofunctionalized, 
and Biodegradable Click Capsules. Biomacromolecules 9, 3389-3396 (2008). 
24 Such, G. K., Tjipto, E., Postma, A., Johnston, A. P. R. & Caruso, F. Ultrathin, 
Responsive Polymer Click Capsules. Nano Letters 7, 1706-1710 (2007). 
25 Ochs, C. J., Such, G. K., Yan, Y., van Koeverden, M. P. & Caruso, F. Biodegradable 
Click Capsules with Engineered Drug-Loaded Multilayers. ACS Nano 4, 1653-1663 
(2010). 
26 Zhang, Y., Guan, Y., Yang, S., Xu, J. & Han, C. C. Fabrication of Hollow Capsules 
Based on Hydrogen Bonding. Advanced Materials 15, 832-835 (2003). 
27 Sukhorukov, G., Fery, A. & Möhwald, H. Intelligent micro-and nanocapsules. 
Progress in Polymer Science 30, 885-897 (2005). 
28 Decher, G. & Hong, J.-D. Buildup of ultrathin multilayer films by a self-assembly 
process, 1 consecutive adsorption of anionic and cationic bipolar amphiphiles on 
charged surfaces. Makromolekulare Chemie. Macromolecular Symposia 46, 321-327 
(1991). 
29 Johnston, A. P. R., Read, E. S. & Caruso, F. DNA Multilayer Films on Planar and 
Colloidal Supports:  Sequential Assembly of Like-Charged Polyelectrolytes. Nano 
Letters 5, 953-956 (2005). 
30 Gittins, D. I. & Caruso, F. Multilayered Polymer Nanocapsules Derived from Gold 
Nanoparticle Templates. Advanced Materials 12, 1947-1949 (2000). 
141 
 
31 Lamprecht, A. & Benoit, J.-P. Etoposide nanocarriers suppress glioma cell growth by 
intracellular drug delivery and simultaneous P-glycoprotein inhibition. Journal of 
Controlled Release 112, 208-213 (2006). 
32 Gittins, D. I. & Caruso, F. Tailoring the Polyelectrolyte Coating of Metal 
Nanoparticles. The Journal of Physical Chemistry B 105, 6846-6852 (2001). 
33 Schneider, G. & Decher, G. From Functional Core/Shell Nanoparticles Prepared via 
Layer-by-Layer Deposition to Empty Nanospheres. Nano Letters 4, 1833-1839 (2004). 
34 Städler, B., Price, A. D. & Zelikin, A. N. A Critical Look at Multilayered Polymer 
Capsules in Biomedicine: Drug Carriers, Artificial Organelles, and Cell Mimics. 
Advanced Functional Materials 21, 14-28 (2011). 
35 Büchel, B., Klaus, K. U., Akihiko, M. & Kazuo, T. A Novel Pathway for Synthesis of 
Submicrometer-Size Solid Core/Mesoporous Shell Silica Spheres. Advanced Materials 
10, 1036-1038 (1998). 
36 Caruso, F., Trau, D., Möhwald, H. & Renneberg, R. Enzyme encapsulation in layer-
by-layer engineered polymer multilayer capsules. Langmuir 16, 1485-1488 (2000). 
37 Schmitt, J. et al. Internal structure of layer-by-layer adsorbed polyelectrolyte films: a 
neutron and X-ray reflectivity study. Macromolecules 26, 7058-7063 (1993). 
38 Sukhorukov, G. B. et al. Layer-by-layer self assembly of polyelectrolytes on colloidal 
particles. Colloids and Surfaces A: physicochemical and engineering aspects 137, 
253-266 (1998). 
39 Voigt, A. et al. Membrane filtration for microencapsulation and microcapsules 
fabrication by layer-by-layer polyelectrolyte adsorption. Industrial & engineering 
chemistry research 38, 4037-4043 (1999). 
40 Ilium, L. Chitosan and its use as a pharmaceutical excipient. Pharmaceutical research 
15, 1326-1331 (1998). 
41 Sivakumar, S. et al. Degradable, Surfactant-Free, Monodisperse Polymer-
Encapsulated Emulsions as Anticancer Drug Carriers. Advanced Materials 21, 1820-
1824 (2009). 
42 Caruso, F., Caruso, R. A. & Mohwald, H. Production of Hollow Microspheres from 
Nanostructured Composite Particles. Chemistry of Materials 11, 3309-3314 (1999). 
43 Mehta, K., Pantazis, P., McQueen, T. & Aggarwal, B. B. Antiproliferative effect of 
curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs 
8, 470–481 (1997). 
44 Shukla, R. et al. Biocompatibility of gold nanoparticles and their endocytotic fate 
inside the cellular compartment: a microscopic overview. Langmuir 21, 10644-10654 
(2005). 
45 Oetari, S., Sudibyo, M., Commandeur, J. N. M., Samhoedi, R. & Vermeulen, N. P. E. 
Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat 
liver. Biochemical Pharmacology 51, 39-45 (1996). 
142 
 
46 Pandey, R., Sharma, S. & Khuller, G. K. Chemotherapeutic Efficacy of Nanoparticle 
Encapsulated Antitubercular Drugs. Drug Delivery 13, 287-294 (2006). 
47 Wang, Y.-J. et al. Stability of curcumin in buffer solutions and characterization of its 
degradation products. Journal of Pharmaceutical and Biomedical Analysis 15, 1867-
1876 (1997). 
 
 
143 
 
4.6 Appendix 
4.6.1 Quantifying of the number of capsules 
For an effective comparison of the fabricated capsules and their properties, ie drug 
loading, cytotoxicity etc, the number of capsules had to be known. However, due to the 
difficulty in determining the number of capsules fabricated through optical or counting 
methods, we based our calculations on the number of template particles, with the assumption 
that each template particle resulted in a capsule.   
Due to the optical properties of silica, the particle number could not be determined by 
atomic absorption spectroscopy or a particle counter. Therefore a similar approach to many 
cell counting techniques was employed, whereby the number of particles were counted in a 
smaller sample size and then multiplied. A known mass of the largest available spheres (490 
nm) was dispersed in water and diluted down multiple times. Next 0.5 µL was drop cast onto 
an SEM stub and the number of particles present in the droplet were counted. Due to the 
extremely large number of particle and the time consuming process of particle counting, only 
the large sized solid cores were counted by this method. 
It was assumed that the density of silica within the particles, regardless of their 
diameter, was the same. Using this information, and knowing the number of 490 nm spheres 
present in 1 mg of silica powder, the relative number of particles per mg of silica power of the 
LbL and SC/MS template particles could be calculated using their diameter. However, this 
method of calculation could only be used before the addition of a mesoporous shell required 
in the SC/MS template. Therefore,  before the mesoporous shell was grown on the SC/MS 
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particles, the number of solid core (SC) particles was calculated, and the change in weight that 
occurred due to the addition of the mesoporous shell (measured before and after shell growth) 
had to be taken into account and used to recalculate the number of particles.  
Due to the assumption that each template particle resulted in a capsules, it is important 
to note the potential error that could have occurred. However, due to the inability to count the 
capsules in any other manner we found this process of particle calculation to be satisfactory. 
Furthermore, to decrease the potential error during the sample counting of the large particles, 
over 1000 particles were counted.  
 
 
  
145 
 
CHAPTER 5 
SC/MS TEMPLATED SYNTHESIS OF CHITOSAN 
NANOCAPSULES FOR DRUG DELIVERY 
APPLICATIONS 
 
Amphiphilic nanoparticulate carriers have gained intense interest as potential drug delivery 
vehicles for a myriad of biomedical applications. However, many current development 
methods lack control and consistency in the structural characteristics of the drug delivery 
vehicles. This chapter focuses on the successful production of homogeneous chitosan 
nanocapsules with tunable properties such as controlled capsule size, shell thickness and 
porosity. Through a facile template-mediated approach using SC/MS silica nanoparticles with 
variable core size, mesoporous shell thickness and porosity, chitosan nanocapsules with 
replicated structural properties have been developed.  The anti-cancer drug curcumin was 
used to act as a model drug-in-oil substance to demonstrate the drug-encapsulation efficiency 
and cell toxicity as a function of capsule size, thickness and porosity. The cell toxicity of the 
nanocapsules was also determined in an in vitro study with P815 Mouse cells, whereby the 
chitosan capsules on their own showed low toxicity, which increased drastically with 
curcumin loaded capsules. This study provides a detailed investigation into a novel method of 
chitosan nanocapsule synthesis, as well as the effect of the synthesis parameters on the drug-
loading and cellular toxicity of these capsules. 
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5.1 Introduction  
Chitosan [Poly-(1,4) 2-amino-2-deoxy-β-D-glucan] is a biopolymer that has shown 
immense promise as a preferred carrier system due to its broad range of proven biomedical 
applications (the chemical structure is shown in Figure 5.1) .
1,2
 Unlike most polypeptides 
which are typically immunogenic, chitosan is a polysaccharide and demonstrates low 
immunogenicity, low toxicity, and good mechanical properties.
3
 Furthermore, chitosan can be 
broken down in the body by lysozymes to harmless N-acetyl glucosamine making the 
biodegradable material highly desirable in forming carrier vehicles for drug delivery.
4
 Due to 
the advantages of chitosan nanocapsules, further investigation into these particles has been 
made to increase their potential as drug delivery vehicles. 
 
Figure 5.1. The chemical structures of chitosan
5
 
Different approaches have been undertaken in the past to prepare chitosan-based 
nanoparticulate systems, including chitosan nanosphere and bead fabrication by way of 
emulsion cross-linking,
6-8
 spray-drying,
9-11
 coacervation/precipitation,
12
 ionic gelation,
13-15
 the 
emulsion-droplet coalescence method,
16
 the reverse micellar method,
17
 and the sieving 
method.
18
 Although these particles represent very promising drug delivery platforms, most of 
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these methods produce solid chitosan particles, thereby restricting their drug loading capacity 
to the carrier system and neglecting to protect the drug from degradation by the external 
environment. Moreover, it is extremely difficult to control the polydispersity of the chitosan 
particles synthesized via these routes, thus limiting their ability to control the drug payload 
during administration. 
Demonstrated in the previous chapter, the use of a solid core/mesoporous shell silica 
template into which chitosan is deposited, followed by subsequent removal of the template 
matrix, can result in a chitosan nanocapsule with superior drug delivery properties. The 
combination of the SC/MS method and chitosan acting as the polymer material demonstrated 
significant drug loading and cytotoxic efficiency over other templating method and polymers 
tested, exhibiting good monodispersity, a high loading capacity of a drug-in-oil mixture, low 
cytotoxicity before drug infiltration, and efficient cytotoxicity after drug is incorporated into 
the capsules.  
The choice of polymer material is not the only factor in determining a nanocapsule’s 
therapeutic capabilities. A range of structural properties, such as the nanocapsule size, shape, 
wall thickness and porosity may play an important yet complex role in determining the 
therapeutic efficiency of the particle. These properties can affect the drug loading capacity, 
the cellular uptake and cytotoxic efficiency against cells.
19-22
 By altering these structural 
features, their individual effects can be investigated, and the properties that are most 
influential can be identified.   
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5.1.1 Rationale 
The structural characteristics of a drug delivery system can define its application and 
affect its functionality. In this chapter it is demonstrated for the first time that, by tuning 
relevant features of the sacrificial SC/MS template, chitosan nanocapsules of controllable 
size, wall thickness and porosity can be fabricated. The approach presented here combines the 
versatility of solid core particles with the high loading capacity of mesoporous shells to 
prepare nearly monodispersed chitosan capsules of three different diameters (220, 270 and 
440 nm), three different wall thickness (28, 45 and 56 nm), and three different pore sizes 
(inversely corresponding to template pore diameter of 2.9, 3.68 and 4.85 nm). This led to 
seven structurally different chitosan capsules, amongst which one capsule type was common 
with the intermediate features of 270 nm for capsule size, 45 nm wall thickness and 3.68 nm 
template pore size. To understand the role of different structural properties (size, wall 
thickness and porosity) of the chitosan nanocapsules in drug delivery, these capsules were 
further infiltrated with curcumin, a hydrophobic anticancer drug, naturally found in the yellow 
curry spice turmeric,
23
 and the effect of these seven different types of curcumin-loaded 
chitosan nanocapsules on the cell viability of mouse mastocytoma cells was studied.  
And finally, although nanocapsular systems have been heavily studied,
24-34
 it is not 
entirely clear which amongst the various structural properties plays the dictating role in 
determining their therapeutic efficiency. It is the aim of this study to decouple the effects of 
the size, shell thickness and porosity of nanocapsular polymer vehicles to enable researchers 
in identifying the most influential structural feature of nanocapsule-based drug delivery 
systems. 
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5.2 Experimental Section 
In this chapter we have fabricated seven structurally different SC/MS template 
particles. This was achieved by fabricating three different sized solid silica cores based on the 
method optimised in Chapter 3, followed by a secondary stage of synthesis where a 
mesoporous shell of various thickness and porosity was grown onto each of the cores. By 
employing these SC/MS silica particles as sacrificial templates into which chitosan polymer 
was infused and cross-linked, several structurally diverse chitosan nanocapsules were 
fabricated (Figure 5.2). 
5.2.1 Preparation of Solid Silica Particles 
Based on the modified Stöber method
35
 used in chapter 3, the solid core (SC) silica 
spheres were prepared in appropriate amounts of ethanol, deionized water (MilliQ) and 
ammonia solution (28%) as per Table 5.1 and the solutions were mixed well before heating to 
the required temperature. After the solution temperature had stabilised, 75 µL of 
tetraethoxysilane (TEOS) was added and the solution was mixed for 4 seconds. The solutions 
were then kept very still and held at their appropriate temperatures while the reaction took 
place over a 1 hour period.  
 
Table 5.1: The experimental conditions for the synthesis of the three size solid cores of the SC/MS 
silica template particles. 
 
Template Type Ethanol (µL) Water (µL) Ammonia (µL) Temperature (°C)  Core Size (nm)
TempC1 1000 135 100 30 170 ± 12
TempC  1000 135 113 25 290 ± 24
TempC2 1000 135 133 18 490 ± 14
150 
 
 
Figure 5.2: Schematic representation of the solid core/ mesoporous shell (SC/MS) approach 
employed to fabricate seven different types of chitosan nanocapsules with different structural 
features, with one common type of SC/MS template in each category (highlighted by an arching 
triangle).  
5.2.2 Preparation of SC/MS Silica Templates 
To grow the mesoporous shell (MS) of specified thickness and porosity on the solid 
cores, solutions containing mixtures of TEOS and n-octadecyltrimethoxysilane (ODTMS) 
were slowly added to the solutions from the previous step containing solid core silica particles 
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over a period of 20 min at 25 °C under shaking conditions (Table 5.2 for the TEOS and 
OTMS volumes).  
 
Table 5.2: The experimental conditions for the synthesis of the mesoporous shells of the SC/MS 
silica template particles. 
Note that there are significant variations in the total volume of the TEOS/OTMS 
solutions, as well as the ratios of TEOS:ODTMS that have been used. The solutions were then 
incubated under shaking at 25 °C for 1 hour, followed by centrifugation and washed three 
times with ethanol to obtain the precipitated powder. This powder was heated to 550 °C for 6 
h to remove the porogen ODTMS through calcination, this resulted in the SC/MS silica 
particle templates.  
The obtained SC/MS templates were characterised by scanning and transmission 
electron microscopy (SEM and TEM). The surface area and pore diameter of the SC/MS 
templates were measured using the (BET) technique.
36
  
Template Type TEOS (µL) ODTMS (µL)
Shell Thickness 
(nm)
TempCSP 65 13 46 ± 7
TempC1SP 125 25 49 ± 16
TempC2SP 5 1 42 ± 13
TempCS1P 25 5 31 ± 21
TempCS2P 135 27 55 ± 12
TempCSP1 70 7 42 ± 9
TempCSP2 50 25 48 ± 14
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5.2.3 Preparation of Chitosan Nanocapsules 
The chitosan capsules were fabricated using the same method employed in chapter 4. 
Briefly, the capsules were prepared by dispersing 5 mg SC/MS template particles in 450 µL 
of deionised water, followed by overnight incubation after adding 1 mL aqueous solution 
containing 4 mg low molecular weight chitosan (Sigma Aldrich – dissolved using 0.8% acetic 
acid) in pH 7.2 phosphate buffer saline (PBS). Following overnight incubation, the chitosan-
infiltrated SC/MS particles were obtained by centrifugation, and redispersed in 800 µL PBS 
and 50 µL glutaric dialdehyde for 2 hours to cross-link the chitosan within the mesoporous 
shell of SC/MS particles. After washing three times with deionized water, the SC/MS silica 
template was removed by hydrofluoric acid (2M) treatment in an ammonium hydroxide buffer 
(8M), followed by centrifugation and repetitive washing with deionised water (Warning: 
hydrofluoric acid is highly corrosive, and extreme care should be taken while handling 
hydrofluoric acid). The chitosan nanocapsules thus obtained were analysed using TEM, and 
the thickness of the capsule wall was determined from TEM images of ultramicrotomed 
sections of capsules embedded within epoxy resin. The degree of chitosan loaded within the 
mesoporous shell of SC/MS silica template was determined by thermogravimetric analysis 
(TGA) using Perkin Elmer Pyris 1 TGA instrument.  
5.2.4 Loading and Quantification of Curcumin in Chitosan Nanocapsules 
Following the synthesis of seven different types (different sizes, wall thicknesses and 
porosities) of chitosan nanocapsules, these capsules were dehydrated in ethanol and dispersed 
in curcumin/oleic acid mixture (10 µg curcumin per mL of oleic acid) to allow infiltration of 
the oil phase through the porous walls of chitosan nanocapsules and filling the capsules over a 
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period of 12 hours on a rotary shaker. Following incubation, curcumin-loaded chitosan 
nanocapsules were obtained by centrifugation and washed thrice with hexane to remove any 
non-infiltrated curcumin/oleic acid. These curcumin-filled chitosan capsules were found to 
make stable dispersions on addition to water and biological buffers. The high solubility of 
curcumin in absolute ethanol was exploited to determine the curcumin loading within 
different type of chitosan nanocapsules by exposing the drug-infiltrated capsules to absolute 
ethanol after their precipitation. This resulted in the release of all the curcumin internalized 
within chitosan capsules to the supernatant, which was further quantified by making standard 
curves using a Cary 50 Bio UV-Vis spectrophotometer at absorbance maxima of curcumin at 
430 nm. 
5.2.5 Cellular Uptake and Cytotoxicity of Curcumin-loaded Chitosan 
Nanocapsules 
P815 mouse mastocytoma cells (obtained from Manassas, VA, USA) were used to 
study both the uptake and the toxicity of the chitosan nanocapsules. The cells were cultured in 
RPMI-1640 media (Sigma) containing 10% FBS and supplemented with gentamycin, glucose, 
pyruvate, 2-mecaptoethanol and L-glutamine. The cells were maintained in a humidified 
incubator at 37 °C and 5% CO2. For cell uptake studies, 10
5
 P815 cells were exposed to 10
8
 
chitosan capsules for 24 h, followed by cell harvesting, washing three times with PBS, and 
seeding onto glass slides for imaging by confocal laser scanning microscopy (CLSM; Nikon 
A1 Confocal Microscope). As the glutaraldehyde cross-linking step during chitosan 
nanocapsules makes them highly fluorescent, fluorescent dye labelling was not required for 
CLSM studies.  
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To determine the efficiency of curcumin-infiltrated chitosan capsules on cell mortality 
of P815 mouse mastocytoma cells, 10
5
 cells were exposed to different numbers (final 
concentration ranging from 10
5
 to 10
8
 capsules per treatment) of seven different types of 
capsules for 24 h in 96-well plates under appropriate growth conditions as explained in the 
previous section. This was followed by determination of cellular viability using a soluble 
tetrazolium-based colorimetric assay (Promega MTS CellTiter 96® aqueous kit) and 
measuring the absorbance at 490 nm using a microplate reader (Perkin Elmer, USA). The 
same experiments were performed on pristine chitosan capsules, which served as a control. 
Since pristine capsules did not show significant cytotoxicity, for brevity, only the mean 
cytotoxicity of seven different types of pristine chitosan capsules used in this study has been 
shown. The cytotoxicity studies of curcumin dispersed in water was also performed for 
comparison. Each treatment was performed in quadruplicate and repeated three times, which 
means that the data presented here is an average of 12 experiments, with standard error of 
mean shown as error bars. 
5.3 Results and Discussion 
Several modifications were made to the protocol, including variations in the reaction 
temperature, as well as ammonia, porogen and TEOS concentration during particle synthesis 
to achieve SC/MS silica particles of different solid core sizes (TempC1SP, TempCSP and 
TempC2SP); mesoporous shell thicknesses (TempCS1P, TempCSP and TempCS2P); and 
porosities (TempCSP1, TempCSP and TempCSP2) (Figure 5.3), wherein variable ‘C’ 
corresponds to different core diameters, ‘S’ corresponds to shell thicknesses and ‘P’ 
corresponds to different porosity levels. To compare the structural variations and their effects 
155 
 
between templates and the resulting capsules, TempCSP particles were used as a common 
control in the three sections of size, shell thickness and porosity. Furthermore, TempCSP is 
the same SC/MS template used in chapter 4, allowing comparisons between the results of the 
previous and current chapters.  
The synthesised SC/MS particles were then employed to fabricate chitosan 
nanocapsules with comparable structural characteristics with their corresponding templates, 
with variations in capsule size (CapC1SP, Cap CSP, and CapC2SP), capsule wall thickness 
(CapCS1P, CapCSP, and CapCS2P), and capsule wall porosity/density (CapCSP1, CapCSP, 
and CapCSP2). 
5.3.1 Capsules with Different Diameters 
The size of a drug delivery vehicle can have a dramatic effect on the clinical 
application of particles due to major influences in their drug loading capabilities, retention 
time in the body, and the efficiency in cellular uptake.
19,20,37
 Consequently, by controlling the 
size of a drug delivery vehicle it is possible to tune these characteristics for a particular 
application rather than have the application dictated by the capabilities (and limitations) of a 
drug vehicle of a single size. In this section, we showed that chitosan nanocapsules of 
different diameter can be fabricated by controlling the size of the template particles from 
which they are formed, and in doing so, demonstrate the variation in their potential to act as 
drug delivery vehicles. 
The chitosan nanocapsules were fabricated using SC/MS silica particles as template, 
however, before the growth of a mesoporous shell on these template particles, solid core 
particles were first fabricated based on the method used and optimised throughout Chapter 3. 
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At the time that these experiments were carried out the smallest and largest silica spheres that 
were successfully achieved with high monodispersitiy were 170 nm and 490 nm in diameter. 
These were achieved by altering the reaction temperature and the ammonia concentration 
during particle synthesis. As discussed in Chapter 3, the particle size is inversely related to the 
reaction temperature, and to a lesser extent directly related to the ammonia concentration. An 
intermediate solid core silica sphere of 290 nm was also grown using intermediate 
temperature and ammonia parameters. The three particles of increasing core size from 170, 
290 and 490 nm will be referred to as TempC1, TempC andTempC2 for brevity, and are 
displayed in Figure 5.3 A-C.   
After synthesis of the near monodispersed solid silica cores, these particles were used 
to develop three SC/MS template by growing a secondary, mesoporous shell on the surface. 
To better compare the effect of their core size on the resulting capsules, the mesoporous shells 
were all grown to ~45 nm in thickness (see Table 5.3). However, as the surface area of the 
particles varied significantly from 25.9 m
2
g
-1 
(for the particles with the smallest diameter) to 
8.5 m
2
g
-1 
(for the largest particles), the amount of TEOS/TMS mixture added had to be in 
accordance with this change (see Table 5.2) After the growth of the mesoporous shells, the 
surface area of the particles then rose to 300.0, 252.6 and 164.2 m
2
g
-1
 from the smallest to 
largest SC/MS templates, respectively (see Table 5.3). The solid core particles of three 
different diameters with ~45 nm mesoporous shell were now of total diameter 268 ± 14 nm 
(TempC1SP), 382 ± 19 nm (TempCSP) and 574 ± 12 nm (TempC2SP), with the SEM images 
shown in Figure 5.3 D-F. 
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Table 5.3: A summary of the structural characteristics of i) the solid cores (before mesoporous shell 
growth) of the SC/MS templates, and ii) the SC/MS templates. 
The SC/MS silica templates with three significantly different sized cores were then 
employed in the aim to fabricate chitosan nanocapsules with similar capsule wall thickness 
and porosity, but with a hollow inner cavity that would closely compare to the diameter of the 
solid cores of their corresponding templates. The chitosan capsules were fabricated by 
incubating aqueous chitosan solution with the appropriate SC/MS silica template, followed by 
polymer cross-linking using glutaraldehyde and subsequent removal of the silica template. 
Illustrated in Figure 5.3 G-I are the TEM images of chitosan nanocapsules of different 
diameters synthesized using the SC/MS silica templates shown in Figure 5.3 D-F, 
respectively. By utilizing templates of increasing diameter, the resulting size of the capsules 
can be controlled accordingly. It can be seen from Figure 5.3 G-I that the total diameter of the 
chitosan capsules, including wall thickness, increased to ca. 220 nm, 270 nm and 440 nm with 
respect to the increase in template size of 268 nm, 380 nm and 574 nm, respectively. This 
Template Description
Core Size 
(nm)
MP Shell 
Thickness (nm)
Surface Area 
(m²  g-1)
Pore Size in 
Shell (nm)
Pore Volume 
(mL g-1)
Solid Cores
TempC1 Small diameter 170 ± 12 - 25.86 - -
TempC Medium Diameter 290 ± 24 - 14.37 - -
TempC2 Large Diameter 490 ± 14 - 8.50 - -
Solid Cores, Mesoporous Shell
TempC1SP
Medium Diameter, Medium 
Shell Thickness, Medium 
Pores Size
290 ± 24 46 ± 7 252.6 3.68 0.27
TempCSP
Small diameter, Medium 
Shell Thickness, Medium 
Pore size
170 ± 12 49 ± 16 300.0 5.12 0.44
TempC2SP
Large Diameter, Medium 
Shell Thickness, Medium 
Pore Size
490 ± 14 42 ± 13 164.2 3.30 0.16
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correlation is further displayed in Figure 5.4, which demonstrated the relative increase in the 
capsule size. The capsules are in good accordance with the templates and demonstrated 15–30 
% shrinkage when imaged in the TEM. However, a large amount of shrinkage would only 
occur upon drying before TEM imaging.  
   
Figure 5.3: SEM images of different sizes of solid silica cores (A-C), corresponding to (A) TempC1, 
(B) TempC, and (C) TempC2. These solid cores where then employed to fabricate the  solid 
core/mesoporous shell (SC/MS) silica templates (D-F), which correspond to (D) TempC1SP, (E) 
TempCSP and (F) TempC2SP, respectively. (G-I) TEM images of chitosan nanocapsules of three 
different sizes (G) CapC1SP, (H) CapCSP and (I) CapC2SP, synthesized using (D-F) as templates, 
respectively. Scale bars correspond to 500 nm. 
BA C
D FE
500 nm
BH IG
159 
 
 
Figure 5.4: The correlation between the size of the SC/MS template particles and the size of the 
capsules fabricated from the respective template.   
Following the synthesis of these chitosan nanocapsules with significantly different 
diameters, their drug loading capabilities were investigated to determine what effect the size 
of the nanocapsules has. One of the major advantages of using capsular systems is the ability 
to separate the encapsulated material from the surrounding environment. This enables an oil 
phase to be incorporated into a hydrophilic environment through its encapsulation into a 
partically amphiphilic capsule, bypassing the difficulties that can arise when trying to 
introduce an oil phase into an aqueous phase.  
Even though chitosan is known to act as a hydrophilic biopolymer due to its amine 
groups, it can also accommodate hydrophobic components within its partially hydrophobic 
centre, and this advantageous ability of introducing oil in water was demonstrated. By 
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incubating the chitosan nanocapsules in a curcumin/oleic acid mixture the drug/oil was 
allowed to permeate through the semi-porous walls of the capsules before the system was 
transferred to hydrophilic phosphate buffer (pH 7.2). This technique has been previously used 
to investigate the drug/oil encapsulation in other nanocapsular systems using a technique 
reported by Sivakumar et al.
38
  
Curcumin was used as a model anticancer drug because recent studies have established 
that not only does it inhibit the growth of a number of human cancer cell lines, it is also a 
potent anti-oxidant and it possesses anti-proliferative activities against tumor cells in vitro. 
Furthermore, as shown in chapter 4, curcumin has limited applicability due to its instability in 
the aqueous environment,
39
 but encapsulation of curcumin within the capsules prevents the 
degradation of the compound and enables the investigation of its toxicity during its active 
form. 
 
Figure 5.5: A representation to the loading of curcumin per capsule with regards to the A) 
capsule type, and B) capsule size. 
After dehydration of the internalised drug/oil solution, the drug loading was quantified 
using UV-vis spectroscopy. As expected, the capsules of different sizes demonstrated 
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significant disparity in curcumin loading capacities (Figure 5.5) ranging from 0.16 fg per 
capsule of 220 nm (CapC1SP) to 2.15 fg and 23.49 fg, for 270 nm (CapCSP) and 440 nm 
capsules (CapC2SP), respectively.  This indicates that the largest and the medium sized 
capsules can be loaded with ca. 145 and 13 times more curcumin, respectively, than the 
smallest capsules. It also demonstrates that the dosage of drug can be controlled based on the 
initial template employed for capsule fabrication. It should be noted that; if the volume 
capacity of these capsules of three different sizes is considered, their volumes should be in the 
ratio of 1:2:8 for smaller, medium and large size capsules. The disparity between the 
theoretical volume capacity of the capsule cavity (1:2:8) and the actual capsule drug loading 
ability (1:13:145) strongly indicates that, in addition to the curcumin infiltrated in capsule 
cavity, a significant amount of curcumin must also be loading into the capsule wall. 
These results demonstrate that SC/MS templates can be employed to successfully 
fabricate chitosan nanocapsules of three different diameters which, exhibit a variation in 
curcumin drug loading ability over a large dosage range. Furthermore, the drug loading 
capability of these nanocapsules can be tuned through the use of differently sized SC/MS 
template particles. 
5.3.2 Capsules with Different Wall Thickness  
After discovering that there may have been a significant amount of drug loading 
occurring into the capsule wall, an investigation into the relationship between the thickness of 
the capsule wall and the drug loading capabilities was carried out. It is extremely important 
that the effects of the wall thickness are well understood as any additional drug loading due to 
the thickness in the capsule wall will have repercussions on their uses in clinical applications.  
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Referring back to the SC/MS template particles, it was determined that the thickness 
of the mesoporous shell surrounding the solid core silica spheres could be controlled by 
altering the amount of TEOS/TMS mixture that was added to the particles. This in turn was 
expected to alter the wall thickness in the resulting chitosan capsules. In order to investigate 
the effect that the thickness of the mesoporous shells of the SC/MS template has on the 
resulting chitosan capsules, it was required that all other variables were kept as constant as 
possible. To minimise the number of variables, the same medium size solid core developed in 
the previous section (Temp C of diameter 290 nm) was employed here to grow SC/MS 
particles with three dissimilar mesoporous shell thickness, see Figure 5.6. By using the same 
SC/MS particles TempCSP from previous section it is also possible to compare these results 
with results from the other sections.  
Through exposure to varying volumes of TEOS/TMS mixture while keeping a 
constant TEOS:TMS ratio of 5 (Table 5.2), mesoporous shells of three different thicknesses 
were grown around the same medium size solid core (290 nm diameter). Measured from TEM 
images in Figure 5.6, the mesoporous shell thickness increases with an increase in the volume 
of TEOS/TMS mixture, creating SC/MS particles of identically-sized solid cores with 
increasingly different mesoporous shell thicknesses of 31 nm (TempCS1P), 46 nm (TempCSP 
as in section 5.3.1), and 55 nm (TempCS2P), see Figure 5.7. 
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Figure 5.6 TEM images of (A-C) SC/MS silica templates of the same core diameter of 290 nm but 
different mesoporous shell thickness viz. (A) 31 nm, (B) 45 nm, and (C) 55 nm. (D-F) Chitosan 
nanocapsules of three different wall thickness (D) CapCS1P, (E) CapCSP and (F) CapCS2P, 
synthesized using SC/MS templates shown in A-C, respectively. (G-I) show TEM images of 
ultramicrotomed chitosan nanocapsules shown in D-F, respectively. Scale bars correspond to 200 
nm. 
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Figure 5.7: The variation in the thickness of the mesoporous shell of the SC/MS template particles 
when exposed to different volumes of the TEOS/TMS mixture during synthesis. 
To ensure that there were more potential sites in the template shell where the chitosan 
could infuse, BET analysis of the pore size and volume was carried out. As can be seen in 
Figure 5.8A, the pore diameter remains relatively constant at ca. 3 nm, however as the 
mesoporous shell is increased in thickness the pore volume increases proportionally as shown 
in Figure 5.8B. These SC/MS particles of the same core size but with varying mesoporous 
shell thickness were then used to fabricate three types of chitosan nanocapsules, of which it 
was expected to have a corresponding increase in capsule wall thickness.  
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Figure 5.8: A) BET-BJH pore distribution with regards to the templates with various shell 
thickness. B) A representation of the relationship between the mesoporous shell thickness of the 
template and the pore volume and chitosan loading. 
The mass of chitosan that was infused into the templates TempCS1P, TempCSP, and 
TempCS2P was determined by TGA, where the change in weight from the template + 
chitosan, and the template after chitosan has burned off, was measured. The TGA determined 
that the amount of chitosan present per capsule was proportional to the thickness in the 
corresponding templates (Figure 5.8B), with the weight of chitosan polymer loading 
increasing from 65.84, 76.35 to 83.25 mg per gram of silica template with shell thicknesses of 
31, 46 and 55 nm (TempCS1P, TempCSP, and TempCS2P) respectively.  
After TGA was performed, the template particles were removed though selective 
etching to produce the chitosan capsules CapCS1P, CapCSP and CapCS2P. TEM images of 
these capsules were taken in an effort to observe the increase in capsule wall thickness (Figure 
5.7D-F), however, due to extensive shrinkage upon TEM sample preparation and drying, it 
became very difficult to accurately determine the thickness of the walls. To overcome this 
obstacle, ultramicrotomed slices of the three chitosan capsules were obtained and TEM 
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images of thin sections were taken. As can be seen in Figure 5.7G-I there is a noteworthy 
increase in the thickness of the capsules wall with regards to the increase in the mesoporous 
shells of the corresponding templates. By measuring the thickness by this approach, we could 
estimate the relative increase in capsule wall thickness from ca. 28 nm to 45 nm to 56 nm. 
Furthermore, these images confirm the structural integrity of the capsules and show that a 
uniform shell is formed around the fabricated capsules.  
Similar to the previous section, the loading capacity of curcumin/oleic acid into the 
capsules with different wall thickness was again investigated using UV-vis spectroscopy at a 
wavelength of 430 nm. In the case of capsule wall thickness, the loading was found to be 
proportional, with the drug encapsulation increasing from 0.74, 2.16 and 6.87 fg/capsule for 
the thinnest to thickest walls, respectively. This further supports the notion that significant 
amounts of curcumin is being loaded into the cavity wall because if the curcumin was 
primarily in the capsule cavity, the amount of curcumin observed here should have been very 
similar. Although the curcium loading range is not as broad as in the previous section where 
the capsule size was varied, the curcumin loading was still found to be proportional to the 
wall thickness. It can be seen in Figure 5.9(B) that there is a direct link between the drug 
encapsulation and the thickness of the shell of the template that has been used to fabricate the 
capsules.  
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Figure 5.9: A representation of the curcumin loading with regards to A) the shell thickness of the 
template particles B) the three capsule types which have different capsule wall thickness. 
This trend between shell thickness and drug loading suggests that while employing 
nanocapsules for drug delivery applications, it is highly important to consider drug loading 
both within the capsule cavity and its polymeric shell, which is often neglected, and this 
parameter has been shown to be controllable, allowing for further control of the drug dosage.  
Furthermore, this parameter offers a potential secondary site to include more than one 
chemotherapeutic agent using a single drug-delivery platform, wherein a hydrophilic or a 
hydrophobic drug may be conjugated to the capsule wall and another lipophilic drug may be 
loaded within the capsule cavity in a controllable manner.  
5.3.3 Capsules with Different Shell Porosity 
In a third set of separate experiments, the degree of porosity in the mesoporous shell of 
the SC/MS templates was an additional parameter which could be controlled and therefore 
exploited for the synthesis of more structurally unique capsules. Again, the same medium 
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solid core (TempC of diameter 290 nm) was employed; however the ratio of the porogen 
(TMS) to the silica precursor (TEOS) was varied from 0.1 to 0.5 (See Table 5.2) during 
mesoporous shell growth to produce the templates TempCSP1, TempCSP, and TempCSP2. 
This led to fabrication of templates with the same core size (290 nm) and similar mesoporous 
shell thickness (~45 nm), but with variations in the average pore diameter, and in turn the pore 
volume of the mesoporous shell. (Please note that the template TempCSP is the same template 
for the previous two sections, and was made with an intermediate ratio of 0.2 TMS to TEOS). 
TEM images for templates with different porosity levels have not been shown for brevity, as 
the pores are too small to distinguish and as such the TEM images for such templates appear 
identical. Instead, the variation in porosity levels of the silica templates was confirmed by 
BET surface area measurements, as shown in Figure 5.10. In comparison to the previous 
section where pore volume increases while the average pore size remained relatively constant 
(Figure 5.8A), here we see that both the pore volume and the average pore size increase in 
almost a linear fashion in regards to the changes in the ODTMS:TEOS ratio. From these 
results it is reasonable to expect an increase in chitosan loading, and therefore denser chitosan 
capsules which should show the higher curcumin loading in the order of 
TempCSP2>TempCSP>TempCSP1. 
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Figure 5.10: A) shows the BET-BJH pore size distribution of the SC/MS templates with varying 
porosity, and B) describes the changes in pore diameter and pore volume with respect to the TMS 
to TEOS ratio. 
These SC/MS template particles which have demonstrated to have the same core and 
shell diameter but different shell pore diameters (TempCSP1, TempCSP and TempCSP2) were 
employed for a further set of structurally unique chitosan capsules with different levels of 
porosity. As the pore diameter effects the pore volume of the templates, the potential amounts 
of polymer infiltrated into the template for capsule fabrication can be controlled, and as the 
chitosan capsules were created using a templating process, the porosity of capsules is 
expected to be inversely proportional to the porosity of the SC/MS silica templates. Capsules 
prepared using templates with larger pores would allow more chitosan molecules to adsorb, 
thus generating capsule walls of the same thickness but increased chitosan density (Figure 
5.3).  
After template removal, the capsules CapCSP1, CapCSP, and CapCSP2 were produced 
and are displayed in Figure 5.11. Visually it seems that the capsules are becoming denser, 
with more chitosan material present across the capsules CapCSP1, CapCSP, and CapCSP2, 
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respectively. However, to more conclusively demonstrate that more chitosan material was 
present in the various templates shells before template removal, TGA analysis was carried out 
and the difference in weight was correlated to the amount of chitosan loading.   
 
Figure 5.11: TEM images of chitosan nanocapsules of different porosity levels (A) CapCSP1, (B) 
CapCSP and (C) CapCSP2, synthesized using SC/MS templates TempCSP1, TempCSP and 
TempCSP2, respectively. Scale bars correspond to 200 nm. 
TGA analysis revealed that as the pore volume of the mesoporous shell template 
increases from 0.13 to 0.27 and 0.33 mL g
-1
, the weight of chitosan infiltrated within the 
template rose from 47.11, 76.35 to 81.26 mg per gram of silica template, respectively (Figure 
5.12B). This supports the notion that different levels of porosity have been achieved in 
chitosan nanocapsules as the use of a mesoporous template produces inverse capsule. This is 
also further supported from the comparison of TEM images shown in Figure 5.11 where 
chitosan capsules with lowest loading (highest porosity) have significantly more folds and 
creases (Figure 5.11A) in comparison to other capsules, while the ones with lowest porosity 
(Figure 5.11C) appears well-formed and structurally rigid.  
A B C
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Figure 5.12: A representation of the chitosan and curcumin loading in regards to A) the TMS to 
TEOS ratio used, and B) the pore volume of the templates. 
The amount of chitosan present in the SC/MS template particles has also demonstrated 
an effect on the curcumin drug loading capacity, with a close correlation between the pore 
volume and the chitosan loading. This indicates that there is at least some drug binding 
occurring onto the chitosan material as the capsules CapCSP1, CapCSP and CapCSP2 possess 
very few structural and functional differences from one another, meanwhile their drug loading 
capability are quite dissimilar, ranging from 0.851 to 4.507 fg per capsule. It is also plausible 
that the capsules with the denser wall (CapCSP2) have a greater ability in retaining the 
encapsulated drug due to lower porosity, whereas the other capsules could undergo a small 
amount of leakage. 
This controllable property of porosity is highly advantageous as it might allow for 
tunable diffusion and release kinetics of an incorporated drug, with denser capsules taking 
much longer to break down, allowing enough stability to reach a target site before drug 
delivery. Similar to a controllable capsule wall thickness, the controllability in the density of 
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the capsule wall also offers the potential of dosage control of a secondary drug if conjugated 
to the polymer material before capsule synthesis. 
5.3.4 Cellular Uptake and Cytotoxicity of Curcumin-loaded Chitosan 
Nanocapsules 
All types of chitosan nanocapsules which have been described throughout this chapter 
which possess the various structural characteristics of capsule size, capsule wall thickness and 
porosity, have been investigated and their chemotherapeutic cytotoxicity and efficiency 
against P815 mouse mastocytoma cells (leukemia cell line) was determined. As stated in the 
previous chapter, for comparative investigations the number of capsules between capsules of 
different type was kept constant, and the method of quantifying the number of capsules is 
outlined in Appendix 5.6.2. Although this method of quantification was exposed to potential 
error, it was the only possible method for comparison between capsule types, and therefore 
was deemed acceptable. Before the cytotoxicity studies were undertaken, the uptake of the 
chitosan capsules by P815 mouse mastocytoma cells was first determined. Confocal 
microscopy confirmed that there was a significant uptake of chitosan nanocapsules into the 
cells which can be seen as the fluorescent signal in Figure 5.13. 
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Figure 5.13: (A) Fluorescent and (B) an overlay of fluorescent and phase contrast image, showing 
cellular uptake of chitosan nanocapsules by P815 mast cells, as obtained by confocal microscopy. 
Scale bars correspond to 20 µm. 
After capsule internalization into a cell, the enzymes present in lysosomes are known 
to be able to breakdown the cross-linked chitosan capsule wall to release the drug inside to 
cause a measurable and unique cytotoxic effect, therefore all the different types of chitosan 
capsules (CapCSP, CapC1SP, CapC2SP, CapCS1P, CapCS2P, CapCSP1 and CapCSP2) were 
tested through the incubation of i) pristine, chitosan only capsules, and ii) curcumin-loaded 
chitosan capsules over a 24 hour period, and the percentage of live cells that remained after 
treatment were counted.  
On exposure to the pristine curcumin-free chitosan capsules, it was found that the 
capsules were highly biocompatible, showing negligible cytotoxicity with more than 95% cell 
viability on exposure to 750 capsules per cell, which slightly reduced to more than 85% on 
exposure to 1000 capsules per cell (Figure 5.14). Conversely, all types of curcumin-loaded 
capsules caused 95-100% cell death on exposure to less than 1000 capsules. The following 
investigations found that the minimum number of capsules required to cause >95 % cell death 
varied with the type of capsule used, wherein capsule size was found to show the most 
influential effect on toxicity, followed by porosity and wall thickness.  
The cytotoxicity data displayed in Figure 5.14 corresponds to number of capsules per 
cell and therefore can be used to compare the ability of a single capsule of different type 
towards causing cytotoxicity, while later Figure 5.15 compares the chemotherapeutic 
efficiency of a particular capsule type with regards to amounts of curcumin available to cells 
during exposure to different type of capsules. 
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Figure 5.14: Comparison of the cytotoxicity profile of P815 mouse leukemic mast cells on exposure 
to equivalent numbers of different types of chitosan capsules per cell 
Figure 5.15 suggests that if chemotherapeutic drugs are administered based on the 
lowest number of capsules required to cause cytotoxicity, in the order of decreasing 
cytotoxicity potential, the largest capsule (CapC2SP) outperform all other capsule types, 
where smallest capsule (CapC1SP) show lowest cytotoxicity potential and all other capsule 
types show intermediate effect in the order CapCSP2> CapCS2P> CapCSP> CapCS1P> 
CapCSP1. For instance, comparison of capsule size revealed that while exposure of only 100 
largest size capsules (CapC2SP) per cell is required to cause 100 % cell death, it will require a 
ten-fold higher number of smallest size capsules per cell to cause similar cytotoxicity. This is 
not surprising considering that a large capsule will have significantly higher amount of 
curcumin loading in comparison with a small capsule (23.49 and 0.16 fg per capsules, 
respectively). This is also the case with capsules that have a different wall thickness and wall 
density, with the cytotoxic potency increasing with an increase in capsule wall thickness or 
wall density, which in both cases also corresponds to an increase in curcumin loading.  
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Although these results give us a good idea of how the capsules will behave in clinical 
applications, these results reflect more on the drug loading capacities per capsules rather than 
the efficiency of the capsules. To compare their overall efficacy and to determine which 
capsule parameters display the greatest promise for drug delivery vehicles, the cell viability 
has been represented as a function of curcumin dosage, irrespective of the number of capsules 
required.   
When comparing the overall efficiency of these nanocapsule systems (Figure 5.15), it 
becomes evident that the capsules with the smallest diameter are likely to be most efficient for 
therapeutic applications. This is notable because the overall amount of curcumin present in a 
dose of small capsules to achieve full cell death, regardless of the number required, is 
significantly lower (0.163 pg) than that required in a dose of largest  
 
Figure 5.15: A depiction of the cytotoxicity efficiency of different types of capsules with regards to 
the amount of curcumin present in the specific capsule type 
capsules (2.349 pg). This indicates that only 7% of the drug is required to achieve similar 
cytotoxic effects if smaller size capsules are used for drug delivery applications. 
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Interestingly, if one compares the efficiency of free curcumin molecules with that of 
smallest capsules loaded with curcumin, the latter requires one-sixth of the curcumin to 
achieve 95-100% cell death. In fact, most of the curcumin-loaded nanocapsular systems 
showed higher cytotoxic efficiency over free curcumin. This was as expected as it has been 
demonstrated in the previous chapter 4 that the free curcumin is not as efficient as 
encapsulated curcumin due to its degradation in the aqueous environment.   
The next most influential factor (after capsule size) in controlling chemotherapeutic 
efficiency was found to be the thickness of the capsule wall, as is evident from Figure 5.15, 
wherein thinner capsules (CapCS1P) were found to outperform capsules of medium thickness 
(CapCSP) and capsules with thickest walls (CapCS2P), respectively. In comparison with the 
capsule size and wall thickness, the porosity of the capsule was found to have minimal effect 
on the chemotherapeutic efficiency of curcumin loaded within the capsules of different 
porosities, wherein the capsules of different porosities (CapCSP1, CapCSP and CapCSP2) 
showed very similar chemotherapeutic efficiencies (Figure 5.15). 
From the above discussion, it is clearly evident that all the three factors viz. size, wall 
thickness and wall porosity contribute towards controlling the drug delivery profile of loaded 
curcumin. However, to further confirm that the size of the drug delivery vehicles is indeed the 
most influential factor to enable higher chemotherapeutic efficiency, and where variations in 
the shell thickness and porosity have minimal influence when the size is constant, a histogram 
in the order of their decreasing chemotherapeutic efficiency was plotted. The histogram 
(Figure 5.16) clearly shows that when these parameters are plotted in the order of their 
decreasing chemotherapeutic efficiency (as derived from Figure 5.15), the only trend that is 
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consistent is that of capsule diameter. Both the shell thickness and pore diameter show no 
linear relationship with the decrease in efficiency as the plot moves to the right. This suggests 
that amongst different structural characteristics of a nanocapsule-based drug carrier system, 
size of the nanocapsules is likely to play the most important role in dictating the 
chemotherapeutic efficiency of such systems. 
 
Figure 5.16: Experimental conditions for the synthesis of meosporous shell of  
SC/MS silica template particles. 
5.4 Conclusion 
It has been demonstrated for the first time that the structural characteristics of chitosan 
nanocapsules such as capsule size, wall thickness and wall porosity can be fine-tuned in a 
facile manner by simply controlling the structural characteristics of the SC/MS template 
particles without varying the chemical characteristics of the capsules. Studies into the effect of 
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size on a capsule’s drug loading and cell toxicity characteristics have been previously 
investigated.
19,40
 However, to the author’s knowledge there are currently no reports in which 
the three interconnected characteristics of capsule size, wall thickness and porosity have been 
investigated in a single, comprehensive study. The loading of seven types of chitosan capsules 
possessing different structural features (e.g. nanocapsule diameters ranging from ca. 220 to 
440 nm, nanocapsule shell thickness ranging from ca. 31 to 55 nm, and pore diameter varying 
from 2.9 to 5.1 nm) with curcumin, a lipophilic anticancer drug, enabled us to correlate the 
effect of these structural features of chitosan nanocapsules with their anticancerous efficiency. 
These investigations revealed that by controlling the structural characteristics of chitosan 
nanocapsule, the amount of curcumin loading within these capsules can be controlled between 
ca. 0.2 to 23.5 fg per capsule. The pristine chitosan nanocapsules were found to be 
biocompatible and interestingly, the capsules with the smallest diameter (220 nm) were found 
to be six times more efficient for cancer therapy in comparison with equivalent amount of free 
curcumin. This suggests that encapsulation of water-intolerant drug molecules such as 
curcumin within chitosan capsules provides a significant opportunity to achieve higher 
efficiency of existing chemotherapeutic drugs. Most importantly, this study establishes an 
important finding in the field of nanocapsule-based drug delivery systems that although 
several structural characteristics of a nanocapsule might be responsible in influencing their 
efficiency as a chemotherapeutic carrier, size of the nanocapsules is likely to play the most 
important role in dictating the chemotherapeutic efficiency of such systems. This finding will 
generate new exciting opportunities for designing drug delivery vehicles for a range of 
therapeutic applications.  
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5.6 Appendix 
5.6.1 Tabular summaries of the silica template particles and chitosan 
nanocapsules fabricated  
 
Table 5.4: A summary of the structural characteristics of the SC/MS silica template particles 
fabricated throughout the chapter. 
  
Template Description
Core Size 
(nm)
MP Shell 
Thickness (nm)
Surface Area 
(m²  g
-1
)
Pore Size in 
Shell (nm)
Pore Volume 
(mL g
-1
)
TempC1 Small diameter 170 ± 12 - 25.86 - -
TempC Medium Diameter 290 ± 24 - 14.37 - -
TempC2 Large Diameter 490 ± 14 - 8.50 - -
TempC1SP
Medium Diameter, Medium Shell 
Thickness, Medium Pores Size
290 ± 24 46 ± 7 252.6 3.68 0.27
TempCSP
Small diameter, Medium Shell 
Thickness, Medium Pore size
170 ± 12 49 ± 16 300.0 5.12 0.44
TempC2SP
Large Diameter, Medium Shell 
Thickness, Medium Pore Size
490 ± 14 42 ± 13 164.2 3.30 0.16
TempCS1P
Medium Diameter, Small Shell 
Thickness, Medium Pores Size
290 ± 24 31 ± 21 144.1 3.83 0.16
TempCS2P
Medium Diameter, Large Shell 
Thickness, Medium Pores Size
290 ± 24 55 ± 12 308.7 3.33 0.30
TempCSP1
Medium Diameter, Medium Shell 
Thickness, Small Pores Size
290 ± 24 42 ± 9 184.0 2.90 0.13
TempCSP2
Medium Diameter, Medium Shell 
Thickness, Large Pores Size
290 ± 24 48 ± 14 253.1 4.85 0.33
Solid Cores
Solid Cores , Mesoporous  Shell
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Table 5.5: A summary of the structural characteristics and loading capabilities of the chitosan 
nanocapsules fabricated throughout the chapter.  
Capsule Description
Capsule 
Diameter (nm)
Shell Wall (nm)
Chitosan Loading     
(mg g-1)
Curcumin Loading     
(fg/capsule)
CapCSP Medium Diameter, Medium Wall 
Thickness, Medium Porosity
270 45 76.35 2.155
CapC1SP
Small Diameter, Medium Shell 
Thickness, Medium Porosity
220 47 97.73 0.163
CapC2SP
Large Diameter, Medium Wall 
Thickness, Medium Porosity
440 40 73.36 23.492
CapCS1P
Medium Diameter, Thin Wall 
Thickness, Medium Porosity
235 28 65.84 0.748
CapCS2P
Medium Diameter, Thick Wall 
Thickness, Medium Porosity
325 56 83.25 6.870
CapCSP1
Medium Diameter, Medium Wall 
Thickness, High Porosity
269 40 47.11 0.851
CapCSP2
Medium Diameter, Medium Wall 
Thickness, Low Porosity
283 42 81.26 4.507
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5.6.2 Quantifying of the number of capsules 
As used in the previous chapter, the number of capsules was quantified by calculating 
the relative number of silica template particles based on the number of large spheres counted 
by a sample method. After the number of large particles was known, this value could be used 
to calculate the number of the other templates. As the diameters of the spheres were known, 
their volumes could be calculated and used to estimate the relatively number of particles in 
the samples of  templates with three different core sizes (where the silica source/mass of 
particles fabricated was constant but the number of particles produced varied with size). 
Furthermore, as the weights of the samples varied greatly after the mesoporous shell growth, 
these values had to be recalculated and recalibrated to take into account the new weights. This 
was achieved by measuring the templates before and after shell growth. The number of 
capsules could then be correlated back to the weight of the templates that were used during 
capsule fabrication so that drug loading and toxicity could be represented with regards to a 
single capsule.  
As stated in the previous chapter, this method of quantification allows for potential 
error to occur, however as there was no other method of counting the number of particles 
required for a sufficient comparison of the capsule types, the method and its potential error 
was accepted. 
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CHAPTER 6 
CONCLUSIONS 
 
 
 
This chapter provides a summary of the key findings of this thesis, and also elaborates on the 
potential for future work. 
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6.1 Summary of Accomplished Work 
Although current cancer treatments help to reduce or eliminate cancerous cells from 
the body, they are not always effective, efficient and often cause adverse side effects. For 
example, chemotherapeutic drug do not greatly differentiate between healthy and cancerous 
cells, consequently they attack both types and cause systemic toxicity. Furthermore, the free 
circulating drug molecules are often rapidly eliminated from the body before carrying out 
their desired function.  
Drug delivery systems (DDS) which confine an anticancerous drug within a carrier 
vehicle have proven enhanced cell toxicity, targeting, and retention time in the body, with 
fewer adverse side effects to the patient.
1,2
 The aim of this thesis was to develop a DDS with 
improved structural and physio-chemical characteristics that could impose the desired 
cytotoxic effects ideal for cancer therapy applications. This was achieved through the 
fabrication of drug-loadable polymeric nanocapsules by employing monodispersed silica 
nanoparticles with tunable physico-chemical properties as templates.  
Before the capsules were fabricated, fine control over the size and monodispersity of 
the silica template particles was established. To achieve this control, the effects of solvent, 
temperature, ammonia and water concentration on silica nanoparticle synthesis were 
investigated through single variable experiments, where it was determined that the solvent and 
temperature had major influences on the rate of particle nucleation, while the ammonia and 
water concentrations effected the reaction mechanisms in a dynamic and complex manner. An 
Artificial Neuron Network (ANN) was then applied to simulate the effects of these 
experimental parameters over a more comprehensive, 3-dimensional parameter range. Using 
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additional, multivariable experiments, a forecasting model of particle size with regards to 
temperature, ammonia and water concentration was generated. When compared with the 
single experimental results the forecast model was found to be relatively accurate, and allows 
for the prediction of the approximate experimental conditions required for the fabrication of 
silica template particles of a defined size.  
These silica nanoparticles were then used as sacrificial templates to generate 
polymeric nanocapsules. The two template-facilitated fabricating approaches SC/MS and LbL 
were employed along with the polymers chitosan, poly(allylamine hydrochloride), 
poly(sodium 4-styrenesulfonate) to generate four unique capsules. The capsules fabricated 
using the SC/MS approach demonstrated an increased amount of polymer loading and 
increased capsule wall thickness, while also undergoing less aggregation when compared with 
the capsules fabricated using the LbL approach. Although it was found that the drug loading 
capability was found to be influenced by the polymeric material, the cytotoxicity efficiency of 
the capsules was predominantly governed by the degree of aggregation that occurred on 
exposure of capsules to mammalian cells. It was found that the combination of chitosan and 
the SC/MS fabrication method generated the capsules with the most desirable characteristics 
for a drug delivery system, warranting further investigation.   
The SC/MS templates in combination with chitosan polymer were further adapted to 
fabricate seven structurally unique chitosan nanocapsules. Three sizes of the solid core of the 
SC/MS templates were fabricated based on previous investigations into experimental 
condition and silica size, to produce chitosan capsules with three different internal diameters. 
The shell thickness and porosity of the mesoporous shell of the templates were also modified 
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to create capsules with dissimilar capsule wall thicknesses and porosities. The effect of the 
structural changes in the template on the physio-chemical characteristics of the capsules such 
as polymer loading, drug loading, and cytotoxic efficiency against P815 mastocytoma cells 
was investigated. It was found that, although the amount of drug loading was proportional to 
the capsule size and wall thickness, it is the decrease in capsule diameter that increases the 
capsule’s cytotoxic efficiency. 
Through systematic investigation, a highly controlled, chitosan-based nanocapsular 
drug delivery system has been developed for the first time. Through a template assisted 
approach that demonstrated improved results, the fabrication of robust, near monodispersed, 
chitosan-based nanocapsules with a variety of structural and physio-chemical characteristics 
have been successfully generated. This thesis illustrates that through the modification of 
SC/MS template particles, nanocapsules can be turned based on their required properties such 
as capsule polymeric material, size, shell thickness, porosity, drug loading capability and 
cytotoxic efficiency, with the intention of applying these materials in future cancer therapies. 
6.2 Possible Future Endeavours 
Considering the vast possibilities that the work contained within this thesis could be 
applied to, a select number of suggested investigations for the future have be briefly 
discussed.  
The SC/MS template-facilitated approach to nanocapsule synthesis can be applied to 
any ionic polymeric material which is below the dimensions to be able to infiltrate the pores 
of the template shell. As a result, it would be worthwhile fabricating nanocapsules of a 
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negatively charged polymer such as poly(L-glutamate), and investigating the effects of a 
negatively charged nanocarrier on its ability to act as a DDS.  This may have important 
implications in drug delivery as cell membranes are negatively charged.
3,4
 It would be 
interesting to study that whether negatively charged capsules will show reduced uptake due to 
electrostatic repulsion or the polymeric charge would not significantly influence capsule 
uptake, as endocytotic forces may dominate over electrostatic forces. It was indeed observed 
previously that physical form of polymer may have significant influence on their biological 
uptake profile.
5
   
Another very advantageous endeavour with the presented drug delivery system would 
be to conjugate targeting ligands or antibodies onto the surface of the capsules to enhance 
specific uptake by tumour cells. Furthermore, non-fouling polymers such as polyethylene 
glycol (PEG) can also be conjugated to the surface to improve the stealth characteristics and 
increase retention time. Once again, the endocytotic cellular uptake profile of nanocapsules 
post-functionalization with targeting ligands or non-fouling polymers may be very different 
than those of non-modified systems.
6
  
Finally, the incorporation of additional materials such as magnetic nanoparticles or 
fluorescent quantum dots into the template particles could lead to the development of 
multifunctional drug delivery systems. The combination of these materials would result in a 
controllable drug delivery system that would demonstrate enhanced targeting and imaging 
capabilities for theranostic (therapy and diagnostic) applications.  
There remain many more fabrication methods and materials which could offer 
advantages over the drug delivery system presented in this thesis, but it is hoped that the 
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knowledge generated in this thesis contributes to the ongoing research in finding an effective 
tool in the fight against grievous illnesses like cancer.  
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